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DISSECTING THE FUNCTIONAL HETEROGENEITY OF SEROTONERGIC 
SYSTEMS THAT REGULATE FEAR AND PANIC 
Serotonin (5-HT) is heavily implicated in severe anxiety and trauma-related disor-
ders, such as panic and post-traumatic stress disorders. Overall, site-specific pharmacolog-
ical manipulations show that while 5-HT enhances anxiety-associated/avoidance behaviors 
in the amygdala, 5-HT inhibits panic-associated escape behaviors in the perifornical hypo-
thalamus region (PeFR). Yet, our understanding of how specific serotonergic networks and 
co-transmitters regulate these conditions, but also other aspects of innate panic (e.g., car-
dioexcitation or thermal response that occur during a flight or escape response) or condi-
tioned fear behaviors is still elusive. Therefore, utilizing circuit-based gain- and loss-of-
function approaches to selectively manipulate amygdala- and PeFR-projecting sero-
tonergic systems, we hypothesize that specific serotonergic networks projecting to the 
amygdala and PeFR respectively enhance conditioned fear responses and attenuate innate 
panic-associated behaviors and physiological responses. There are two main chapters in 
this dissertation. In Chapter III, retrograde tracing revealed that the amygdala-projecting 
neurons from dorsal Raphe (DR) were almost exclusively serotonergic (92-95%) concen-
trated in the dorsal/ventral (DRD/DRV) DR, with few non-serotonergic neurons. While 
selective lesioning of this network with saporin toxin (SAP) facilitated the extinction of 
conditioned fear behavior, selective optogenetic activation of amygdala-projecting 
DRD/DRV cell bodies using intersectional genetics reduced extinction of conditioned fear 
behavior and enhanced anxiety avoidance. In Chapter IV, retrograde tracing showed that 
the PeFR was innervated by equally selective serotonergic networks concentrated in the 
vi 
lateral wings DR (lwDR) and median Raphe (MR). Contrasting with the results from the 
amygdala-innervating 5-HT system, lesioning the PeFR-projecting serotonergic network 
from lwDR/MR was accompanied by reduced extinction of conditioned fear behavior, in-
creased anxiety avoidance, and increased CO2-induced panic (elevated escape responses 
and enhanced cardioexcitation). Conversely, selective activation of lwDR/MR serotonergic 
terminals in the PeFR decreased anxiety-associated behaviors; inhibited CO2-induced 
panic, and induced unconditioned and conditioned place preferences. The circuit-based ap-
proach data presented here show that amygdala- and PeFR-projecting 5-HT neurons com-
prise distinct circuits underlying opposite roles enhancing anxiety/fear responses in the 
amygdala and dampening fear/panic responses in the PeFR. The identification of distinct 
circuits controlling anxiety, fear, and panic responses is a fundamental step towards the 
development of more effective therapies for psychiatric conditions such as anxiety and 
trauma-related disorders. 
Theodore R. Cummins, PhD, Chair 
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1. Chapter I: Introduction 
1.1. Establishing Operational Criteria to Evaluate Emotion States 
The neuroscience field is experiencing an ongoing revolution of molecular tools 
that are allowing researchers to interrogate the function of neural circuits and their contri-
bution to various physiological and behavioral processes in laboratory animal models. 
Amongst these processes, perhaps the most controversial and elusive is emotion and be-
havioral responses that potentially indicate emotional responses. Even though it might 
seem simple and obvious when one examines emotion introspectively, emotion still re-
mains scientifically challenging to define in objective terms. Although many proposals 
have failed to reach a consensus definition for emotion, removing this term as suggested 
by LeDoux (2012) does not solve the problem of how to study and compare the fundamen-
tal aspects of animal and human emotions. 
From an anthropomorphic perspective, emotions are referred by many psycholo-
gists and neurobiologists (Barrett et al., 2007; Barrett and Russell, 1999; Russell, 2003; 
Salzman and Fusi, 2010; Scherer, 2009) as experiences that lead to the subjectively de-
scribed “feelings” in humans. Expanding from these authors standpoint, any given inter-
nal/external stimuli would lead to a combination of different responses (i.e. cognitive, mo-
tivational, somatic, motor, and autonomic) and ultimately converge into an emotional ex-
perience that is knowingly voiced by humans as feelings. Yet, with animals only behavior, 
somatic, and visceromotor responses are measurable. Many argue that since these feelings, 
such as fear, can only be assessed by verbal report, they cannot be extended to and studied 
in other non-human mammals due lack of such spoken language. Going further, because 
of the direct connection between emotional response and feelings described above, it has 
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been proposed that emotions are also anthropomorphic experiences and could not be stud-
ied in any other animal other than humans (LeDoux, 2012). 
However, what if emotions were cause, instead of merely consequences as de-
scribed above, of externally observable behaviors, cognitive, somatic, and autonomic re-
sponses, as proposed by Anderson and Adolphs (2014)? This was first recognized by 
Darwin (1872) in his assay about The Expression of the Emotions in Man and Animals. He 
suggested that some physical manifestations of emotional expressions are shared from a 
functional and evolutionary perspective and could be easily recognized across mammal 
species, as illustrated in Figure 1. However, Darwin did not provide an operational criteria 
for identifying the emotional expressions described in his work other than his own intui-
tions. Providing consistent, operational criteria is essential when suggesting that emotions 
are a conserved feature across the species. 
From Anderson and Adolphs’ perspective, 
“…emotion constitutes an internal, central (as in central nervous system) 
state, which is triggered by specific stimuli (extrinsic or intrinsic to the or-
ganism). This state is encoded by the activity of particular neural circuits 
that give rise, in a causal sense, to externally observable behaviors, as well 
as to associated cognitive, somatic, and physiological responses” (Anderson 
and Adolphs, 2014). 
This perspective is illustrated in Figure 2. 
 
Figure 1 – Emotional expressions across species. Fear expression in a human (A), chim-
panzee showing disappointment (B), and hostility in a cat (C) and a dog (D). From Darwin 
(1872). 
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Because species as whole evolve through the course of generations, so do their 
brains and neuronal circuits. Therefore, there may be emotional states that are unique to 
humans, such as social or moral emotions underlying pride and embarrassment (Tangney 
et al., 2007). The focus here, however, are primitive emotional states (e.g. fear, panic, re-
ward, anxiety, amongst others) elicited by conserved neuronal circuits and expressed by 
measurable behaviors and physiological changes, rather than idiosyncratic emotions that 
may be particular to one or other species with higher complexity in the phylogeny tree. 
In an attempt to provide operant criteria to delineate central emotions, Anderson 
and Adolphs laid out four different features that are common to different emotional re-
sponses across species, namely: scalability, valence, generalization, and persistence 
(Anderson and Adolphs, 2014). Even though scalability mean the intensity of a given re-
 
Figure 2 – Model of the causal relationship between emotions and behavior. Stimuli (ex-
teroceptive and interoceptive) perceived by the subject induces activation of specific neural 
circuits (central emotion state), which in turn causes multiple parallel responses, including 
subjective feelings in humans. Note that in this model, central emotion states produce sub-
jective feelings in parallel with behavioral and somatic responses in humans. Modified 
from Anderson and Adolphs (2014). 
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sponse, a good example for the first feature would also be the qualitatively different defen-
sive responses of a mouse (prey) when facing a rat (its natural predator). At a safe distance, 
the mouse displays freezing behavior so it can avoid being detected, but as the rat gets 
closer, this freezing behavior qualitatively shifts into flight or, as a last resource, fight to 
avoid predation (Blanchard et al., 1998). Moving on, while valence would simply state to 
the value (positive or negative) of a given emotion, the generalization allows the individual 
to display the same response over different stimuli across different environments, such as 
the responses observed in the classical Pavlovian fear conditioning (Davis, 1992). In this 
case, repeated pairings between conditioned neutral (tone) and unconditioned aversive 
(shock) stimuli can evoke a measurable behavior (freezing) even after unpaired tones 
presentations. The last feature, persistence, is in regards to the fact that emotional responses 
typically outlast the stimuli that evoked them. Using the conditioned response example 
given above, the freezing or risk assessment behaviors observed in mice typically remain 
for a while even when the aversive stimulus goes away. 
Utilizing the definition of emotions as a type of central neural state elicited by sen-
sory stimuli that in turn control various behavioral, cognitive, somatic, motor and auto-
nomic responses (Figure 2), we can objectively explore evidences of emotional states in 
animal models by directly manipulating specific neuronal circuits of interest. Even though 
each correlate of primitive emotional states observed in less complex animals very likely 
differ from those described by humans, there is still a significant overlap between the neural 
circuits underlying the emotional states. Therefore, there will be instances in this disserta-
tion where I will refer to the collection of responses observed in rats with the terms often 
used to describe human emotions, such as anxiety (i.e., worry or apprehension), fear to a 
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potential imminent threat, or panic to an imminent threat. This should not be taken as con-
ceptual mistake, carelessness, nor interpreted as an attempt to anthropomorphize rodents’ 
behavior, but rather as a reference to primitive emotions shared across the species to deal 
with different temporal or distal threats. 
 
1.2. The Predatory Imminence Continuum Theory 
In an ethological context, threats are typically situations where an encounter be-
tween prey and predator may occur depending on the distance between these two. It was 
the ethological perspective of life-threatening encounters between prey and predators that 
led Robert Bolles to start developing the “Predatory imminence” or “predatory imminence 
continuum” theory (Bolles, 1970). This theory was modified over the years to adjust to 
empirical observations and criticism (Bolles and Riley, 1973; Fanselow et al., 1987), and 
it was later seen as a collection of hierarchically organized behavioral responses, also re-
ferred as defensive responses, according to the level of threat that the animal was perceiv-
ing to be in (Fanselow and Lester, 1988; Fanselow, 1994). Based on factors such as the 
distance and likelihood of meeting a predator and routes for escape, three general stages 
were proposed based on behavioral observation: pre-encounter, post-encounter, and circa-
strike (Fanselow and Lester, 1988; Fanselow, 1986). 
The first stage, pre-encounter, is typically observed when the animal is foraging 
before a predator has been identified. Experimentally, some argue that shocks can be com-
monly used as an aversive stimulus that can represent the risk of a predator. Therefore, by 
varying the amount of shocks given to rats prior to offering food, one can manipulate the 
perceived predatory imminence (Fanselow and Lester, 1988; Fanselow et al., 1988; 
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Helmstetter and Fanselow, 1993). Depending on the predatory imminence, the animal can 
display increased vigilance and arousal, as well as different foraging patterns. For instance, 
when a perceived threat is low (none to only a few shocks), rats tend to spend more time 
foraging and consuming food while being exposed at the food source. On the other hand, 
when the threat increases (several shocks) rats may decrease time spent foraging at the 
source while bringing a significant amount of meals to the safety of a nest (Fanselow and 
Lester, 1988; Fanselow et al., 1988; Helmstetter and Fanselow, 1993). 
The second stage, post-encounter, is activated when the threat is identified at a dis-
tance. Here, the behavioral responses will directly depend not only on the species, but also 
on the type and distance that the threat is from the animal. Threatening stimuli cause on-
going behaviors to cease, and the most common observed behaviors encompass freezing, 
fleeing, or threatening (Blanchard et al., 2011; Bolles, 1970). In rats, however, freezing is 
typically seen even when escape routes are available (Blanchard et al., 2011; Fanselow and 
Lester, 1988; Fanselow, 1986). Freezing is a passive defensive response and even though 
it might look simple, it is a powerful avoidance strategy that reduces motion and visibility, 
thus decreasing the likelihood the prey will be detected by the predator. Freezing can de-
crease threat imminence since predators typically use motion to keep track of their prey 
(Suarez and Gallup, 1981). On a side note, contextual conditioning may occur during sub-
sequent encounters with the predator in the same context, which in turn can evoke freezing 
responses even in the absence of the threat (Canteras, 2003). 
The last stage is circa-strike, which initiates when the predator has started the pur-
suit towards the prey and is ready to strike. In this case, the predator imminence is the 
highest, and the typical active defensive behavior observed in rats is fleeing (e.g. jumping 
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and running) if escape is available, but also vocalization and, less frequently, fighting if 
there is no escape (Blanchard et al., 1998; Fanselow and Lester, 1988; Fanselow, 1986). 
 
1.3. Anxiety, Fear, and Panic in Rodents and the Predatory Imminence Continuum Hy-
pothesis 
The predatory imminence continuum hypothesis explained above encompasses a 
group of orchestrated behavioral responses that can help illustrate the concepts of anxiety, 
fear, and panic. Depending on the source, intensity, and duration, intero and exteroceptive 
stimuli can initiate specific sets of measurable behavioral (e.g. passive versus active defen-
sive responses), physiological, hormonal, and autonomic responses. Example of these re-
sponses are increased heart rate (HR), stress hormone secretion, restlessness, vigilance, 
avoidance of potentially dangerous environments, freezing, and decreased feeding/explor-
atory behavior, and fleeing responses. Collectively these terms are often used to infer anx-
iety, fear, or panic in pre-clinical research (Anderson and Adolphs, 2014; Davis et al., 2010; 
LeDoux, 2014, 2000).  
Past research emphasized that these emotional states are particularly controlled by 
well-defined synaptic and neuromodulatory processes within identified brain regions. 
However, emerging evidences indicate that these emotional states correspond to the func-
tional states of defined neuronal circuits not only within, but also between various brain 
regions that have been implicated in anxiety, fear, and panic. The neural basis of these 
emotional states will be discussed in the section 1.5 below. 
Amongst those three emotional states, perhaps the distinction between anxiety and 
fear is the most tenuous, yet they differ in terms of key dimensions. In particular, anxiety 
8 
is often evoked by less predictable and specific threats, or even by specific threats that are 
physically distant and do not pose immediate risk to the bearer. Typically associated with 
increased vigilance and arousal, anxiety is best described as a future oriented emotional 
state encompassing a set of mild measurable behavioral, physiological, hormonal, and au-
tonomic responses that are triggered by potential or distal threats. Consequently, anxiety is 
a more long-lasting emotional state (Davis et al., 2010) that can be applied to situations 
similar to those described in the first stage (pre-encounter) of the predatory imminence 
continuum, often evoking avoidance and increased vigilance. On the other hand, fear is 
generally an adaptable emotional state measurable by moderate levels of behavioral, phys-
iological, hormonal, and autonomic responses to tangible threats that are detected or 
evoked by sensorial stimuli. Fear is able to begin and dissipate rapidly according to the 
duration of the threat presentation (Davis et al., 2010), events similar to those observed in 
the post-encounter stage. Here, the signature features are freezing, moderate cardioexcita-
tion, and stress hormone response. Lastly, panic, frequently referred to “fight-or-flight” 
responses, is unquestionably the most intense emotional state of the three. It leads to intense 
activation of the responses described above due imminent confrontation (circa-strike) with 
a predator or conspecific confrontations in situations that pose a life-threatening danger 
(Blanchard and Blanchard, 1990; Blanchard et al., 1998). Figure 3 illustrates the associa-
tion between anxiety, fear, and panic and pre-encounter (green), post-encounter (brown), 
and circa-strike (red), respectively. 
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Around the same time the “predatory imminence continuum” theory was proposed, 
Caroline and Robert Blanchard observed that wild rodents displayed a very similar pattern 
 
Figure 3 – Adaptive innate behaviors in response to threat. Schematic illustration showing 
the association of specific behaviors (at the bottom) observed in rodents and emotional 
states (top) when facing a threat (predator). Green, brown, and red colors in the illustration 
respectively represent pre-encounter, post-encounter, and circa-strike stages described in 
the text above. Dashed line represents increasing level of threat. 
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of defensive repertoire that depended upon the presence and distance of a predator 
(Blanchard and Blanchard, 1988, 1989). According to these authors, the behaviors could 
be organized into three different levels of defense reactions. The first, defined as risk as-
sessment, takes place when there is a potential unidentified danger. Rats would extend their 
heads out of a tunnel into the open area and make scanning head movements and occasional 
stretching and approaching before foraging was initiated. The second level would be ob-
served in the presence of a predator in a distance without any immediate danger. Here, rats 
often displayed freezing, ceasing all previously ongoing behaviors even in the presence of 
an escape route. Lastly, when the encounter between prey and predator was imminent, 
flight was always observed whenever an escape route was available, and defensive fight 
took place as a last resource when contact was inevitable (Blanchard et al., 1993, 1986). 
 
1.4. Anxiety, Fear, and Panic in Humans: Anxiety Disorders 
Anxiety, fear, and panic elicit orchestrated defensive behavioral and physiological 
responses that have evolved to enable the organism to avoid or reduce harm and thus ensure 
its survival. Given their importance to survival, it is not surprising that these emotional 
states evoke a similar set of responses across the species. The presence of shared and con-
served traits also implies that predatory threat is pervasive and present throughout evolu-
tionary time (Nonacs and Dill, 1993). 
A question that arises though is where the boundary lies between evolved function 
and dysfunction. From the evolutionary perspective, a mechanism is working functionally 
if the responses it produces maximize survival for the individuals as a population. How-
ever, when anxiety, fear, or panic become pathological (i.e. excessive for the current 
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stressor, present in the absence of a stressor, or leads to significant distress or disability), 
these emotional states lead to huge suffering and disability that can markedly disrupt family 
life as well as the life of the sufferer. 
According to the Diagnostic and Statistical Manual of Mental Disorders fifth edi-
tion (DSM-V), anxiety disorders are classified as a group of mental conditions character-
ized by significant feelings of anxiety and fear [American Psychiatric Association and 
(APA), 2013]. In humans, anxiety can be perceived as worry about future events, whereas 
fear and panic, much like in animals, are respectively moderate and strong reactions (emo-
tional, physical, and physiological) to current events (APA, 2013). These events can be 
perceived as external (or exteroceptive, e.g. social situations) or internal (or interoceptive, 
e.g. bodily sensations) threats. 
With a high lifetime prevalence estimate in the United States of approximately 31% 
(Baxter et al., 2013), anxiety disorders constitute the largest group of mental disorders and 
are a leading cause of disability in most countries of the western society (Forouzanfar et 
al., 2016; Haro et al., 2013; Wittchen et al., 2011) that rarely undergo spontaneous remis-
sion (less than 23% of the cases) (Bittner et al., 2004; Wittchen et al., 2000). It has been 
estimated that more than $42 billion dollars a year in the U.S. (Greenberg et al., 1999) and 
$74 billion euros in Europe (Wittchen et al., 2011) were attributed to indirect costs such as 
disability for individuals and their families suffering from anxiety disorder. 
On the basis of the clinical picture, anxiety disorders can be divided into seven main 
psychiatric diagnostic subtypes: generalized anxiety disorder, specific phobia, social anxi-
ety disorder, separation anxiety disorder, agoraphobia, panic disorder (PD), and selective 
mutism. Because anxiety disorders are a diverse group of conditions, different vulnerability 
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and risk factors have been particularly implicated in promoting dysfunctional anxiety in 
different conditions. However, female sex, family history of anxiety, and early-life stress 
are common factors that can predispose or increase the chances of one having any of those 
anxiety disorders and thus deserve special attention. 
 
1.4.1. Vulnerability and Risk Factors for Anxiety Disorders 
Women are almost twice as likely as man to develop any type of anxiety disorders. 
Even though almost no differences between sexes are observed during childhood, they start 
developing during this phase and peak at adult stage (Costello et al., 2016; McLean et al., 
2011). While the reasons for this increased risk are still debatable, it seems that women 
differ from men in how conditional fear memories are formed and extinguished (Maeng 
and Milad, 2015). The plausible candidates for these difference are the gonadal hormones, 
especially estrogen, which has been shown to be implicated in important processes modu-
lating fear responses, such as neurogenesis, synaptic plasticity, and the expression of re-
ceptors that are key substrates for learning and memory (Cover et al., 2014). For instance, 
augmented levels of estrogen in both female rats and women enhance fear memory 24 
hours after fear learning (Hwang et al., 2015). The amygdala is a good candidate to modu-
late this, since studies in female rats have shown that the central amygdala expresses both 
estrogen receptors  and β (Shughrue et al., 1997; Shughrue and Merchenthaler, 2001), 
and site specific injection of estrogen in the same region facilitated fear conditioning in 
ovariectomized mice (Jasnow et al., 2006). 
Another important predisposition to developing anxiety disorders is heritability. It 
has been shown that children of individuals diagnosed with at least one anxiety disorder 
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have up to fourfold increased risk for developing anxiety disorders at significantly earlier 
stages in life when compared to children with no family history of anxiety disorders (Lieb 
et al., 2002). Some valuable insights regarding a considerable genetic overlap between 
some overall symptoms of different anxiety disorders during adulthood are gathered from 
monozygotic and dizygotic twins studies (Kendler et al., 2011). These studies also estimate 
that the heritability of anxiety disorders range between 30% and 40% (Holmes and 
Singewald, 2013; Kendler, 2001; Shimada-Sugimoto et al., 2015), although some symp-
toms were not shared and seem to differ mainly on disorders characterized by fear (Kendler 
et al., 2003). The specific mechanisms of familial transmission and genetic risk loci, how-
ever, have yet to be established (Otowa et al., 2016). 
Although not applicable to all anxiety disorders, early-life stressful situations such 
as physical, sexual, and emotional abuse (Afifi et al., 2012; Sareen et al., 2013; Taillieu et 
al., 2016), as well as parent’s divorce (Otowa et al., 2014), have been suggested to act as 
predictors for subsequent development of such conditions (Vrshek-Schallhorn et al., 2014). 
More importantly, longitudinal studies have been pointing out that anxiety disorders, with 
special attention to PD, social anxiety disorder, and agoraphobia are important predictors 
for the development of depressive disorders and substance abuse (Wittchen et al., 2000). 
The comorbidity between these conditions is a matter of concern, since it greatly decreases 
the overall quality of life (Kessler et al., 2009) and leads to an increased mortality rate 
(Saeed Mirza et al., 2015). 
Amongst the psychiatric conditions classified as anxiety disorders, of particular im-
portance to this dissertation are PD, agoraphobia, and post-traumatic stress disorder 
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(PTSD). An import note is that although PTSD was listed under the anxiety disorders um-
brella prior to DSM-V classification, this condition is no longer classified as such, being 
moved to adjoining chapter of trauma-related disorders in the DSM-V (APA, 2013). 
 
1.4.2. Panic Disorder 
Panic Disorder (PD) is a severe anxiety disorder which causes significant disability 
and is characterized by recurrent episodes of unexpected panic attacks (PAs). Typically, 
PAs peak within approximately 10 min, have a duration of 25-45 min, and can occur during 
calm or anxious states (de Beurs et al., 1994; Margraf et al., 1987; Taylor et al., 1986) and 
the majority of PAs occur without an identifiable trigger (Shulman et al., 1994). Panic 
attacks are an abrupt surge of four or more of the following psychological and physical 
symptoms (see Table 1), with the most common being pounding heart/tachycardia, dizzi-
ness, and paresthesia. With the typical onset of PD occurring in early adulthood (Reed and 
Wittchen, 1998), the twelve-month and lifetime prevalences estimates of PD in the U.S. 
are 2.7% (J. et al., 2006) and 4.7% (Kessler et al., 2006, 1994), respectively. 
Approximately 50% of PAs in PD patients are considered to be spontaneous since 
they occur in relatively non-threatening and non-agoraphobic contexts (de Beurs et al., 
1994). A remarkable feature of the majority of individuals (60-65%) suffering from PD is 
that PAs can be precipitated upon hypertonic (0.5 M) sodium lactate (NaLac) infusions 
(Liebowitz et al., 1985, 1984), or breathing air with higher (>5%) carbon dioxide (CO2) 
concentrations (Gorman et al., 1994). These challenges typically do not elicit PAs in 
healthy controls. Therefore, the initial pathology in PD patients can be conceptualized as 
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an alteration in the central neural pathways such that a maladaptive panic reaction is initi-
ated in response to a non-life threatening viscerosensory stimuli. This could result in PD 
patients becoming susceptible to ‘unexpected’ panic symptoms when exposed to mild vis-
cerosensory stressors (Vickers and McNally, 2005). 
Table 1 – DSM-V criteria for panic attack (APA, 2013). 
A remarkable feature of both naturally occurring and experimentally induced PAs 
is that they are often followed by respiratory alterations (see Table 1) or sensation of suf-
focation (Sinha et al., 2000). Indeed, there are reports showing a high comorbidity between 
PD patients and several chronic obstructive pulmonary diseases (Simon and Fischmann, 
2005). Along those lines, it was proposed that PAs were mostly due respiratory issues as 
seen in the suffocation theory of panic, in which difficulty of breathing would be the trigger 
to the intense fear often accompanying the attack (Ley, 1992). Expanding from this, Donald 
Klein proposed that PAs would be triggered by a dysfunction in the so-called suffocation 
alarm system. According to Klein, PD patients would be more sensitive to slight elevations 
A discrete period of intense fear or discomfort, in which four (or more) of the following 
symptoms developed abruptly and reached a peak within 10 min. 
1. Palpitations, pounding heart, or accelerated heart rate 
2. Sweating 
3. Trembling or shaking 
4. Sensations of shortness of breath or smothering 
5. A feeling of choking 
6. Chest pain or discomfort 
7. Nausea or abdominal distress 
8. Feeling dizzy, unsteady, lightheaded, or faint 
9. Feelings of unreality (derealization) or being detached from oneself (deperson-
alization) 
10. Fear of losing control or going crazy 
11. Fear of dying 
12. Numbness or tingling sensations (paresthesia) 
13. Chills or hot flushes 
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of physiological parameters such as arteriole partial pressure of CO2 or lactate levels capa-
ble of triggering the dysfunctional suffocation alarm system, thus precipitating a PA (Klein, 
1993). 
Conversely, expected PAs differ from the unexpected counterpart in that there is an 
external cue where unexpected PAs have occurred and that is now associated with the in-
duction of the attacks (Shulman et al., 1994). The expected PAs also occur in more stressful 
situations, such as work or driving, but the remaining episodes typically occur in agora-
phobic situations where the person believes that escape might be difficult, or help might 
not be available. Example of these are public transportation, being in open or enclosed 
spaces, being in a crowd, or being outside of the home alone (APA, 2013; de Beurs et al., 
1994). This argued to be a development of cognitive bias toward threat perception 
(McNally et al., 1990) and conditioning to cues where subjects experienced unexpected 
PAs (Van Den Heuvel et al., 2005). 
It is at late teenage/early adult stage when major plasticity events take place in the 
prefrontal cortex (PFC) (Huttenlocher, 1984, 1979; Insel, 2010; Spear, 2000), and there are 
consistent decreases in volumes of this structure in PD subjects (Asami et al., 2009; Lai et 
al., 2010; Protopopescu et al., 2006). This helps explain why psychological therapies that 
strengthen PFC activity, such as cognitive behavioral therapy, are the most effective treat-
ments for PD (Mitte, 2005). Beyond PD, PAs are also prevalent in patients with PTSD 
(Jensen et al., 1998), mood and substance abuse disorders (Grant et al., 2006). PD is also a 
significant predictor of poor health outcomes such as hypertension and strokes (Esler et al., 
2008), and increases the likelihood of suicidal behaviors. PD also has a high comorbidity 
with agoraphobia, which occurs in over half of the patients (Kessler et al., 2006), and nearly 
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two thirds of such patients are more resistant to traditional therapies and suffer long-term 
disability (Grant et al., 2006; Roy-Byrne et al., 2006; Skapinakis et al., 2011). In Figure 4 
there is a chart illustrating the summarized main features of PAs. 
 
1.4.3. Panic Attacks Are not Limited to Panic Disorder 
Initially considered to be an exclusive feature of PD, the most recent DSM-V clas-
sified PAs as a specifier to other conditions other than PD. For instance, PAs have also 
 
Figure 4 – Chart illustrating the main symptoms and the percentage of expected and un-
expected panic attacks (PAs). Note that only a subset of individuals presenting PAs develop 
panic disorder (PD) and PD with agoraphobia. Adapted from Kessler et al. (2006). 
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been observed in patients with mood, psychotic, substance abuse disorders, and other res-
piratory disease (APA, 2013; Goodwin and Pine, 2002). Moreover, the presence of PAs 
only are associated with increased suicidal ideation in several psychiatric conditions, such 
as bipolar disorders and schizophrenia (Frank et al., 2002; Ulas et al., 2007). These obser-
vations suggest that PAs can also serve as predictors of greater symptom severity and 
poorer treatment course when present in a comorbid fashion with other conditions. 
 
1.4.4. Agoraphobia 
The diagnoses of PD with or without agoraphobia and agoraphobia without history 
of PD of versions prior to DSM-V have been replaced by two separate conditions: PD and 
agoraphobia. This was defended in the review from Wittchen et al. (2010), who suggested 
agoraphobia to be classified as an independent condition from PD. These authors laid out 
several reasons to defend their case, and to list a few they emphasized the existence of 
agoraphobia in communities without symptoms of PAs, epidemiological data showing that 
PD not always are followed by agoraphobia, agoraphobia only symptoms were associated 
with outcomes similar to other anxiety disorders, and differences between PD and agora-
phobia regarding incidence, gender distribution, and treatment outcome, amongst others 
(Wittchen et al., 2010). 
According to the DSM-V, agoraphobia is described by marked fear or anxiety about 
exposure, or the anticipation of it, to public spaces such as using public transportation, 
being in open or enclosed spaces, standing in line, being in a crowd or outside of the home 
unaccompanied. Patients avoid these situations because in case of panic-like or elevated 
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fear/anxiety symptoms the subject believes that either help might unavailable or escape 
might be hindered (APA, 2013). 
 
1.4.5. Research Domain Criteria Approach 
An alternative view to the symptom-based classification used by the DSM-V is the 
Research Domain Criteria (RDoC) approach. The goal of this research framework is not to 
serve as diagnostic guide, but rather to focus on integrating different levels of information 
(genomic, neural circuits, behaviors, and self-reports) in order to explore basic functioning 
of human behavior spanning from normal to abnormal. The RDoC framework is hierarchi-
cally organized into domains, constructs, and units of analysis. 
While domain is a broader term to reflect contemporary knowledge about major 
systems of emotion, cognition, motivation, and social behavior, constructs within each do-
main define behavioral elements, processes, mechanisms, and responses that comprise dif-
ferent aspects of the overall range of functions. The last, units of analysis, are simply a set 
of several different methods devoted to manipulate and assess molecular, genetic, neurocir-
cuit, and behavioral components of the constructs [National Institute of Mental Health 
(NIMH), 2019]. 
Of particular importance for this dissertation is the negative valence systems do-
main, where lays the responses to aversive situations and contexts, such as fear and anxiety. 
Within the negative valence systems domain are the constructs defining threats as potential 
(anxiety), acute (fear), and sustained (escape). Note that these constructs definitions sig-
nificantly overlap with the pre-encounter, post-encounter, and circa-strike stages of the 
“predatory imminence continuum” theory discussed in section 1.2. 
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1.5. Neural Basis of the Emotional States Involving Fear and Panic 
In the case of the emotional states involving anxiety, fear, and panic, it is well un-
derstood that physiological and behavioral responses are ubiquitously expressed through-
out animal phylogeny. Therefore, much of the knowledge regarding the neural basis of 
these emotional states came from early pre-clinical studies using animal models associated 
with intracranial stimulation or lesioning of key brain regions to investigate avoidance 
(anxiety), freezing (fear), and escape (panic) responses in laboratory animals. 
 
1.5.1. The Amygdala Plays a Central Role in Conditioned Fear Responses 
As described in section 1.3, fear is generally an adaptable emotional state measur-
able by moderate levels of behavioral, hormonal, and autonomic responses to tangible 
threats that are detected by sensorial stimuli or evoked by memories that are associated to 
an aversive event. The initial observations that the amygdala played a role on fear arose 
with the study in monkeys with bilateral removal of the temporal lobe (Brown and Schafer, 
1888; Klüver and Bucy, 1939), and more specifically lesioning within the amygdala 
(Aggleton and Passingham, 1981). These monkeys had a striking absence of motor and 
vocal reactions normally associated with stimuli that evoked fear in non-lesioned monkeys, 
such as manipulations by the experimenter and presenting monkeys with snakes. Serendip-
itously, humans with a rare bilateral calcification confined to the amygdala (Urbach-
Wiethe disease) showed impaired acquisition of conditioned fear (Klumpers et al., 2015), 
but also failed to identify the emotion of fear in pictures of human faces, although the 
identification other emotions, such as happiness and anger, remained intact (Adolphs et al., 
1995, 1994). 
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Early data also showed that the fear-associated freezing responses are tied to con-
ditioned tones paired with unconditioned shock stimulation. For instance, monkeys with 
amygdala lesions submitted to a conditioned avoidance paradigm presented a lower rate of 
conditioned fear acquisition when compared to non-lesioned subjects (Weiskrantz, 1956; 
Weiskrantz and Wilson, 1958). Equally important, these monkeys also showed faster ex-
tinction rates during the extinction protocol (absence of shock) (Weiskrantz, 1956; 
Weiskrantz and Wilson, 1958). The same patterns of fear conditioning and extinction were 
observed in early studies involving rats (Robinson, 1963) and cats (Brady et al., 1954) with 
similar lesions in the amygdala. 
But the major paradigm of fear conditioning that has been instrumental to uncov-
ering the neural mechanisms of emotional processing has its roots on the early experiments 
of classical conditioning carried out by Ivan Pavlov. Considered to be the foundation of 
the conditioned-fear paradigms utilized nowadays, Pavlov paired the presentation of food 
(unconditioned stimulus, US), at which the dogs would respond by salivating (conditioned 
response, CR), to the sound of a bell (conditioned stimulus, CS). He later showed that after 
several CS-US pairings, dogs would salivate upon the presentation of the CS alone (Pavlov, 
1910). Based on this experiment, the cued fear conditioning paradigm pairs footshocks 
(US) to auditory cues (usually tones, CS) to induce a freezing response (CR) in the animals 
being tested. As previously mentioned, freezing is interpreted as a fear response in rodents 
since it reduces the chances from being detected by predators (see section 1.1). 
In rats, unilateral (LaBar and LeDoux, 1996) or bilateral (Blanchard and Blanchard, 
1972; LaBar and LeDoux, 1996; LeDoux et al., 1990; Maren et al., 1996) lesions of the 
amygdala respectively displayed reduced or blunted conditioned freezing responses to 
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tone/shock pairings during acquisition or to tone presentation during extinction of fear. 
Additional deficits in increased HR (Antoniadis, 2000; LeDoux et al., 1990) and corti-
costerone secretion (Goldstein et al., 1996) have also been observed. Interestingly, patients 
submitted to unilateral temporal lobectomy had also impaired galvanic skin response dur-
ing simple and complex fear conditioning tasks (LaBar et al., 1995), suggesting the im-
portance of this brain region in both rodents and humans in mediating fear responses to 
aversive stimuli. 
A question that emerges is how does the amygdala control the array of behavioral, 
autonomic, and hormonal responses evoked by fear-promoting situations? The answer to 
this question can be found on the inputs and outputs connecting the amygdala to key brain 
regions underlying those responses as discussed below. 
 
1.5.2. The Amygdala is an Anatomically Complex Structure that Coordinates Fear Re-
sponses with Different Brain Regions 
Anatomically, the amygdala is an almond-like shape structure that can be divided 
into four main nuclei: lateral (LA), basal (BA, which alongside the LA is known as baso-
lateral, BLA), basal medial (BMA), and central (CeA) nuclei. The BLA has a cortex-like 
structure and is composed of 20% of interneurons expressing gamma-aminobutyric acid 
(GABA) and 80% glutamatergic principal neurons (Alexander J. McDonald, 1982; 
McDonald, 1985; Rainnie et al., 2006). While the LA is the main input site for sensory 
information from sensory cortical and thalamic areas (Burwell et al., 1995; Mcdonald, 
1998; Turner and Herkenham, 1991), the BA is rather reciprocally connected with other 
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brain regions, such as the prefrontal cortex or ventral hippocampus (Hoover and Vertes, 
2007; Mcdonald, 1998; Petrovich et al., 2001; Pitkänen et al., 2000; Senn et al., 2014). 
A fundamental principle in consolidation of memories associated with aversive 
events has been attributed to synaptic plasticity in the amygdala complex, more specifically 
the BLA. This process is known to be mediated by long-term potentiation (LTP) via α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate 
(NMDA) receptors when auditory (e.g. tone) and somatosensory (e.g. shock) stimuli inputs 
converge into the BLA. LTP has been suggested to be a key cellular mechanism mediating 
acquisition of CRs during fear conditioning (Nabavi et al., 2014; Quirk et al., 1995; Rogan 
et al., 1997; Romanski et al., 1993). In line with this are the recent findings showing that 
optogenetic protocols inducing LTP or long-term depression (LTD) of sensory inputs to 
the LA were able to respectively produce or inhibit fear conditioned responses post-fear 
conditioning (Nabavi et al., 2014). 
Another important component for the expression of fear responses is the connec-
tions made with different brain regions. The somatosensory stimuli arriving in the BLA are 
conveyed to the CeA, a nucleus formed by GABAergic medium spiny neurons with stria-
tum-like properties that is the major output region of the amygdala (McDonald, 1982). For 
instance, electrical and chemical stimulations of the CeA have been reported to consistently 
produce somatic and autonomic components of the fear response which include increases 
in HR, blood pressure (BP), and freezing (de Molina and Hunsperger, 1962; Hilton and 
Zbrożyna, 1963; Iwata et al., 1987; Roldán et al., 1974; Ursin and Kaada, 1960). Indeed, 
electrolytic- or NMDA-induced lesions that included the CeA post-fear conditioning atten-
uated auditory CS evoked freezing (Goldstein et al., 1996; Goosens and Maren, 2001) and 
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corticosterone release (Goldstein et al., 1996). These responses can be explained by the 
direct CeA projections to the hypothalamus, which mediates prominent endocrine and au-
tonomic responses, and the midbrain, more specifically the ventro-lateral (vlPAG) peria-
queductal gray (PAG), which mediates motor responses, such as freezing, to fear stimuli 
(Gray et al., 1989; Krettek and Price, 1978). 
Further exploring these projection regions, LeDoux and colleagues observed that 
while lesions in lateral hypothalamus (LH) prevented elevation in the arterial BP induced 
by tone (CS) post-shock (US)-CS pairings without affecting freezing responses, caudal 
PAG lesions disrupted freezing but failed to prevent elevation in arterial pressure (LeDoux 
et al., 1988). Moreover, Tovote et al. (2016) utilized circuit-based optogenetic to further 
dissect the CeA-PAG pathway mediating freezing responses. These authors elegantly 
showed that a group of GABAergic projections from the CeA disinhibited vlPAG excita-
tory outputs to pre-motor neurons in the magnocellular nucleus of the medulla that con-
trolled freezing responses (Tovote et al., 2016). 
However, in addition to understanding the processes by which fear memories are 
formed and expressed, another important feature is the mechanisms by which safety learn-
ing occurs. Fear extinction is not simply forgetting since it requires exposure to the CS in 
the absence of US instead of simply letting the time goes by. In support of this, studies 
have shown that fear memories can last from months to years if no extinction protocol is 
carried out (Gale et al., 2004). Even though fear responses diminish during the process of 
fear extinction (i.e. when presented with only neutral CS), it is widely accepted that extinc-
tion per se is a new type of learning in which distinct networks inhibit fear expression [for 
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review, see (Myers and Davis, 2007)]. Understanding the mechanisms underlying fear ex-
tinction has important clinical implications for treating disorders of fear and anxiety, such 
as phobias, PTSD, and PD. 
One of the main structures implicated in the extinction process is the PFC, more 
specifically the infra-limbic (IL) cortex (a ventromedial PFC region, vmPFC). A number 
of studies in rats show CS-related unit activity (Milad and Quirk, 2002) and increased plas-
ticity (Herry and Garcia, 2002; Herry and Mons, 2004; Hugues et al., 2006) post fear ex-
tinction, and brief electrical stimulation of IL during extinction training reduced CR and 
facilitated retention of extinction (Milad et al., 2004; Milad and Quirk, 2002). More im-
portantly, human BOLD signal assessed by fMRI showed increased activity in the subgen-
ual anterior cingulate (a vmPFC region) that was associated with fear extinction during 
extinction protocol (Phelps et al., 2004). 
Interestingly, Amano et al. (2010) found a link between PFC activity and inhibition 
of CeA output neurons during fear extinction. They observed that PFC activity during ex-
tinction potentiated synaptic inputs to GABAergic intercalated cell mass neurons in the 
amygdala, which in turn project to the CeA (Amano et al., 2010).This increased level of 
synaptic inhibition in the CeA fear output neurons is suggested to mediate the suppression 
of CR at various projection sites of the amygdala, such as perifornical hypothalamus (PeF), 
paraventricular nucleus of the hypothalamus, and vlPAG. Local lesions in these regions 
respectively reduced blood pressure response, pituitary-adrenal stress hormones release, 
and freezing responses to the presentation of CS post CS-US pairing (LeDoux et al., 1988; 
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Morton et al., 1989). This makes the CeA an important target for pharmacological inter-
vention for treating psychiatric conditions whose symptoms rely on resistant extinction to 
aversive events, such as PTSD. 
 
1.5.3. The Perifornical Hypothalamus Plays a Pivotal Role in Panic Responses 
Up to date, two main brain regions have been equally implicated in the genesis of 
panic responses in both animal models and humans: PAG and perifornical hypothalamus 
(PeF)/dorsomedial nucleus of the hypothalamus. While there are both clinical and pre-clin-
ical studies supporting the former [for review, see (George et al., 2019; Schenberg, 2010; 
Schenberg et al., 2014)], this section is going to focus on the implications of the PeF on 
adaptive and pathological panic. 
Adaptive PA is a survival response that occurs to an imminent threat (Stein and 
Bouwer, 1997). Such attacks can be triggered by either external/exteroceptive (e.g. preda-
tor attacks) or internal/interoceptive (e.g. severe hypercapnia that leads to a suffocation 
sensation) sensory stimuli (Ehlers and Breuer, 1996; Street et al., 1989). The brain regions 
underlying these responses started being unveiled in the mid-1920s by Cannon and Briton 
in decorticate cats. These authors found that cats submitted to this procedure had sympa-
thetic responses (e.g., increases in BP, HR, and plasma concentrations of stress hormones) 
and “sham rage” behavior (e.g., hissing, arching of back and attempts to bite) to non-threat-
ening stimuli (Cannon and Britton, 1925). Following studies showed that “sham rage” was 
produced by transections of the cat forebrain immediately prior to posterior regions of the 
hypothalamus, but any transections caudal to this point then suppressed the “sham rage” 
(both autonomic and somatic) responses (Bard, 1928). This led Philip Bard to conclude 
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that structures in the forebrain regions exerted some sort of tonic inhibition of “sham rage” 
responses, which in turn were attributed to the caudal hypothalamus. Indeed, studies dec-
ades later showed that retrograde tracers injected into the PeF lead to robust labeling in the 
IL cortex (Chen and Smith, 2003; Johnson et al., 2008). 
Notwithstanding earlier studies of Cannon, Briton, and Bard, it was only later in 
the 1940s with the seminal work conducted by Hess and Brugger that the PeF emerged as 
a brain region underlying the “sham rage” responses described above. Hess and Brugger 
showed that electrical stimulation of discrete regions of the posterior hypothalamus near 
the PeF of cats evoked strong autonomic and somatic responses (Hess and Brugger, 1943). 
Later studies conducted in rodents and rabbits showed that electric stimulations of same 
PeF region (PeFR) evoked similar cardioexcitation, but also tachypnea (Díaz-Casares et 
al., 2009; Markgraf et al., 1991), decreases in visceral blood flow, and increases in hind 
limb blood flow (McCabe et al., 1994). Other authors also found agitated running responses 
that were proportional to stimulus intensity (Duan et al., 1996), but also escape (Olds and 
Olds, 1962). These responses are remarkably similar to the adaptive panic/defense reac-
tions (e.g., increased BP, piloerection, arching of back). 
The hypothalamus is one of the many regions in the brain that is under tonic GA-
BAergic inhibition which occurs primarily through signaling onto ionotropic GABAA re-
ceptors [for review, see (Lee and Maguire, 2014)]. In support of this are studies using phar-
macological stimulation of discrete regions of the PeF in rodents showing these sites to be 
critical for increased physiological (BP, tachycardia, hyperventilation) and behavioral 
(running and escape) components of the “fight or flight” response. For instance, local in-
jections of GABAA antagonists in the PeF elicits escape and flight behaviors (Shekhar and 
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DiMicco, 1987), anxiety behaviors in the operant conflict test (Shekhar et al., 1990), as 
well as cardiorespiratory responses [e.g., hyperventilation, tachycardia, pressor response, 
and thermal changes (Anderson and DiMicco, 1990; DiMicco et al., 2002; Shekhar et al., 
1990; Shekhar and DiMicco, 1987; Soltis and DiMicco, 1992). Collectively, these reac-
tions encompass the autonomic and behavioral components of the “fight or flight” re-
sponse, widely associated with panic/defense reactions. 
Additional ex vivo analyses of markers that indicate cell activity post panicogenic 
challenges utilized in the clinics have provided further evidences of the involvement of the 
PeF. For instance, increased signal of the protein product of the immediate early gene cFos 
has been observed in the PeF post exposure to gas containing normoxic (i.e. 20-21% O2) 
20% CO2 (Johnson et al., 2011, 2005) and post i.v. infusions of the panicogenic yohimbine, 
FG-7142 (inverse GABAA receptor agonist), d-fenfluramine, or caffeine (Li and Rowland, 
1993; Singewald et al., 2003; Singewald and Sharp, 2000). Moreover, exposure to etho-
logically relevant exteroceptive threats, such as predator odor also induced cell activation 
in the PeF (Dielenberg et al., 2001). 
Indeed, the PeF is one of the key neural substrates that induces core symptoms of 
PAs in humans. For instance, multiple patients submitted to neurosurgery and deep brain 
stimulation of the PeF reported intense cognitive fear symptoms, such as panic and fear of 
dying, as well as physiological perturbations, such as tachycardia, increased BP, and hy-
perventilation (Rasche et al., 2006; Schoenen et al., 2005; Wilent et al., 2011, 2010). 
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1.5.4. Animal Model of Panic Vulnerability and Implication of Perifornical Hypothalamus 
Orexin System 
Based on the evidences supporting the PeF as one of the key panic generating sites 
in the brain and the presence of a tonic GABAergic inhibition in the region, Shekhar and 
colleagues developed a pre-clinical model of panic vulnerability by chronically reducing 
GABA synthesis in the PeF. More specifically, slow and sustained unilateral infusions of 
L-allylglycine, a glutamic acid decarboxylase (GAD) inhibitor (enzyme crucial for GABA 
synthesis), into the PeF increased anxiety behaviors in the elevated plus-maze (EPM), so-
cial interaction (SI), and defensive burying tests without affecting baseline cardiovascu-
lar/respiratory parameters (Shekhar et al., 2006, 1996; Shekhar and DiMicco, 1987; 
Shekhar and Keim, 1997). Interestingly, these animals presented panic behavior when chal-
lenged with i.v. infusion of 0.5 M sodium lactate or inhalation of low concentration of CO2, 
displaying increased general locomotor, rapid increases in BP, and tachypnea (Fitz et al., 
2003; Johnson et al., 2010; Johnson et al., 2008; Johnson and Shekhar, 2006; Molosh et 
al., 2010; Shekhar et al., 2006, 1996; Shekhar and Keim, 2000, 1997). It is noteworthy that 
these challenges trigger PAs only in PD patients in the clinic (Gorman et al., 1984; 
Liebowitz et al., 1984). More importantly, classical panicolytic drugs, such as alprazolam, 
also attenuated the aforementioned symptoms when administered prior to panic provoca-
tion (Johnson et al., 2010; Shekhar et al., 2011), like in PD patients (Liebowitz et al., 1986). 
Indeed, this panic vulnerability model can be considered as a valid model of panic 
predisposition since it 1) recapitulates and array of symptoms that are similar to those pre-
sented by patients with PD, therefore providing face validity; 2) has prediction validity 
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once panic-like attacks are precipitated by several panic-inducing agents (e.g. NaLac, yo-
himbine, and inhalations of CO2) and are attenuated by therapeutic agents such as alprazo-
lam (Johnson et al., 2010; Shekhar et al., 2011); and 3) has construct validity since stimu-
lation of the PeF has been demonstrated to elicit PA-like behavioral and autonomic re-
sponses in animals (Díaz-Casares et al., 2009; Duan et al., 1996; Hess and Brugger, 1943; 
Markgraf et al., 1991; McCabe et al., 1994; Shekhar and DiMicco, 1987) that are also ac-
companied by self-reports of panic and fear of dying in humans (Rasche et al., 2006; 
Schoenen et al., 2005; Wilent et al., 2011, 2010). 
Even though the PeF is a critical site underlying panic responses, the PeF is also an 
extremely diverse region that harbors heterogeneous population of neurons producing a 
plethora of hormones and neurotransmitters, such as steroid hormones (e.g. pregnanolones 
oestrogens, androgens) and peptides (e.g. oxytocin, vasopressin, neuropeptide Y, leptin, 
orexin, melanin concentrating hormone, amongst others) [for review, see (Borrow et al., 
2016)]. A question that emerges is what neurochemical system within the PeF is underlying 
the PAs observed in PD individuals? 
An interesting candidate underlying the panic responses within the hypothalamus 
are the orexin (OX) neuropeptide synthesizing neurons found only in the PeFR and adja-
cent LH (Peyron et al., 1998b; Thannickal et al., 2000). Initial work showed that loss of 
function of the OX system was initially attributed to disrupted sleep in dogs (Lin et al., 
1999) and mice (Chemelli et al., 1999), and later clinical studies showed that central OX 
tone and OX neurons were dramatically reduced in narcoleptic patients (Nishino et al., 
2000). 
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However, these OX producing neurons were also found to be critical for inducing 
anxiety and panic responses in rats. For instance, studies conducted by our lab found that 
silencing the hypothalamic gene encoding OX or systemic treatment with ORX-1 receptor 
antagonists blocked the behavioral and autonomic responses induced by NaLac challenge 
in panic vulnerable rats (Johnson et al., 2010). Moreover, panic-associated behaviors and 
cardiovascular responses elicited by 20% CO2 inhalation were attenuated (Bonaventure et 
al., 2019; Johnson et al., 2015a, 2012c) or even blocked (Molosh et al., unpublished data) 
upon pharmacological inhibition of the OX1 receptor, but not OX2. More importantly, OX 
was found to be elevated in the cerebrospinal fluid of human subjects with panic when 
compared to controls (Johnson et al., 2010). In line with this, the dual OX receptor antag-
onist suvorexant was found to improve depression and anxiety symptoms in patients suf-
fering from insomnia in a recent clinical trial (Nakamura and Nagamine, 2017). Experi-
ments to test safety, tolerability, and pharmacokinetics of selective OX1 receptor antago-
nist in healthy subjects have already started (Salvadore et al., 2019) to set the ground for 
future clinical trial studies with patients suffering from severe anxiety disorders. 
 
1.6. What is the Role of Serotonin in Fear/Panic? 
Serotonin is an indoleamine and is synthesized from the amino acid tryptophan in 
two stages. With the aid of the rate-limiting enzyme tryptophan hydroxylase (TPH), a hy-
droxyl group is added to tryptophan, converting it into 5-hydroxytryptophan (5-HTP). This 
is followed by a decarboxylation mediated by the enzyme aromatic L-amino acid decar-
boxylase, which removes a carboxyl groups from 5-HTP, converting it into 5-hydroxytryp-
tamine (5-HT), also known as serotonin. These reactions occur in two different cells: in 
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enterochromaffin cells in the intestine (reaction mediated by TPH 1), but also by the great 
majority of Raphe nuclei neurons in the central nervous system (reaction mediated by TPH 
2) (David and Gardier, 2016). 
There are seven families of 5-HT receptors that can be divided into a total of 14 
known subtypes of 5-HT receptors (Table 2Error! Reference source not found.) (Nestler 
et al., 2014). All 5-HT receptors except 5-HT3, which is a ligand-gated cation channel, are 
G protein-coupled receptors that can be further organized into three major classes accord-
i n g  t o  t h e i r  e f f e c t o r  m e c h a n i s m s . 
Table 2 – Serotonin Receptors Present in the Central Nervous System. 
Family Subtypes Central nervous system distribution 
5-HT1 5-HT1A Hippocampus, amygdala, septum, entorhinal cortex, hypo-
thalamus, Raphe nuclei 
5-HT1B Substantia nigra, basal ganglia, superior colliculus 
5-HT1D Substantia nigra, basal ganglia, superior colliculus 
5-HT1E Not known 
5-HT1F Cerebral cortex, striatum, hippocampus, olfactory bulb 
5-HT2 5-HT2A Claustrum, cerebral cortex, olfactory tubercle, striatum, nu-
cleus accumbens 
5-HT2B Not known 
5-HT2C Amygdala, choroid plexus, globus pallidus, cerebral cortex, 
hypothalamus, septum, substantia nigra, spinal cord 
5-HT3 - Hippocampus, entorhinal cortex, amygdala, nucleus accum-
bens, solitary tract nerve, trigeminal nerve, motor nucleus of 
the dorsal vagal nerve, area postrema, spinal cord 
5-HT4 - Amygdala, hippocampus, striatum, olfactory tubercle, subs-
tantia nigra 
5-HT5 5-HT5A Not known 
5-HT5B Not known 
5-HT6 - Not known 
5-HT7 - Cerebral cortex, septum, thalamus, hypothalamus, amygdala, 
superior colliculus 
Modified from Nestler et al. (2014). 
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The first one, 5-HT1 receptors class, is coupled to Gi/o that inhibits adenylyl cyclase, de-
creasing the production of cAMP. While the second class is made of 5-HT2 receptors cou-
pled to Gq, which activates phospholipase C, the third class encompasses 5-HT4, 5-HT6, 
and 5-HT7 receptors, which in turn are coupled to Gs that activates the cAMP-dependent 
pathway (Nestler et al., 2014). 
After being released from serotonergic boutons, 5-HT neurotransmission is termi-
nated by clearing 5-HT from the synaptic cleft with the aid of the pre-synaptic transmem-
brane protein 5-HT transporter (SERT). SERT is dependent on the concentration of potas-
sium, sodium, and chloride ions to remove 5-HT from the cleft back into the terminals. 
This is a two-purpose process which interrupts 5-HT neurotransmission and also enable its 
reuse by the presynaptic neuron (Nestler et al., 2014). 
Serotonin transporter is the target of many selective 5-HT reuptake inhibitors 
(SSRIs) and tricyclic antidepressant classes, first line pharmacological treatment options 
to treat patients with anxiety and mood disorders (Nestler et al., 2014). Interestingly, pol-
ymorphisms in the promoter region of the gene coding for SERT has been shown to lead 
to low functional expression of the SERT on serotonergic terminals and linked to affective 
disorders (Collier et al., 1996). Exploring this polymorphism, Lesch and colleagues ob-
served that humans had increased anxiety-associated traits (Lesch et al., 1996). Specifically 
in regards to PAs and PD, while the SERT polymorphism has not been shown to be asso-
ciated with increased incidence of PAs, it has been shown to be associated with the severity 
of panic symptoms (Lonsdorf et al., 2009). 
Serotonin plays a role in a variety of brain functions, including motor activity, cog-
nition, sleep, appetite, sensory processing, and particularly emotion. Indeed, 5-HT has long 
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been implicated in the regulation of aversive emotions such as fear and panic as proposed 
by several authors (Deakin and Graeff, 1991; Lowry et al., 2005). 
The first conflicting evidences supporting the role of 5-HT in the modulation of 
fear and anxiety date to early 1960s with Geller-Seifter conflict test and electrical stimula-
tion of the dorsal PAG (dPAG). The Geller-Seifter paradigm is one of the oldest, yet still 
robust, assays to study anxiety and is based on an operant conditioning box to train an 
animal to press a lever for a food reward. However, during the lever pressing an unpleasant 
electrical shock is paired with food delivery, thus adding a conflict parameter in that the 
animal must decide whether to receive food while getting a small shock or receive no food 
at all (Geller and Seifter, 1960). Rats treated with anxiolytic drugs, such as the benzodiaz-
epines chlordiazepoxide and alprazolam (but not other psychoactive drugs), display more 
lever pressing when compared to controls [for review, see (Bali and Jaggi, 2015)]. 
This model was first utilized to show the anxiogenic role of 5-HT in behavioral 
inhibition. For instance, early studies using either systemic (Geller and Blum, 1970; 
Robichaud and Sledge, 1969) or intra-amygdala injections of the TPH inhibitor para-chlo-
rophenylalanine (Hodges et al., 1987), intra-amygdala deliveries of the partial 5-HT1 ago-
nist/5-HT2 receptor antagonist methysergide (Graeff and Schoenfeld, 1970), and the 5-
HT2A/C receptor antagonist ketanserin (Petersen and Scheel-Krüger, 1984) increased the 
amount of lever pressing/pecking, releasing the punished behavior. Conversely, decreased 
lever pressing was found post intra-amygdala injection of 5-HT or the 5-HT1A receptor 
agonist 8-OH-DPAT in rats (Hodges et al., 1987). Collectively, these results suggest that 
5-HT was anxiogenic in prosencephalic structures such as the amygdala. 
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On the other hand, results regarding the anxiolytic role of 5-HT started to emerge. 
Different groups observed that while reduction of 5-HT neurotransmission in the dPAG 
facilitated what the authors called “fear-like” escape responses elicited by electrical stim-
ulation of the same region, local microinjection of local 5-HT produced anti-aversive ef-
fects (Kiser et al., 1978; Kiser and Lebovitz, 1975; Schenberg and Graeff, 1978; Schütz et 
al., 1985). These results suggested that 5-HT was anxiolytic in the dPAG, contradicting 
those effects observed in the amygdala. 
The conflicting results whether 5-HT promoted or attenuated anxiety/fear was 
based on a late assumption that both the amygdala and the dPAG were thought to mediate 
the same emotional state, i.e. anxiety/fear responses. However, following the work of the 
Blanchards about distal threat evoking freezing and proximal threats eliciting “fight-or-
flight” behaviors (Blanchard and Blanchard, 1989, 1971), and based on a limited number 
of clinical results [see author's comments on Deakin (2013)], Deakin and Graeff proposed 
an elegant theory about the dual role of 5-HT. These authors suggested that while 5-HT 
neurotransmission mediated by dorsal Raphe nucleus (DR) projections via the prosence-
phalic tract to the amygdala would facilitate anxiety/fear (avoidance/freezing) when pro-
cessing potential/distal threats, the 5-HT neurotransmission from the DR to the dPAG via 
the periventricular tract projections would restrain unconditioned “fight-or-flight” panic 
responses to proximal threats (Deakin and Graeff, 1991). Another role of 5-HT neurotrans-
mission on resilience in the hippocampus was also proposed (Deakin and Graeff, 1991), 
but its implications are beyond the scope of this dissertation and will not be discussed. 
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According to Deakin and Graeff, the same neurotransmitter would modulate differ-
ent emotional states, facilitating the expression of anxiety/fear in the amygdala and inhib-
iting “fight-or-flight” panic in the dPAG (Deakin and Graeff, 1991). On a biological per-
spective, 5-HT’s mechanism of defense would be to prevent futile “fight-or-flight” reac-
tions when threat is uncertain or distal, which would ultimately avoid unnecessary energy 
expenditure and detection by nearby predators (Graeff, 1991). 
 
1.6.1. Serotonin Modulates Panic Behaviors in the Perifornical Hypothalamus 
Surprisingly, however, no credit was given to the interplay between 5-HT and PeF 
mediating panic or “fight-or-flight” behaviors in the Deakin/Graeff hypothesis (Deakin and 
Graeff, 1991). Even though these authors recognized that “human patients when electri-
cally stimulated at the PAG, medial hypothalamus…during the course of stereotaxic brain 
surgery” experienced intense fear followed by marked autonomic activation (typical symp-
toms of PAs), the PAG, alongside the prosencephalic amygdala and PFC, were the protag-
onists of Deakin/Graeff hypothesis (Deakin and Graeff, 1991). On a side note, the elusive 
“medial hypothalamus” referenced by these authors encompassed not only the PeF, but 
also vicinal hypothalamic regions. 
This is surprising since early studies in cats suggest that 5-HT modulates defensive 
behaviors (fight or threatening responses) in the PeF. For instance, oral and systemic in-
jections of the TPH inhibitor para-chlorophenylalanine induced growling, hissing, defen-
sive posturing and increasing attacks on conspecifics and experimenters (Ferguson et al., 
1970; MacDonnell et al., 1971), and that pre-treating cats with the non-selective SERT 
inhibitor imipramine elevated the threshold of electrical stimulation of the PeF necessary 
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to evoke growling, hissing, and defensive posturing (Dubinsky and Goldberg, 1971). Even 
though these systemic injections could be affecting any brain region, these effects seem to 
be mediated at least partially by the PeF since local injections of 5-HT into this region 
produced placidity and attenuated the defensive reactions induced by chemical (carbachol-
induced) (Allikmets, 1974; Gołebiewski and Romaniuk, 1985) and electrical (Allikmets, 
1974) stimulations of the PeF. More importantly, these anti-aversive effects were prevented 
with local PeF injection of methysergide prior to chemical stimulation (Gołebiewski and 
Romaniuk, 1985). Conversely, lesioning of 5-HT fibers with local injections of 5,7-dihy-
droxytryptamine (5,7-DHT) in the PeF potentiated the PeF chemical-elicited defensive re-
sponses (Gołebiewski and Romaniuk, 1985). 
Recent experiments in rats by Zangrossi and colleagues have corroborated and ex-
panded the aforementioned studies in cats. The defensive behaviors (e.g. flight and jump-
ing) elicited by electrical (de Bortoli et al., 2013) or chemical (bicuculline-induced) 
(Biagioni et al., 2016) stimulations of the PeF were attenuated by local injection of 5-HT1A 
and 5-HT2A receptor agonists. These results led the authors to suggest that the modulation 
of escape responses by 5-HT in the PeF happens in a phasic rather than tonic manner 
(Biagioni et al., 2016; de Bortoli et al., 2013). Additionally, analyzing the escape response 
from the open arm in the elevated T-maze (ETM), Zangrossi and colleagues found that 
deep brain stimulation applied to the DR decreased escape responses (Wscieklica et al., 
2017), and similarly to the electrical and chemical stimulation of the PeF, local injections 
of 5-HT1A/2A receptor agonists reduced escape (da Silva et al., 2011; Nascimento et al., 
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2014). Even though local PeF administration of 5-HT1A antagonist by its own did not pro-
duce any effect on escape, it blocked the anti-escape effects when administered prior to its 
agonist equivalent (Nascimento et al., 2014). 
Parallel studies indicate that the aforementioned behaviors might be mediated, at 
least in part, by 5-HT modulation of the OX system. Even though the OX-producing neu-
rons have been implicated in anxiety and panic only recently (see section 1.5.4), studies 
prior to OX discovery (de Lecea et al., 1998; Sakurai et al., 1998) have already correlated 
reductions of 5-HT in the PeF with increased arousal (Imeri et al., 1994). Following those 
lines, later unilateral perfusion of 5-HT into the PeF using inverted microdialysis reduced 
the number of cFos staining and decreased the discharge of OX neurons in vivo (Kumar et 
al., 2007). Electrophysiology of PeF-containing brain slices showed that these inhibitions 
are directly mediated by post-synaptic 5-HT1A and GABAA receptors (Chowdhury and 
Yamanaka, 2016; Muraki et al., 2004). It remains to be tested whether the GABAA post-
synaptic inhibitory current comes directly from co-release of GABA from serotonergic 
neurotransmission or indirectly from activation of local GABAergic interneurons presum-
ably via activation of 5-HT2A receptors. 
More importantly, even though some aforementioned studies suggest that 5-HT in-
hibits escape behaviors associated with panic via the 5-HT1A and 5-HT2A receptors (da 
Silva et al., 2011; Nascimento et al., 2014), it has not been investigated yet other aspects 
of an integrative panic response, such as cardioexcitation and thermal changes. Therefore, 
there is still a gap in knowledge in serotonergic regulation of the PeFR in the context of 
panic-associated behaviors and physiological responses. More importantly, since site spe-
cific injections of drugs ignore circuit-specific neurotransmission and its physiological 
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properties that occur in vivo, it remains to be explored what is the contribution of selective 
manipulation of PeF-projecting 5-HT networks on aversive responses to clinically relevant 
panic-inducing challenges, such as CO2 inhalation. 
1.6.2. Serotonin Modulates Fear Behaviors in the Amygdala 
Two fundamental aspects suggest that 5-HT is involved with anxiety and fear emo-
tional states processing via modulation of amygdala function. First, acute systemic injec-
tion of drugs that block 5-HT reuptake in humans enhances amygdala activation to emo-
tional stimuli (Bigos et al., 2008; Murphy et al., 2009) and increases fear-potentiated startle 
response (Browning et al., 2007; Grillon et al., 2007). Indeed, these drugs were shown to 
increase extracellular 5-HT in the amygdala by ~150% (Bosker et al., 2001) and enhance 
freezing responses during acquisition and consolidation sessions of conditioned fear be-
havior in rodents [(Ravinder et al., 2013); for review, see (Burghardt and Bauer, 2013)]. 
Along those lines, extracellular levels of 5-HT increase in the amygdala during fear condi-
tioning (Zanoveli et al., 2009) and in response to inescapable stress (Amat et al., 1998). 
Meanwhile, administration of anxiogenic drugs with diverse pharmacological properties, 
or administering a CS that was previously paired with a US (shock) increases cFos in 5-
HT neurons in the DR (Abrams et al., 2005; Spannuth et al., 2011). 
Second, genetic variations that reduce membrane expression of SERT (Lesch et al., 
1996) influence amygdala response to aversive stimuli. For instance, human subjects with 
at least one copy of the short allele of the SERT promoter exhibit: 1) greater amygdala 
neuronal activity in response to fearful face presentation stimuli (Hariri et al., 2002); 2) 
abnormal levels of anxiety/fear (Katsuragi et al., 1999; Lesch et al., 1996; Melke et al., 
2001); and 3) are more likely to acquire conditioned fear responses (Garpenstrand et al., 
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2001) compared with individuals with normal copies of the allele. Similarly to humans, 
mutation of the SERT gene is also implicated with reduced transcription of SERT in rats 
(Homberg et al., 2007). Rats with complete loss of SERT have high baseline anxiety-asso-
ciated behaviors (Johnson et al., 2019; Olivier et al., 2008), enhanced acquisition/delayed 
extinction of fear, and disrupted inhibition within the BLA (Johnson et al., 2019). 
The BLA is indeed a critical part of the innate and learned fear network. Sero-
tonergic fibers are dense in the BLA and primarily originate from specific regions within 
the DR (Hale et al., 2008). These fibers innervate both BLA principal neurons and various 
types of local GABAergic interneurons (Muller et al., 2007). Therefore, it has been pro-
posed that 5-HT could modulate the relay of CS and US information to BLA. In support of 
this, electrophysiological recordings show that there is a short-term depression in the BA, 
a region of the BLA, followed by LTP. These effects are suggested to be mediated 5-HT 
signaling at different levels. The transient inhibition would be mediated by presynaptic 5-
HT1A receptors located on LA axon terminals that project to BA principal neurons. Acti-
vation of these receptors were shown to depress glutamate release and decrease BA activity 
(Cheng et al., 1998). A second level of the transient inhibition would come from activation 
of local BA GABAergic interneurons expressing 5-HT2A receptors (Jiang et al., 2009; 
McDonald and Mascagni, 2007; Rainnie, 1999; Yamamoto et al., 2012). On the other hand, 
5-HT also promotes long-lasting facilitation of synaptic transmission in the BA. This is 
mediated by NMDA-dependent mechanisms upon activation of 5-HT2C receptors in py-
ramidal neurons (Chen et al., 2003), but also by LTP of BA neurons via activation of 5-
HT4 receptor activation (Huang and Kandel, 2007). 
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More importantly, the prolonged increase in extracellular 5-HT concentration 
within the amygdala following stress may contribute to a net loss of local GABA inhibition 
and subsequent increase in excitation of glutamatergic projection neurons. In support of 
this is that stress can downregulate the 5-HT2A receptor and reduce 5HT’s effects on local 
GABAergic tone (Jiang et al., 2009), but also enhance cell surface expression of 5-HT2C 
receptors in the amygdala (Baratta et al., 2016). The combination of these factors under 
stressful conditions may bias 5-HT neurotransmission toward excitation of 5-HT2C recep-
tors on fear-promoting BLA glutamatergic projection neurons, ultimately enhancing fear-
associated behaviors. Overall, these studies suggest that serotonergic projections to the 
BLA play a role in the modulation of anxiety-like behavioral responses and conditioned 
fear behavior. 
An important note is that these studies have used bath application of 5-HT which 
may activate more extrasynaptic receptors and not necessarily recapitulated the physiolog-
ical mechanisms of 5-HT neurotransmission (Unal et al., 2015). To shed light into these 
mechanisms, Sengupta et al. (2017) used optogenetic stimulation of serotonergic axon ter-
minals in the BA. These authors showed that while low frequency stimulation (≤1 Hz) of 
5-HT terminals in the BA evokes glutamate-mediated excitation of local interneurons, high 
frequency stimulation (10-20 Hz) elicits 5-HT-mediated excitation and/or inhibition of the 
same neurons via 5-HT2A and 5-HT1A receptors, respectively (Sengupta et al., 2017). This 
complex pattern most likely reflects the diversity of GABAergic interneurons present in 
the BLA [for review, see (Capogna, 2014)]. Furthermore, specific stimuli may selectively 
activate particular serotonergic networks in a behaving rodents, which in turn could pro-
mote differential activation of 5-HT networks in the LA, BA, or CeA, or even in specific 
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neuronal populations within these nuclei. However, a circuit-based approach to selectively 
activating amygdala-projecting 5-HT networks on anxiety/fear is still lacking. 
 
1.6.3. Anatomical, Functional, and Molecular Heterogeneity of the Dorsal Raphe Nucleus 
The first evidence of serotonergic neurons in the Raphe nuclei arose with the work 
of Dahlström and Fuxe (1964a). Based on the anatomic distribution along the Raphe, these 
authors proposed in a following paper that the serotonergic neurons should be grouped into 
9 distinct nuclei, B1-B9, according to their rostro-caudal organization (Dahlström and 
Fuxe, 1964b). Their initial nomenclature followed the proposal of Olszewski and Baxter 
(1954), but nowadays the Raphe nuclei are recognized as nucleus Raphe pallidus (B1), 
nucleus Raphe obscurus (B2), the nucleus Raphe magnus (B3), B4 is located in the floor 
of the fourth ventricle (no specific nomenclature was given), pontine Raphe nucleus (B5), 
dorsal Raphe nucleus (B6-B7), median Raphe nucleus (B8), and caudal linear nucleus (B9). 
None of these nuclei is exclusively serotoninergic. Of importance to this dissertation are 
the DR and median Raphe nucleus (MR). 
While both DR and MR are brainstem structures, the DR is localized below the 
cerebral aqueduct and the MR is adjacent to the pontine reticular formation and below the 
DR. In the mouse brain, the DR and MR contains about 35% and 8% of 5-HT-producing 
neurons, respectively, and are the major source of serotonergic innervation to forebrain 
structures, such as hypothalamus and amygdala (Azmitia and Segal, 1978; Ishimura et al., 
1988; Muzerelle et al., 2016; Vertes, 1991). 
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Initially controversial, the idea that the serotonergic neurons were topographically 
organized in subnuclei within the DR, with unique afferents, efferents, and functional prop-
erties, has since become dogma. Evidences gathered over the last two decades support the 
view that the DR is not a homogenous structure, but rather a diverse nucleus with different 
subpopulations of both 5-HT and non-5-HT neurons with distinct molecular signature, 
morphology, and function (Calizo et al., 2011; Clark et al., 2006; Commons, 2015; 
Fernandez et al., 2015; Gaspar and Lillesaar, 2012; Hale and Lowry, 2011; Kiyasova et al., 
2011; Soiza-Reilly and Commons, 2014). 
Topographically, the DR is further divided into five subregions based on the mor-
phology and neuronal density, namely: rostral (DRR), caudal (DRC), ventral (DRV), lat-
eral wings (lwDR), and dorsal (DRD) [(Baker et al., 1990; Steinbusch, 1981), for an ex-
tensive review of the anatomical organization, see (Hale and Lowry, 2011)]. Conversely, 
the MR seems a much less diverse structure, with less heterogeneity of gene expression 
and no apparent anatomical subdivisions (Clark et al., 2006). 
An extensive list of studies have characterized efferent projections originating from 
the DR [for review, see (Waselus et al., 2011)], but it was Jacobs and colleagues who ini-
tially showed that injection of a retrograde tracer into the amygdala and several other dif-
ferent regions lead to a different pattern of labeled neurons within the DR (Jacobs et al., 
1978). Following those lines, anterograde tracer injection into the rostral and caudal mid-
line DR led to a distinct pattern of innervation between the amygdala/basal ganglia and 
hypothalamus/PAG/hippocampus, respectively (Imai et al., 1986; Vertes, 1991). Recent 
anatomical studies using conditional viral tracer and mouse lines expressing Cre-recom-
binase in SERT neurons revealed that while most of the serotonergic neurons innervating 
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the hypothalamus originated from the lwDR and the MR, the amygdala is mainly inner-
vated by the midline DR (Muzerelle et al., 2016). 
The functional organization of the DR gained strength with the use of the indirect 
marker of neuronal activity cFos (Dragunow and Faull, 1989). Building evidence showed 
that aversive stimuli, such as inescapable footshocks, are able to induce cFos activity in 
various regions of DR (Grahn et al., 1999). In the same vein, intraperitoneal injections of 
anxiogenic drugs, such as caffeine, the 5-HT2C agonist mCPP, and the GABAA inverse 
agonist FG-7142 (Abrams et al., 2005) and local amygdala or intracerebroventricular mi-
croinjections of corticotrophin releasing factor (CRF)1 (Spiga et al., 2006) or CRF2 recep-
tor agonists (Staub et al., 2005), induced cFos activation of specific subdivisions of the DR, 
particularly the DRD/DRV regions. Conversely, exposure to panicogenic stimuli, such as 
CO2 inhalation (Johnson et al., 2005), i.v. infusion of sodium lactate (Johnson et al., 2008), 
and exposure to unescapable stressors such as forced swimming test (Roche et al., 2003) 
preferably activated lwDR subdivision of DR, but not the MR. Interestingly, activation of 
the latter region was linked to anxiety-associated tasks, such as the inhibitory avoidance in 
the ETM test (Spiacci et al., 2012). 
Collectively, the aforementioned evidences support the hypothesis proposed by 
Deakin/Graeff about the dual role of 5-HT on anxiety and panic (Deakin and Graeff, 1991). 
According to Lowry and colleagues, while serotonergic neurons in the DRD/DRV subdi-
visions of the DRs project to forebrain limbic regions involved in stress/conflict anxiety-
related processes, serotonergic neurotransmission originating from the lwDR of the DR 
provide inhibitory tone over brain regions controlling fight-or-flight responses. The MR, 
however, was suggested to be implicated in coping with aversive stimuli and it could be 
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important for mood disorders like depression [for review, see (Paul et al., 2014; Paul and 
Lowry, 2013)]. This is interesting because the MR innervate the panic-associated OX sys-
tem (Sakurai et al., 2005), and these serotonergic inputs strongly hyperpolarizes OX neu-
rons through postsynaptic 5-HT1A receptors (Chowdhury and Yamanaka, 2016; Muraki et 
al., 2004). 
As discussed above, a variety of studies with systemic and site-specific injections 
of 5-HT receptor agonists/antagonists proposed to investigate how 5-HT is involved in the 
modulation of anxiety, fear, and panic responses. Even though these studies can provide 
important insights about the overall role of 5-HT in these emotional states, site-specific 
pharmacological microinjections ignore circuit-specific neurotransmission and its physio-
logical properties that occur in vivo. One way to circumvent this is the use of opto or 
chemogenetic techniques in combination with circuit-based manipulations. However, very 
few studies proposed to investigate the role of 5-HT using a circuit-based approach to ques-
tion the serotonergic systems’ role in anxiety, fear, and panic. For instance, targeting DR 
subpopulations by using optogenetic activation of serotoninergic terminals in the bed nu-
cleus of the stria terminalis (BNST), Marcinkiewcz and colleagues observed that 5-HT 
enhanced fear and anxiety by activating a subpopulation of local CRF neurons that silenced 
anxiolytic BNST outputs to the LH (Marcinkiewcz et al., 2016). Following those lines, 
while activation CeA-projecting DR circuits increased overall freezing time to the condi-
tioned tone in fear learning and memory recall, specific TPH depletion in the same circuit 
did not affect those freezing parameters (Ren et al., 2018). 
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1.7. Goals of the Dissertation 
It has been almost 30 years since Deakin/Graeff proposed their influential hypoth-
esis of the dual role of 5-HT promoting anxiety in the amygdala and inhibiting panic in the 
PAG (Deakin and Graeff, 1991). However, the efforts to study the role of 5-HT modulating 
anxiety, fear, and panic emotional states have relied mostly on behavioral responses and 
have rarely assessed autonomic parameters (e.g. cardiovascular excitation). These param-
eters are a pronounced feature of those emotional states, especially panic (see sections 1.4.3 
and 1.4.2). Moreover, even though most studies have focused on conventional chemi-
cal/electrical stimulation and intracranial pharmacological approaches to question the role 
of 5-HT modulating anxiety, fear, and panic, there is still a gap in knowledge of what would 
be the role of specific 5-HT networks in these conditions as the conventional approaches 
ignore circuit-specific neurotransmission and its physiological properties that occur in vivo. 
Furthermore, even though early evidence pointed towards the involvement of 5-HT mod-
ulating panic responses in the PeF, this region was largely overlooked in Deakin/Graeff 
hypothesis (see sections 1.5.3 and 1.6.1). 
Taking in consideration the literature discussed above, our hypothesis is that there 
are independent 5-HT networks that facilitate fear responses in the amygdala, but inhibit 
panic in the PeF. Therefore, the overarching goals of this dissertation are to dissect the 
contribution of 5-HT networks modulating fear and panic responses. In order to do this, I 
will 1) inject retrograde tracer into the amygdala or PeF to determine which 5-HT systems 
innervate these regions; and 2) individually manipulate the amygdala- and PeF-projecting 
5-HT networks using gain- and loss-of-function approaches in relevant animal models to 
establish the role of these networks modulating anxiety, fear, and panic emotional states. 
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1.7.1. Clues to Determining Causes of Anxiety, Fear, and Panic Responses 
Previous work in this laboratory largely focused on the neural substrates of anxiety, 
fear, and panic behaviors and physiology using animal models. It is well established in the 
clinic that while the majority of patients with PD will experience PAs to innocuous intero-
ceptive stimulus, such as brief inhalations of 5-7% CO2, healthy subjects display adaptive 
PAs to much higher (~35%) CO2 concentrations [for review, see (Johnson et al., 2014)]. 
Similarly to the latter case, higher concentration of CO2 (20%) elicits not only anxiety- and 
fear-associated behaviors in rodents, but also marked cardiovascular and thermoregulatory 
responses associated with panic states (Federici et al., 2019; Johnson et al., 2012c, 2011; 
Spiacci et al., 2018; Ziemann et al., 2009). Regarding PD, this laboratory developed a panic 
prone model of PeF GABA disinhibition in which panic prone rats, like humans with PD, 
also respond to innocuous 7% CO2 with marked cardiovascular and thermoregulatory re-
sponses associated with panic states [(Fitz et al., 2003) for review, see (Johnson et al., 
2014)]. Even though this dissertation will not use the GABA disinhibition panic prone 
model in rats, it is important to keep in mind that local 5-HT has been shown to hyperpo-
larize OX neurons in the PeFR (Chowdhury and Yamanaka, 2016; Muraki et al., 2004). In 
this respect, one should expect that antagonizing any neurochemical system that projects 
to and inhibits the PeFR may very well facilitate the precipitation of panic responses to 
innocuous stimuli, such as 7% CO2. 
Our laboratory has a long history of using telemetry probes implanted in the peri-
toneal cavity to measure the autonomic/physiological components of a panic-associated 
response to various anxiogenic or panicogenic stimuli. In addition to the commonly used 
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paradigms to assess important components of behavioral responses in anxiety, fear, and 
panic emotional states, in this dissertation I also assessed core autonomic/physiological 
features of panic utilizing telemetry probes to question the effects of 5-HT network manip-
ulation in the cardiovascular parameters.  
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2. Chapter II: Materials and Methods for Chapters III and IV 
2.1. Animals and Housing Conditions 
All experiments were carried out in post-weening (45-55 g) or adult (300-350 g) 
male Wistar (Chapter III) or Sprague Dawley rats (Chapter IV) acquired from Envigo La-
boratories (Indianapolis, IN, USA) and housed in plastic cages under standard environmen-
tal conditions (12/12 light/dark cycle with lights on at 7:00 AM, tested at light phase; and 
22° C). Post-weening rats were used for virus injections and adult rats were used for sero-
tonergic lesioning studies in the BLA or PeF. Food and water were provided ad libitum. 
Animal caretaking and experimental procedures were in accordance with the National In-
stitutes of Health Guide for the Care and Use of Laboratory Animals, Eighth Edition 
(National Research Council, 2011) and the Institutional Animal Care and Use Committee 







2.2. Experimental Timelines 
 
Figure 5 – Experimental timelines for Chapters III and IV. Abbreviations: BLA basolateral amygdala, BP blood pressure, CBT core 
body temperature, ChR2 channelrhodopsin, CO2 carbon dioxide, CTB cholera toxin b subunit, DR dorsal Raphe nucleus, EPM elevated 
plus-maze, ETM elevated T-maze, HR heart rate, MR median Raphe nucleus, OFT open field test, PeF perifornical hypothalamus, SAP 
saporin toxin, and SI social interaction. For additional details on virus constructs, see section 2.3.1. 
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2.3. Surgical Procedures 
All surgical procedures were conducted under sterile conditions. Rats were anes-
thetized under isoflurane delivered through a nose cone (2-3% by volume MGX Research 
Machine; Vetamac, Rossville, IN, USA, dissolved in pure oxygen; Praxair Inc., Indianap-
olis, IN, USA). Before commencing the surgery, rats were checked for corneal and paw 
withdrawal reflexes to ensure appropriate anesthesia. Animals’ temperature were con-
trolled with the aid of a rectal probe and a heating plate (TCAT-2DF; Physitemp, Clifton, 
NJ, USA). At the end of each surgical procedure, animals received three daily injections 
of carprofen (LevafenTM Injection, Patterson Veterinary, Greeley, CO, USA, 50 mg/ml, 5 
mg/Kg dose, s.c.) for pain management. 
 
2.3.1. Virus Injection and Optical Fiber Implantation Stereotaxic Surgeries 
All viral injections were done in post-weening juvenile male Wistar (Chapter III) 
or Sprague Dawley rats (Chapter IV) that were group housed (2-3 animals) in plastic cages 
under standard conditions for 2-3 days prior to virus injection. Rats were placed on the 
stage of an ultraprecise stereotaxic instrument (David Kopf Instruments) using ear bars and 
with a nose cone connected to the isoflurane system (MGX Research Machine; Vetamac) 
during the virus injections. 
Rats had their head cleaned with Betadine using Q-tips and with 70% alcohol. A 
midline incision on the animal’s head was made with a surgical blade to expose the skull. 
The cranial aponeurosis was removed with a surgical blade, and the skull was dried and 
cleaned with 30% hydrogen peroxide to expose bregma and lambda. The incisor bar set so 
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bregma and lambda were on the same dorsoventral plane based on the tip of the glass pi-
pette or injectors (33 gauge, C311I, Plastics One, Roanoke, VA, USA). Bregma was taken 
as reference for all subsequent virus injections and intracranial cannulations. All stereo-
taxic coordinates were according to a standard stereotaxic atlas of the adult rat brain 
(Paxinos and Watson, 1998). 
Rats were first injected with 300 nl of the canine adenovirus CAV-CMV-Cre (4.3 
x 1012 pp/ml, Institut de Génétique Moléculaire de Montpellier, France) bilaterally into the 
BLA [Chapter III, anteroposterior (AP): -1.48 mm; mediolateral (ML): ±4.25 mm; dorso-
ventral (DV):-8.00 mm] or PeF (Chapter IV, AP: -1.90 mm; ML: ±1.10 mm; DV:-7.20 
mm) and then 300 nl of a Cre-dependent channelrhodopsin (ChR2) adeno-associated virus 
[4.4 x 1012 pp/ml, AAV-EF1a-DIO-ChR2-eYFP; University of North Carolina (UNC) 
Vector Core, Chapel Hill, NC, USA], or its control (5.1 x 1012 pp/ml, AAV-EF1a-DIO-
eYFP; UNC Vector Core) unilaterally into the DR (Chapters III and IV, AP: -6.60 mm; 
ML: -1.40 mm; DV:-5.50 mm, 15 degree oblique to the midsagittal plane) with a flow rate 
set at 100 nl/min. The pipette was left in the site for 2 min and then removed slowly over 
5 min to minimize backflow. These two-virus injections allowed us to specifically target 
DR/MR neurons projecting to either the BLA (Chapter III) or the PeF (Chapter IV), ap-
proach similar to those used by others (Junyent and Kremer, 2015; Schwarz et al., 2015). 
The head of the animals were sutured and they were allowed to recover from virus injec-
tions group-housed (2 to 3 per cage) in their home cages until they reached 300-350 g 
(approximately 5 weeks) and were ready for the wireless optical fiber implantation surgery. 
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Rats were connected to the isoflurane system (MGX Research Machine; Vetamac, 
Rossville, IN, USA) set at 2-3% (volume dissolved in pure oxygen; Praxair Inc., Indianap-
olis, IN) and secured to the ultraprecise stereotaxic frame. Their heads cleaned and skulls 
exposed for the unilateral or bilateral wireless optical fiber (TeleLC-B-6.0-500 Chapter III 
or TeleLC-B-8.9-500-2.5 Chapter IV, TeleOpto, Tokyo, Japan) implantation surgeries 
aiming the DRD/DRV (Chapter III, AP: -7.6 mm; ML: -1.2 mm; DV:-5.6 mm) or the PeF 
(Chapter IV, AP: -3.00 mm; ML: ±1.25 mm; DV:-7.70 mm), respectively. The wireless 
head implants were secured to the skull with the aid of four stainless steel screws (2.8 mm, 
Plastics One) anchored to the parietal and occipital bones, and the surgical site was filled 
with dental cement. Rats were individually housed thereafter and were allowed 7 days to 
recover at the housing facility and monitored daily for 5 days until the intraperitoneal ra-
diotelemetry probe (HD-S11; Data Sciences International, New Brighton, MN, USA) im-
plantation surgery and femoral artery catheterization. 
 
2.3.2. Intracranial Cannulation and Specific Lesioning of the Basolateral Amygdala- or 
Perifornical Hypothalamus-Projecting Serotonergic Neurons with Saporin Toxin Conju-
gated to Anti-Serotonin Transporter 
Guide-cannulas (26 gauge, C311G, Plastics One) were bilaterally implanted into 
the BLA (AP: -2.1 mm; ML: ±5.00 mm; DV:-8.5 mm, Chapter III) or the PeF (AP: -3.0 
mm; ML: ±2.93 mm; DV:-8.5 mm, 15 degree oblique to the midsagittal plane, Chapter 
IV). The guide-cannulas were secured to the skull 1 mm above the injection site with the 
aid of 4 stainless steel screws (2.8 mm, Plastics One) on the parietal and occipital bones 
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and the surgical site was closed with dental cement. Each rat received two bilateral mi-
croinjections per site (100 nl each, 1 μM in artificial cerebrospinal fluid) of either saporin 
toxin (SAP) conjugated with SERT (SERT-SAP) or the control IgG-SAP (Kit-23, Ad-
vanced Targeting Systems, San Diego, CA, USA) via an injector (33 gauge, C311I, Plastics 
One) that fitted into and extended 1 mm over the guide-cannula (26 gauge, C311G, Plastics 
One). A 10 μl Hamilton syringe was placed on an infusion pump (PHD Ultra, Harvard 
Apparatus) and connected to the injectors with PE 50 tubing. Each microinjection lasted 5 
min and the injectors remained in position for another 5 min and were slowly pulled out 
over 5 min. Upon completion of injections, dummy-cannulas (C311DC, Plastics One) that 
went the length of the guide cannula were screwed in place. Rats were individually housed 
thereafter and were allowed 7 days to recover at the housing facility and monitored daily 
for 5 days until the intraperitoneal radiotelemetry probe (HD-S11; Data Sciences Interna-
tional, New Brighton, MN, USA) implantation surgery and femoral artery catheterization. 
Behavioral assessments were carried out 3 weeks after intracranial injection of SAP. Vol-
ume, concentration, and timeline of SERT- and IgG-SAP injections were based on the pre-
vious work done by Nattie et al. (2004).  
 
2.3.3. Tracing Studies: Cholera toxin B Subunit/Phaseolus vulgaris Leucoagglutinin Mi-
croinjections and Allen Brain Atlas Connectome. 
To identify DR/MR projections to the BLA and PeF, an injector was inserted into 
the guide cannulas and 100 nl of the retrograde tracer cholera toxin b subunit (CTB, cat. 
no. 104, List Biological Laboratories, Campbell, CA, USA, 1% w/v in ACSF) was injected 
over 5 min into the BLA (Chapter III) or PeF (Chapter IV) three weeks prior to euthanasia. 
55 
A different cohort of Wistar rats received iontophoretic injection of Phaseolus vul-
garis leucoagglutinin (Phal-l, cat. no. L-1110, Vector Laboratories, Burlingame, CA, USA, 
2.5% w/v in ACSF) in the DR (AP: -6.5 to -7.5 mm; ML: 0.00 mm; DV:-5.5 mm) using 
positive current pulses of 10 µA (7 sec on; 7 sec off) for 15 min as a second method to 
confirm innervations originating from the DR. 
To further confirm that there were serotonergic specific projections to the BLA 
(Chapter III), we utilized the connectome of the mouse brain in the Allen Brain Atlas (Oh 
et al., 2014) and found a SERT-Cre (Slc6a4-Cre_ET33) mouse (Gong et al., 2007) that was 
used in combination with local DR/MR injections of an AAV expressing a Cre-dependent 
fluorescent reporter to selectively identify serotonergic projections. 
 
2.3.4. Radiotelemetry Probe Implantation and Femoral Artery Catheterization 
The rats were submitted to the femoral artery catheterization to measure the cardi-
ovascular (HR and BP) perturbations throughout different behavioral tests. The ventral skin 
was shaved and with the rat laying on its back, two incisions were made using a scalpel, 
one along the natural angle of the hind leg of approximately 1.5 cm exposing the femoral 
artery and one along the abdomen of approximately 2 cm exposing the peritoneal cavity. 
The DSI probes (HD-S11, Data Science International) were implanted in the peritoneal 
cavity and sutured to the internal wall of the abdominal muscle. With the aid of trocar, the 
pressure transducer catheter was tunneled into the hind leg incision and inserted into the 
femoral artery. The surgical sites were closed, and the animals were given 7 days of recov-
ery time at the housing facility and monitored daily for 5 days until the beginning of the 
behavioral assessments. 
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2.4. Optogenetic Stimulation Parameters 
The simulation pulses were generated by a software (Prizmatix Pulser, Version 
2.3.1; Prizmatix, Southfield, MI, USA) connected to a programmable TTL pulse train gen-
erator (Prizmatix Pulser, Prizmatix) and a stimulator device (TeleOpto). The stimulation 
pulses were transmitted via infrared signals from an emitter (TELEEMITTER, TeleOpto) 
located above the apparatus where the animals were being stimulated. A wireless optoge-
netic receiver (TELER-3-P, TeleOpto) was connected to the optical fibers on the animal’s 
head implant to receive the infrared signals from the emitter. The photostimulation param-
eters were dependent on the region (cell bodies versus fibers) and neuronal population be-
ing stimulated. The following stimulation parameters used for serotonergic cell bodies (470 
nm, 20 Hz, 1 mW, 5 ms pulses, Chapter III), fibers (470 nm, 20 Hz, 10 mW, 5 ms pulses, 
Chapter IV), or glutamatergic cell bodies (470 nm, 10 Hz, 1 mW, 10 ms pulses, Chapter 
IV) were based on previous publications (Garcia-Garcia et al., 2017; Li et al., 2016; 
Marcinkiewcz et al., 2016; Molosh et al., 2018). 
 
2.5. Behavioral Tests 
All rats were handled for 5 min by the experimenter for two consecutive days prior 
to the first day of each experiment. Each behavior was video recorded with ANY-maze 
Video Tracking System (Version 5.33, Stoelting, Woods Dale, IL, USA) using a mono-
chrome camera (DMK23UM021, The Imaging Source®, Charlotte, NC, USA). All exper-
iments were conducted in a dark room with a red light (40 lux) and a background white 
noise (60 dB), unless specified otherwise. 
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2.5.1. Effects of Optogenetic Stimulation on Blood Pressure, Heart Rate, and Locomotion 
Before the beginning of the experiments, all animals were habituated to the boxes 
where rats could move freely (50 cm width x 30 cm length x 40 cm height) for 20 min for 
3 consecutive days. On experimental testing day, animals were placed in the experimental 
box and once a baseline was established for BP, HR, and locomotion, rats were optogenet-
ically stimulated (Chapters III and IV) for 5 min. Animals’ behavior and physiological 
responses were recorded for up to two hours after optogenetic stimulation. 
 
2.5.2. Open Field Test 
The open field test (OFT) covered a squared area of 90 cm x 90 cm, with 40 cm 
height walls which was divided into a 6 x 6 grid of equally- sized squares using black tape 
(36 total squares) with 4 squares forming the center; 12 squares forming the middle perim-
eter; and 20 squares forming the outer perimeter. On the test day, rats were placed in the 
center of the apparatus and the time spent in the different zones during the 5 min test was 
video recorded and scored using ANY-maze (Version 5.33, Stoelting) video tracking soft-
ware (Stoelting, Woods Dale, IL, USA). Whenever applicable, animals were optogenet-
ically stimulated during (Chapters III and IV) the OFT.  
 
2.5.3. Social Interaction Test 
The SI test is an experimental anxiety-like behavior test in rats (File, 1980), and 
was conducted as described previously (Sanders et al., 1995). The ‘experimental’ rat and 
an unfamiliar ‘partner’ rat were placed individually in the center of the open field 24 hours 
before the SI test. During the SI test, the two rats were placed on opposite corners of the 
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open field, and the total duration (seconds) of non-aggressive physical contact (grooming, 
sniffing, and crawling over and under) initiated by the ‘experimental’ rat was video rec-
orded and manually scored by a blind experimenter. Whenever applicable, rats were sub-
mitted to optogenetic stimulation for the duration of the SI test. 
In Chapter III, animals were submitted to one trial of SI test. In Chapter IV, animals 
were submitted to four different SI tests with novel partners in each session, namely: base-
line, stimulation, bright light challenge, and CO2 challenge. The bright light challenge con-
sisted of an abrupt transition from dim red light (40-watt red light, 1 lux) to bright white 
fluorescent lighting (488 lux) during the 5-min SI testing session (File and Hyde, 1978). 
The CO2 challenge consisted of pre-exposure of the “experimental” rat to a Plexiglas® gas 
chamber (50 cm width x 30 cm length x 40 cm height) with 20% CO2 (normoxic conditions, 
Praxair Inc., Indianapolis, IN) for 5 min prior to SI test (Johnson et al., 2005). The animals 
were optogenetically stimulated for the duration of the SI test for all sessions except base-
line, and the total duration (seconds) of non-aggressive physical contact (grooming, sniff-
ing, crawling over and under and so on) initiated by the ‘experimental’ rat was manually 
score by a blind experimenter. 
 
2.5.4. Fear Conditioning 
To investigate how the loss (lesioning with SERT-SAP) or gain of function (inter-
sectional genetics) manipulations of the serotonergic neurotransmission to the BLA (Chap-
ter III) or PeF (Chapter IV) would alter the expression of the freezing behavior to the con-
ditioned fear, rats were exposed to the fear conditioning paradigm. The fear conditioning 
protocol was 4 days long (Johnson et al., 2015b) and was implemented 3 or 6 weeks after 
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stereotaxic surgeries to allow lesioning of SERT terminals or expression of the viral con-
structs to take place, respectively. All rats were handled for 5 min by the experimenter prior 
to day 1 of the fear conditioning experiment. For the fear conditioning experiments in the 
gain of function approach, rats were optogenetically stimulated in their home cages for 5 
min prior to acquisition, consolidation, and recall/extinction sessions. 
On day 1 – habituation session – rats were exposed for 10 min to the conditioning 
box (25.5 cm length x 25.5 cm width x 39.5 cm height) with a grid floor that was connected 
to a scrambled shock generator (Ugo Basile, Monvale, Italy). The conditioning box was 
placed in a larger sound-attenuated chamber (Ugo Basile) with a speaker in the rear wall 
of the chamber to provide a 60 dB background noise and a white 15-lux light on the ceiling 
to illuminate the chamber during all sessions. 
On day 2 – acquisition session – rats were submitted to 5 trials consisting of a 20 s, 
4 kHz, 80 dB tone (CS) that co-terminated with a 0.5 s, 0.8 mA single footshock (US) with 
inter-trial interval (ITI) of 100 s. 
On days 3 and 4 – consolidation and recall/extinction sessions – rats were exposed 
to 5 (consolidation) or 20 (extinction) CS only, respectively. 
Total time freezing during the CS presentations (20s tone) was recorded and man-
ually scored by a blind experimenter for each rat. Freezing was defined as the absence of 
all movement except for normal breathing. Before each trial, the chamber and the condi-
tioning box were cleaned with 70% ethanol to minimize any olfactory cues. 
 
60 
2.5.5. Real-Time Place Preference/Avoidance Test 
To test whether stimulating the glutamatergic cell bodies in the PeF or the sero-
tonergic terminals of the DR/MnR-PeF projections (Chapter IV) would support place pref-
erence or avoidance, we placed rats into a two-chamber apparatus in the real-time place 
preference/avoidance (RTPP/A) test where one side of the chamber was paired with optical 
stimulation (modified from Nieh et al., 2016). The RTPP/A apparatus was made of two 
equal sized boxes (30 cm width x 45 cm length x 30 cm height), divided by a center wall 
and connected by a 13 cm diameter opening. Each box presented different visual cues cov-
ered in black and white checkered or stripped paper on the walls and floor. The behavior 
was performed over three days in four different sessions lasting 20 min each. During ha-
bituation session on day one, each animal was assigned to either the stripped or checkered 
box and allowed to explore the apparatus. The box that the animal was first placed during 
the habituation session on day one became the stimulation-off box whereas the opposite 
box became the stimulation-on box for all the subsequent sessions of the test and rats were 
assigned to each side in a counterbalanced manner. During the stimulation session on day 
two, animals were placed in the stimulation-off box and allowed to explore the apparatus 
and were photostimulated whenever they moved into the stimulation-on box. Forty minutes 
and 24 hours after the stimulation session on day 2 (respectively short- and long-term ses-
sions hereafter) the animals were placed back in the stimulation-off box and tested without 
any optogenetic stimulation. 
Each session was video recorded and manually scored later by a blind experimenter 
for the duration each animal spent in each box. The animal was defined to be inside each 
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area when at least 50% of its body was completely located inside the designated compart-
ment. We utilized the difference score (percentage time spent in the stimulation-on box 
minus percentage time spent in the stimulation-off box) to determine place prefer-
ence/avoidance. 
 
2.5.6. Elevated Plus-Maze Test 
To test whether stimulating the PeF-projecting serotonergic terminals (Chapter IV) 
would overcome the aversive properties of the open arm in the EPM, we placed rats into 
the central platform of the EPM and paired the time spent in the open arm with photostim-
ulation. The EPM (Pellow and File, 1986) consisted of two open arms (50 cm length x 10 
cm width x 1cm height rim to prevent falls), and two closed cm arms (50 cm length x 10 
cm width x 40 cm height) with high walls and open roof such that the two arms of each 
type were opposite to each other (Figure 6). The apparatus was elevated to a height of 50 
cm from the floor. The animals were placed on the central platform facing the open arm 
and were allowed to explore the maze for 10 min. Rats were paired with photostimulation 
whenever 50% of their body was in the open arm during the first 5 min. Animals were 
allowed to explore the apparatus without optogenetic stimulation for the last 5 min of the 
test. The time spent in each arm was scored using ANY-maze (Version 5.33, Stoelting). 
 
2.5.7. Elevated T-Maze Test 
To determine whether lesioning the serotonergic projections from to the PeF would 
facilitate the escape responses from the open arm (Chapter IV), rats were tested in the 
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ETM. The ETM is a modification of the EPM in which one of the closed arms is blocked, 
w i t h 
the animal having access only to two open arms and one closed arm in a “T” shape. For 
two consecutive days before the pre-exposure session, animals were handled by the exper-
imenter for 5 min for habituation purposes. During the pre-exposure session, animals were 
exposed to one of the open arms of the ETM for 30 min. A barrier was place at the proximal 
part of the open arm, right before the intersection with the closed arm to prevent the animals 
from accessing the rest of the maze and limiting their exploration only to the open arm. 
The barrier was removed after the pre-exposure session was finalized. On the test day, the 
animals were exposed 3 times to the distal ends of the closed and open arms with ITI fixed 
at 30 seconds, with a total of 6 trials. The time taken by the animal to leave the closed and 
 
Figure 6 – Photo illustrating the elevated plus maze. 
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open arms were determined as inhibitory avoidance and escape behaviors, respectively. A 
cutoff value of 300 seconds was established before terminating the trial in case the animals 
failed to complete the task (Zangrossi and Graeff, 1997). All behaviors were video recorded 
and later scored manually by an experimenter blind to treatments. Immediately after the 
last exposure to the open arm, the animals were placed in the open field to test the baseline 
locomotor activity. 
 
2.5.8. CO2 Challenge 
Since lower subthreshold concentrations of hypercapnic gas (e.g. 5-7% CO2) elicit 
maladaptive PAs (increases in fear/anxiety and cardiorespiratory responses) in the majority 
of patients with panic disorder, but not in healthy controls (Gorman et al., 1984; Klein, 
1993), this model was also used in animals to measure the role of 5-HT modulation on 
escape responses elicited by low (7.5%) and high (20%) concentrations of CO2 [(Johnson 
et al., 2011) for review, see (Johnson et al., 2014)]. 
Flow cages (50 cm width x 30 cm length x 40 cm height) were custom built using 
Plexiglas®. When the lid of the cage was latched, gases could only enter the cage through 
an inlet connector (for the gas infusion) and could only exit the cage through an outlet 
connector. The gas flow into the cages was controlled using a two-stage regulator (Praxair, 
Inc.) at a pressure of 0.6 Bar. Rats were habituated for 10 min to the flow cages prior to 
CO2 challenge, which was carried out in two different concentrations: 7.5 and 20% in a 
counterbalanced manner. Also, a crossover design was utilized so that all rats received 
either 7.5 or 20% CO2 within one week between each challenge. 
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All rats (Chapter IV) were submitted to constant infusion of atmospheric air (< 1% 
CO2 / 21% O2 / 79% N2, Praxair, Inc.) until they ceased exploratory behavior and there was 
a 5 min stable baseline for the cardiovascular parameters (i.e., ~110 mm/Hg and ~400 
bpm). Then a premixed experimental normoxic, 7.5 or 20% hypercapnic gas (7.5% or 20% 
CO2, 21% O2, 71.5% or 59% N2: Praxair, Inc.) was infused for 5 min to increase the CO2 
concentration in the flow cage to the pre-established values (Figure 7). The CO2 and O2 
gas concentrations were measured in real time by UV sensors (CM-0121 and CM-0201, 
respectively, CO2meter.com, Ormond Beach, FL, USA) connected to the flow cage outlet 
and to a software (Gaslab v2.0.8.14, CO2meter.com). Whenever applicable, rats were also 
optogenetically stimulated for 5 min during the CO2 infusion. Atmospheric air infusion 
resumed right after termination of CO2 infusions and remained for additional 40 min. The 
CO2 levels rapidly returned from 7.5 or 16% to < 3% during the following 7 min. Note that 
the concentration of O2 remained constant at ~21% throughout the entire gas (either CO2 
or atmospheric air) infusion. (Figure 7). 
 
2.6. Immunohistochemistry 
In the end of experiments, rats were anesthetized with isoflurane and transcardially 
perfused with 200 ml of 0.1 M phosphate buffered saline (PBS) and then 200 ml 0.1 M 
PBS containing 4% paraformaldehyde. Brains were removed and postfixed with 0.1 M 
PBS containing 4% paraformaldehyde for 3 hours before transferring to anti-freezing so-
lution [0.1 M phosphate buffer (PB) containing 30% sucrose] for 48–72 h until they sank 
and were ready for sectioning. Brains were sectioned (30 µm serial sections) using a mi-
crotome (model HM 400 R, Micron, Walldorf, Germany) with a cooling system (model K 
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4000, Micron) and immediately placed in cryoprotectant solution (30% ethylene glycol and 
30% glycerol in 0.1 M PB). Slices were stored at -20 ºC until the beginning of free-floating 
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Figure 7 – Graph showing percent concentration of gases during the carbon dioxide (CO2) 
challenge. Real-time CO2 (left y-axis) and oxygen (O2, right y-axis) readings over 20 min 
(x-axis) infusion of atmospheric (Atm.) air, 7.5, and 20% CO2 gas infusion in the gas cham-
ber. Readings were taken during all CO2 challenge experiments in Chapter IV and no sig-
nificant difference between groups were found for gas concentration over the course of the 
experiments. 
Our general chromogen immunohistochemistry procedure was as follows: sections 
were incubated on day 1 for 30 min in PBS, 20 min in 1% H2O2 in PBS, 30 min in PBS, 
10 min in PBS with 0.3% Triton X-100 (PBST), and overnight (approximately 12–16 h) in 
primary antibody diluted in PBST (for list of antibodies used, see Table 3). On day 2, 
sections underwent 30 min in PBS, 90 min incubation with the appropriate secondary an-
tibody diluted in PBST. Following the secondary antibody incubations, slices were washed 
in PBST for 30 min, incubated 90 min in avidin-biotin complex kit (cat no. PK-6100, Vec-
tor Laboratories) diluted 1:500 in PBST, 30 min washes in BPST, and 5-10 min chromogen 
reaction with SG Kit (SK-4700, Vector Laboratories) for cFos, CTB, and SERT primary 
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antibodies or 0.01% 3,3’-diaminobenzidine tetrahydrochloride (DAB; cat no. D-5637, 
Sigma-Aldrich, Poole, UK) in PBS containing 0.003% H2O2, pH 7.4 for Phal-l and trypto-
phan hydroxylase (TPH) primary antibodies. The slices submitted to double staining un-
derwent an additional overnight incubation with the appropriate primary antibody. On day 
3, the protocol was identical to the steps carried out on day 2, but it was followed by 7 min 
DAB reaction. After finishing the immunohistochemistry, brain slices submitted to cFos 
or Phal-l immunoreactions were also counter stained with neutral red or cresyl violet, re-
spectively, to facilitate identification of brain nuclei and cell counting. 
Our general procedure for immunofluorescence was as follows: sections were in-
cubated for 30 min in PBS, 10 min in PBST, and overnight in primary antibody (for list of 
antibodies used, see Table 3). On day 2, sections underwent 30 min in PBS, 90 min incu-
bation with the appropriate secondary antibody diluted 1:200 in PBS. Following the sec-
ondary antibody incubations, slices were washed in PBS for 30 min and those submitted to 
double labelling underwent an additional overnight incubation with the appropriate pri-
mary antibody. On day 3 the protocol was identical to the steps carried out on day 2, except 
the secondary antibody. All washes and incubations were done in 12 well polystyrene 
plates with low frequency shaking on an orbital shaker. 
All sections were mounted in 0.1% gelatin dissolved in ultrapure water on glass 
slides, dried overnight, and mounted with coverslips using VectaShield mounting medium 
(cat. no. H-1200, Vector Laboratories, for immunofluorescence) or dried overnight, dehy-
drated and mounted with coverslips using DPX mounting medium (BDH Laboratory Sup-





Table 3 – Summary of staining combinations and antibodies used. 





























































































List of antibodies and vendors: goat anti-CTB (cat. no. 703, List Biological Laboratories, 
Campbell, CA, USA); goat anti-Phal-l antiserum (cat. no. AS-2224, Vector Laboratories, 
Burlingame, CA, USA); mouse anti-TPH antibody (cat. no. T0678, Sigma, St. Louis, MO, 
USA); rabbit anti-cFos (cat. no. SC52, Santa Cruz, Dallas, TX, USA); rabbit anti-orexin A 
(OXA, H003-30, Phoenix Pharmaceuticals, Burlingame, CA, USA); rabbit anti-SERT (cat. 
no. 24330, ImmunoStar, Hudson, WI, USA); biotinylated goat anti-rabbit, horse anti-
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mouse, rabbit anti-goat (cat nos. BA-1000, BA-2000, BA-5000, respectively, Vector La-
boratories); biotinylated donkey anti-goat (cat. no. 705-066-147, Jackson Immunoresearch, 
West Grove, PA, USA); donkey anti-goat Alexa Fluor 568, goat anti-mouse Alexa Fluor 
488 (cat. nos. A-11057, A-11017, respectively, Life Technologies, Carlsbad, CA, USA); 
and donkey CyTM3-conjugated anti-rabbit (cat. no. 711-165-152, Jackson Immu-
noResearch, West Grove, PA, USA). 
 
2.7. Photography and Image Analyses 
Photomicrographs were obtained with a microscope (DMLB, Leica, Wetzlar, Ger-
many) connected to a digital camera (DFC 300, Leica) or a confocal scanning microscope 
(A1R+, Nikon, Tokyo, Japan). Densitometry analyses of SERT+ fibers were done on gray-
scale inverted photographs from the BLA (-2.8 mm from bregma) and PeF (-3.0 mm from 
bregma) using an image editing program (Photoshop version 16, Adobe Systems, San Jose, 
CA, USA). The IgG-SAP group mean represented 100%, which was compared to SERT-
SAP values. The numbers of cFos+ cells were counted in the entire field of view at 400x 
magnification in the BLA, PeF, MR, and subdivisions of the DR (-7.8 mm from bregma). 
The co-localization analysis was determined using Pearson’s correlation coefficient with 
Nikon software (Nikon NIS Elements, Nikon). An observer that was blind to the experi-
mental treatment of each animal did all cell counts. 
 
2.8. Statistical Analysis 
The following dependent variables were analyzed using a two-tailed independent 
Student’s t-test: densitometry, social interaction, total freezing duration, and cell counts). 
The co-localization analysis of SERT and ChR2-eYFP was determined using Pearson’s 
correlation coefficient with Nikon NIS Elements software. Conditioned fear responses (i.e. 
freezing) were analyzed using a one-way analysis of variance (ANOVA) or a one-way 
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ANOVA with repeated measures with SAP or AAV injections as between-subjects factors 
and time as repeated measures. In the presence of significant main effects, between-sub-
jects post hoc tests were conducted using Fisher’s least significant difference (LSD) test. 
Within subjects time effects were also assessed using a Dunnett’s one way analysis with 
the min prior to stimulation (baseline) used as the control. Statistical significance was ac-
cepted with p ≤ 0.05. All statistical analyses were carried out using SPSS 22.0 (SPSS Inc., 
Chicago, IL, USA) and all graphs were generated using GraphPad Prism 7.04 for Windows 
(GraphPad Software Inc. La Jolla, CA, USA) and figure plate illustrations were done using 
CorelDraw version X8 for Windows. 
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3. Chapter III: Using loss and gain of function approaches to manipulate amygdala-pro-
jecting serotonergic neurons in the dorsal Raphe nucleus that enhance anxiety-related 
and conditioned fear behaviors 
 
3.1. Introduction of Chapter III 
Selective serotonin reuptake inhibitors (SSRIs) are the first line of pharmacological 
treatment for anxiety disorders, such as generalized anxiety disorder and social anxiety 
disorder, as well as trauma- and stressor-related disorders, such as posttraumatic stress dis-
order (PTSD) [for review, see (Koen and Stein, 2011)]. The anxiolytic effects of SSRI 
therapy occur 2-3 weeks following daily treatments and there is evidence that they actually 
increase anxiety initially (Masand and Gupta, 1999; Spigset, 1999; Teicher et al., 1990). 
For instance, in humans, taking citalopram prior to fear acquisition increases fear-potenti-
ated startle response (Browning et al., 2007; Grillon et al., 2007), but chronically reduces 
conditioned fear response (Bui et al., 2013). Similarly, in rodents SSRIs initially enhance 
conditioned fear behavior, but chronically will reduce conditioned fear response 
[(Burghardt et al., 2007, 2004) for review, see (Burghardt and Bauer, 2013)]. Thus, the 
mechanism of action appears to be compensatory changes that occur within anxiety and 
fear networks with repeated use. In light of this, we and others hypothesize that a hyperac-
tive or hyperresponsive central serotonergic system contributes to increases in anxiety sen-
sitivity in anxiety disorders and to exacerbated anxiety/fear in response to SSRIs acutely, 
but over time becomes desensitized with chronic SSRIs. 
A critical part of the innate and learned fear network is the basolateral amygdala 
(BLA; which includes the basolateral and lateral nuclei). The BLA is highly responsive to 
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various stress-inducing stimuli (Brydges et al., 2013; Butler et al., 2011; Henderson et al., 
2012; Johnson et al., 2008; Singewald et al., 2003) and increase in amygdala activity is 
associated with increase in anxiety in humans (Rauch et al., 2003). The amygdala plays a 
critical role in fear conditioning in rodents [for reviews, see (Johansen et al., 2012, 2011)], 
and in humans. For instance, humans with bilateral ablation of the amygdala: 1) have nor-
mal facial recognition but do not recognize fearful faces (Adolphs et al., 1994); 2) do not 
display fear in response to normally threatening stimuli (Feinstein et al., 2011); and 3) do 
not show conditioned fear response, even though declarative learning is intact (Bechara et 
al., 1995). 
Serotonergic neurons are clustered within the midbrain in the dorsal (DR) and me-
dian Raphe (MR) nuclei and within the medulla, but the vast majority of serotonergic neu-
rons are localized in the DR. Serotonergic fibers are dense in the BLA and primarily orig-
inate from the midline ventral (DRV) and dorsal (DRD) DR, with far fewer projections 
from the MR (Hale et al., 2008). Extracellular levels of 5-HT increase in the BLA during 
conditioned fear (Zanoveli et al., 2009) and in response to inescapable stress (Amat et al., 
1998). Meanwhile, administration of anxiogenic drugs with diverse pharmacological prop-
erties, or administering a light cue that was previously paired with a shock increases cFos 
in 5-HT neurons in the BLA-projecting regions of the DRV and DRD (Abrams et al., 2005; 
Spannuth et al., 2011). Additionally, single systemic injection of an SSRI in rats increases 
extracellular 5-HT in the amygdala by ~150% (Bosker et al., 2001), enhances freezing 
responses during acquisition and consolidation [(Ravinder et al., 2013) for review, see 
(Burghardt and Bauer, 2013)]. Up to 24 h following exposure to inescapable stress, base-
line concentrations of 5-HT in the BLA are increased, and animals show increased response 
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to two brief footshocks, suggesting that inescapable stress can sensitize BLA-projecting 
serotonergic system (Amat et al., 1998). 
The persistent increase in extracellular 5-HT concentration within the amygdala 
following stress may contribute to a net loss of local GABA inhibition and subsequent 
increase in excitation of glutamatergic projection neurons. In support of this, 5-HT acutely 
increases GABAergic tone in the BLA by exciting local GABAergic interneurons via the 
postsynaptic 5-HT2A receptors (Jiang et al., 2009; McDonald and Mascagni, 2007; Rainnie, 
1999), but also facilitates synaptic plasticity of pyramidal neurons via NMDA-dependent 
mechanisms upon activation of 5-HT2C receptors (Chen et al., 2003). Equally important is 
that stress can downregulate the 5-HT2A receptor and reduce 5HT’s effects on local GA-
BAergic tone (Jiang et al., 2009), but also enhance cell surface expression of 5-HT2C re-
ceptors in the amygdala (Baratta et al., 2016), which may bias toward excitation of 5-HT2C 
receptors on fear-promoting BLA glutamatergic projection neurons. Overall, these studies 
suggest that serotonergic projections to the BLA play a role in modulation of anxiety-like 
behavioral responses and conditioned fear behavior. 
Yet, these data are correlational and pharmacological methods of understanding the 
role of 5-HT in fear are complicated in that 5-HT is capable of exciting and inhibiting both 
GABA and glutamatergic neurons in BLA. In order to test our hypothesis that 5-HT pro-
jections from the DRD/DRV region of the DR promote anxiety- and fear-related behaviors, 
in recent studies we injected a serotonergic neurotoxin 5,7-dihydroxytryptamine (5,7-
DHT) into the BLA, which reduced local 5-HT concentration (but not dopamine, norepi-
nephrine or epinephrine) and attenuated anxiety-like behavioral response in the social in-
teraction test and cue-induced conditioned fear response (Johnson et al., 2015b). These 
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data supported our hypothesis, but the mechanism of action of 5,7-DHT is largely unknown 
and requires co-injection of the norepinephrine reuptake inhibitor, desipramine, in order to 
be selective. In order to further explore our loss-of-function approach, we first injected a 
selective anti-serotonin transporter (SERT)-saporin (SAP) toxin into the BLA (Figure 8) 
and assessed anxiety-like and conditioned fear responses, then injected a retrograde tracer 
into BLA to confirm that we not only lesioned SERT-immunoreactive fibers in the BLA 
but also serotonergic neurons in the DRD/DRV. We then utilized optogenetic approach to 
excite BLA projecting 5-HT neurons in the DR (Figure 8) while assessing anxiety-like and 
conditioned fear behaviors. 
 
 
Figure 8 – Illustration of a midsagittal section of a rat brain indicating the intracranial 
injections carried out in Chapter III. Illustration of what tracers [i.e., Phaseolus vulgaris 
leucoagglutinin (Phal) or Cholera Toxin B (CTB)], toxins [i.e., control IgG conjugated to 
saporin (Con-IgG-SAP) or anti-serotonin transporter conjugated to saporin (SERT-SAP)], 
or viruses [i.e., CAV-CMV-Cre, AAV-EF1a-DIO-eYFP control, or AAV-EF1a-DIO-
ChR2-eYFP] were injected into the dorsal and ventral dorsal Raphe nucleus (DRD/DRV) 
or basolateral amygdala (BLA) from each experiment. Abbreviations: ac, anterior commis-
sure, pc, posterior commissure, oc, optic chiasm. 
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3.2. Results 
3.2.1. Experiments 1 and 2: Effects of retrograde and anterograde tracing of potential DR 
projections to BLA 
Our experiment 1 showed that injections of the retrograde tracer CTB into the BLA 
(Figure 8 and Figure 9a) led to CTB expression in many TPH+ neurons in the DRD and 
DRV (Figure 9c-d), but few in the lwDR or MR (Figure 9e-f, see topography of midbrain 
TPH+ neurons in Figure 9b, n=4) with only 5-8% of CTB being expressed in TPH- neu-
rons. 
Anterograde Phal injections into the midbrain midline DR in the experiment 2 (Fig-
ure 8) induced expression of Phal within the DR that was most highly expressed in the 
DRV, then DRD (Figure 10a). Phal+ fibers were most highly expressed in the BLA, but 
also in surrounding cortex and CeA (Figure 10b-c). In experiment 480074702-DR from 
the Allen Brain Atlas (mouse connectivity), injecting a Cre-dependent AAV-hSyn-EGFP 
construct into the midline DR of a SERT-Cre mouse led to local expression of EGFP flu-
orescence in the DR (Figure 10d), distal EGFP fluorescence in serotonergic fibers in the 
BLA and CeA and surrounding cortex (Figure 10e). 
 
3.2.2. Experiment 3: Effects of SERT-SAP injections in the BLA on behavior and immuno-
histochemical validation of approach 
Compared to the control IgG-SAP group, injection of SERT-SAP into the BLA 
significantly reduced the density of local SERT+ fibers in the BLA by ~90% (t(9)=19.6, 
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p<0.001; Figure 11a, n=6 IgG-SAP, 5 SERT-SAP, one section damaged in control IgG-
SAP group). In contrast, injection of SERT-SAP into the BLA resulted in approximately 
10% reduction in the density of SERT+ fibers in the perifornical hypothalamus (control  
 
Figure 9 – Retrograde tracing from the basolateral amygdala (BLA). (a) Injection site il-
lustrating Cholera Toxin b subunit (CTB, Alexa 488, green) injection into the BLA. (b) 
Topography of tryptophan hydroxylase (TPH, Cy3, red) immunoreactive serotonergic neu-
rons in the midbrain Raphe nuclei [i.e., dorsal (DRD), ventral (DRV) and lateral wing 
(lwDR) divisions of the dorsal (DR) and median Raphe (MR) nuclei] In panels (c) through 
(e) are immunohistochemistry reactions against TPH and CTB highlighting many BLA 
projecting neurons originating from (c) DRD and (d) DRV, but only a few from (e) lwDR 
and (f) MR. Abbreviations: CeA, central amygdala; opt, optic tract. 
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Figure 10 – Anterograde tracing from the rat and mouse dorsal Raphe nucleus to the ba-
solateral (BLA) and central (CeA) amygdala. (a) Coronal sections of the midbrain and 
pontine dorsal Raphe nucleus (DR) illustrating Phaseolus vulgaris leucoagglutinin (Phal)-
immunostained cells and fibers following injection of the anterograde tracer into the mid-
line dorsal (DRD) and ventral (DRV), but not lateral wings (lwDR) divisions of the DR 
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site, data not shown), which receives sparse collateral projections from 5-HT neurons that 
project to the BLA (Muzerelle et al., 2016). Intra-BLA injections of SERT-SAP had no 
effect (i.e., no treatment x time interaction or main effect of treatment) on fear acquisition 
(F(1,10)=0.3, p=0.591; F(1,10)=0.4, p=0.550, Figure 11b, n=7 IgG-SAP, 5 SERT-SAP) 
and consolidation (F(4,40)=1.2, p=0.305; F(1,10)=2.3, p=0.161, not shown), but did reduce 
overall freezing response during fear recall/extinction [i.e., there was a main effect of treat-
ment (line graph F(1,10)=7.52, p=0.02, bar graph t(10)=2.5, p=0.03), Figure 11c, n=7 IgG-
SAP, 5 SERT-SAP, but no treatment x time interaction (F(4,40)=0.6, p=0.645)]. No effects 
of intra-BLA injection of SERT-SAP on SI were detected (t(10)=1.1, p=0.285, Figure 11d, 
n=7 IgG-SAP, 5 SERT-SAP). In control IgG-SAP rats, bilateral injections of CTB into the 
BLA led to CTB expression in many TPH+ neurons in the DRD and DRV, but few in the 
lwDR or MR (see topography of midbrain TPH+ neurons in Figure 9a, and co-localization 
between CTB and TPH in the DRD, DRV, lwDR, and MR in Figure 11e) with 5-8% of 
CTB being expressed in TPH- neurons. SERT-SAP injections into the BLA also reduced 
the total number of TPH+ neurons in the DRD (t(10)=2.1, p<0.05) and DRV (t(10)=1.7, 
p<0.05), but not in the lwDR (t(10)=0.98, p=0.349) or MR (t(10)=1.34, p=0.123; Figure 11f,  
[see orange/brown 3,3’-diaminobenzidine tetrahydrochloride (DAB) chromogen im-
munostaining of Phal with purple cresyl violet staining of cells]. Numbers at bottom of 
each photograph indicate rostrocaudal level [mm from bregma; (Paxinos and Watson, 
1998)]. (b) Coronal sections of the BLA and CeA nuclei of the amygdala with dashed line 
delineating nuclei and solid lines drawn over Phal-immunoreactive anterograde projections 
from DRD/DRV at two bregma levels indicated at bottom left. Boxes in the illustration on 
the left indicate where high magnification photos were taken and shown in (c) for BLA and 
CeA (orange/brown Phal-immunoreactive fibers with purple cresyl violet-stained cells. (d) 
Photos represent coronal sections of the DR from a serotonin transporter (SERT)-Cre 
mouse where a Cre-dependent AAV with a fluorescent reporter was injected into the DR 
and provided by the connectome of the Brain in the Allen Brain Atlas (Oh et al., 2014). e) 
Photos are coronal sections of the BLA and CeA from the SERT-Cre mice in (d) showing 
expression of 5-HT terminals from the midline DR. Image credit for parts (d) and (e): Allen 
Institute for Brain Science. 
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Figure 11 – Effects of bilateral injections of anti-serotonin transporter- (SERT-) or control 
(IgG-) saporin (SAP) into the basolateral amygdala (BLA) on anxiety-related behavior, 
fear acquisition, and fear recall/extinction. (a) reduced local SERT+ fibers in BLA, * indi-
cates p < 0.001 (BLA) in a two-tailed unpaired t-test (see representative photos of BLA to 
the right); (b) Intra-BLA SERT-SAP did not alter conditioned fear freezing following 5 
tone (T) + shock (S) pairings during fear acquisition session, but (c) did reduce freezing 
response when presented with the tone (T) only during recall/extinction session (overall 
treatment effect). (d) Intra-BLA SERT-SAP had no effect on social interaction time. In-
jecting a retrograde tracer (Cholera Toxin B subunit: CTB) bilaterally into the BLA at the 
end of behavioral experiments induced co-localization of CTB (Alexa fluor 488, green) in 
midbrain serotonergic neurons (TPH, Cy3, red) of control IgG-SAP injected rats in (e), 
which shows fluorescent photomicrographs from different division of dorsal (DR) and me-
dian Raphe (MR) nuclei with top row being from control IgG-SAP injected rats and bottom 
from SERT-SAP injected rats. (f) Reduced total number of tryptophan hydroxylase (TPH)+ 
neurons in the ventral (DRV) and dorsal (DRD), but not in the lateral wings (lwDR) divi-
sions of the DR, nor the MR; (g) and reduced number of CTB+/TPH+ neurons in the DRV, 
79 
n=7 IgG-SAP, 5 SERT-SAP for all). SERT-SAP injections into the BLA did not change 
the total number of CTB+/TPH+ neurons in MR (t(8)=2.2, p=0.0581), but led to mild de-
creases in the lwDR (t(8)=4.6, p<0.005), and greater reductions occurring the DRD (t(8)=5.9, 
p<0.001) and DRV (t(8)=5.4, p<0.001; Figure 11g, n=5 each, two control IgG-Sap rats lost 
cap after behavior so no CTB was able to be injected). SERT-SAP did not alter the number 
of TPH- neutral red-expressing cells neither in the DRD (t(10)=3.9, p=0.136) nor in the DRV 
(t(10)=4.6, p=0.716, n=7 IgG-SAP, 5 SERT-SAP, Figure 11h). 
 
3.2.3. Experiment 4: Effects of optogenetic excitation of DR-BLA projections on behavior 
and neural network 
Using an intersectional genetics approach, we injected CAV-CMV-Cre bilaterally 
into the BLA, then either a Cre-dependent control (AAV-EF1a-DIO-eYFP) or the chan-
nelrhodopsin-expressing (AAV-EF1a-DIO-ChR2-eYFP) constructs into the midline DR. 
In animals injected with control construct we observed strong co-localization of eYFP with 
TPH+ neuron in DRV and some in DRD (Pearson correlation coefficient 0.85) with almost 
none in lwDR (Figure 12a, n=7, photo on the left) or MR (not shown). In the ChR2-in-
jected animals we observed ChR2-eYFP expression within fibers in DRV, DRD (Figure 
12a, n=8, photo to the right), BLA (Figure 12b, photo on the left, n=8) that co-localized 
with SERT+ fibers (Figure 12b, photo on the right, Pearson correlation coefficient 0.95). 
Wireless optogenetic excitation of the midline DR did not alter fear acquisition [i.e., there  
DRD, and lwDR, but not MR. (h) In contrast, intra-BLA SERT-SAP did not alter the num-
ber of neutral red+ cells that were not colocalized with TPH in neither the DRV (p = 0.716) 
nor DRD (p = 0.398). n’s per group were 7 IgG-SAP and 5 SERT-SAP for all panels except 
part g, which n=5 each. Bars represent means and standard errors of the means (SEM). 
Abbreviations: mlf, medial longitudinal fasciculus; Aq., cerebral aqueduct. 
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Figure 12 – Bilateral injections of CAV-CMV-Cre into the basolateral amygdala (BLA) 
and unilateral injections of AAV-EF1a-DiO-ChR2-eYFP into the dorsal/ventral divisions 
(DRD/DRV) of dorsal Raphe (DR) and effects of optical stimulation of cell bodies in the 
DR. (a) Cre-dependent expression of eYFP (green) within soma of tryptophan hydroxylase 
(TPH)+ neurons in the DRD and DRV (Cy3, red, photo on the left) and also ChR2 (eYFP, 
green) on terminals in the DRD/DRV near TPH+ neurons (Cy3, red, photo on the right). 
(b) Photo represents ChR2-expressing fibers (eYFP, green) in the BLA (photo on the left) 
that are also co-localized with serotonin transporter (SERT, Cy3, red, photo on the right). 
Wireless optogenetic excitation of DRD/DRV (c) did not alter conditioned fear freezing 
following 5 tone (T) + shock (S) pairings on fear acquisition session; (d) but did increase 
freezing response when presented with the tone (T) only during recall/extinction session 
(* indicates p<0.05, ChR2 main effect); (e) reduced social interaction time; and (f) in-
creased cFos within TPH+ neurons in the DRV and DRD, but not lateral wings (lwDR) or 
median Raphe (MR), and increased cFos in the BLA (* indicates p<0.05). Line and bar 
graphs represent means and standard errors of the means (SEM). (g) Representative pho-
tomicrographs of nuclear cFos (blue/black chromogen) and cytoplasmic TPH (orange 
brown chromogen) immunohistochemistry in the DRV of a control AAV (left) and the 
ChR2 AAV (right). (h) Representative photomicrographs of nuclear cFos (blue/black chro-
mogen) and cytoplasmic neutral red staining in the BLA of a control AAV (left) and the 
ChR2 AAV (right). 
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was no treatment x time interaction (F(1,13)=0.3, p=0.565), or main effect of treatment 
(F(1,13)=3.5, p=0.084, Figure 12c, n=7 eYFP, 8 ChR2), nor consolidation (F(4,52)=0.8, 
p=0.543 and F(1,13)=3.8, p=0.072, not shown), but it did enhance overall freezing during 
fear recall/extinction (ChR2 main effect: line graph, F(1,13)=7.8, p=0.015, bar graph 
t(13)=2.8, p=0.023), but there was no treatment x time interaction (F(4,52)=0.8, p=0.538, Fig-
ure 12d, n=7 eYFP, 8 ChR2). Here, blue light stimulation in the DRV decreased SI time 
(t(12)=2.59, p=0.023, Figure 12e, n=7 each), and also increased cellular cFos response in 
TPH+ neurons in the DRD (t(12)=3.2, p=0.0038) and DRV (t(12)=2.9, p=0.0066, Figure 12f-
g), but not in TPH+ neurons in the lwDR (t(12)=0.3, p=0.785) or MR (t(12)=0.3, p=0.763, 
Figure 12f, n=7 each, one ChR2 rat was removed due to poor staining). The ChR2-ex-
pressing group also had increased cFos in the BLA (t(13)=3.1, p=0.0042, Figure 12f, h, n=7 
eYFP, 8 ChR2). 
 
3.3. Discussion 
Overall, our major findings support the hypothesis that serotonergic neurons within 
DRD/DRV that project to the amygdala nuclei may enhance anxiety-related and condi-
tioned fear behaviors. 
In our first experiment we confirmed that injections of a retrograde tracer into the 
BLA resulted in many CTB+/TPH+ neurons in the DRD and DRV, but few in lwDR and 
MR, with approximately 92% of co-localization between CTB+ and TPH+. Our data are 
consistent with Hale and colleagues (Hale et al., 2008) that demonstrated substantial co-
localization of DRV and DRD serotoninergic neurons after injecting the retrograde tracer 
CTB into the BLA, and thus reproducible. Our anterograde tracer into the midline 
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DRD/DRV in experiment 2 revealed a high density of fibers in the BLA, and this pattern 
further confirmed by referencing the connectome of the mouse brain in the Allen Brain 
Atlas (Oh et al., 2014), where injections of a Cre-dependent AAV with a fluorescent re-
porter into the midline DR in a SERT-Cre mouse (Gong et al., 2007) resulted in dense 
fibers within the BLA. Even though it was already expected, the similar pattern of antero-
grade tracing provided us insight on how conserved the DR projections to the BLA are 
between these two species, an important issue that should be considered when doing pre-
clinical research aiming for translational implications. Collectively, the combination of our 
anterograde and retrograde tracing studies allowed us to determine not only which site 
within the BLA to pursue for our following gain and loss of function experiments, but more 
importantly it showed consistency with the literature, an integral part of research guidelines 
encouraged by NIH to strengthen published studies. 
In our third experiment, we wanted to confirm previous study in which we injected 
the serotonin neurotoxin 5,7-DHT into the BLA, resulting in reduced local 5-HT concen-
tration and anxiety- and fear-related behavioral responses as assessed by reductions in SI 
time and in conditioned fear behaviors, respectively (Johnson et al., 2015b). In order to do 
this, we injected a SERT-SAP into the BLA, which did not alter SI behavior but did atten-
uate fear-associated freezing during consolidation and extinction compared to control 
group injected with IgG-SAP. We confirmed that the SERT-SAP group had ~90% reduc-
tion in the density of SERT immunostaining in the BLA and ~10% reduction in the density 
of SERT immunostaining in the perifornical hypothalamus, a structure that receives less 
innervation arising from midline DR (Muzerelle et al., 2016), thus a control site. Injection 
of SERT-SAP into the BLA also reduced the total number of TPH+ neurons in the DRV 
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and DRD, but not in the lwDR or MR. When we assessed CTB+/TPH+ neurons we saw a 
significant reduction in the DRV and DRD, but also in the few CTB+/TPH+ neurons in the 
lwDR, but not the MR. We also noted that only ~8% of CTB-expressing cells in the DR 
and MR were non-serotonergic. Overall, this loss-of-function approach is consistent with 
our previous work (Johnson et al., 2015b) and previous 5,7-DHT study in which reductions 
of serotonin signaling in the amygdala following contextual fear conditioning reduced re-
call of fear-associated freezing (Izumi et al., 2012). Although we did not see a significant 
reduction in SI here, we (Johnson et al., 2015b) and others (File et al., 1981) did see sig-
nificant reductions in SI following 5,7-DHT injections into the amygdala. 
In light of our findings that 92% of neurons in the DR that project to the BLA are 
serotonergic and to further determine this pathway’s role in regulating anxiety- and fear-
related behaviors, in experiment 4 we utilized intersectional genetics by first injecting into 
the BLA a retrogradely trafficked CAV that expresses Cre-recombinase (Soudais et al., 
2001) which allowed us to selectively introduce a Cre-dependent ChR2 (or its eYFP con-
trol) into BLA-projecting DR neurons (DRD/DRV-BLA projections). After immunostain-
ing for TPH in control rats, we determined that all eYFP was co-localized with TPH, with 
a large expression in the DRV, a few labeled neurons in the DRD, and almost none in the 
lwDR or the MR. In the animals injected with ChR2 AAV, the eYFP expression was pri-
marily located in fibers in the midline DR and BLA. Altogether, these data further con-
firmed our anatomical results from our first three experiments, i.e. the tracing studies and 
the SAP injections. The terminals within the BLA were almost entirely co-localized with 
SERT, and were, thus, serotonergic. Optogenetic excitation of ChR2-eYFP, but not eYFP 
control, in the midline DR did not alter fear acquisition nor consolidation, but did increase 
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freezing during initial tone presentation during recall/extinction session. The stimulation 
also led to anxiety-associated reduction in SI time. We then verified that optogenetic stim-
ulation increased cellular cFos response within serotonergic neurons in the DRV and DRD 
and also within the cells in the BLA.  
Overall, the aforementioned data support the hypothesis that serotonergic neurons 
in the DRD/DRV that project to the BLA enhance anxiety-like behavioral and conditioned 
fear response. It is important to re-emphasize that these experiments lesioned or optoge-
netically excited 5-HT neurons in the midline, of which many are most likely express glu-
tamate as a co-transmitter (Calizo et al., 2011). Baratta and colleagues injected a Cre-de-
pendent Arch-GFP AAV into the midline DR of SERT-Cre mice and observed that opto-
genetic inhibition of the DR attenuated only stress-enhanced fear (Baratta et al., 2016). The 
lack of effect on normal cue-induced fear may have been due to use of a reduced shock 
intensity or species differences. Future studies are needed to understand how exactly le-
sioning or exciting DRD/DRV 5-HT projections to the BLA is altering electrophysiologi-
cal activity of BLA projection neurons that control anxiety- and fear-related behavioral 
responses. In regards to what is known about 5-HT effects in the BLA there are two factors 
to consider: 5-HT induces both excitatory and inhibitory actions depending on the receptor 
subtype and 5-HT receptor subtypes are expressed on both GABAergic interneurons and 
glutamatergic projection neurons (McDonald and Mascagni, 2007). Glutamatergic princi-
pal neurons that enhance anxiety and conditioned fear responses have high expression of 
excitatory 5-HT2C receptors in the dorsal part of the BLA [i.e., lateral amygdala; 
(Greenwood et al., 2012)] and 5-HT excites these neurons via the 5-HT2C receptor 
(Yamamoto et al., 2014). Additionally, acute injections of 5-HT, an SSRI, or a 5-HT2C 
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receptor agonist into the BLA induce anxiogenic responses (Vicente and Zangrossi, 2012). 
Yet, application of 5-HT in the BLA region initially produces inhibitory responses by de-
polarizing GABAergic interneurons (Bocchio et al., 2015; Rainnie, 1999) which have high 
expression of excitatory 5-HT2A receptors (McDonald and Mascagni, 2007) and play a role 
in the depolarization (Bocchio et al., 2015). However, there is previously mentioned evi-
dence that stress- and fear-related conditions can produce prolonged release of 5-HT that 
may lead to loss of local inhibition (Amat et al., 1998; Zanoveli et al., 2009), and there is 
evidence that this can potentially reduce local GABA inhibition and produce excitation of 
glutamatergic neurons. For instance, stress exposure can induce downregulation of 5-HT2A 
receptor expression in the BLA and reduce 5-HT’s effects on local GABAergic tone (Jiang 
et al., 2009). This could lead to excitation of glutamatergic neurons, which play a critical 
role in enhancing fear conditioning. This hypothesis is supported by previously mentioned 
studies where initial treatment of rats with SSRIs increases extracellular 5-HT in the amyg-
dala by ~150% (Bosker et al., 2001), enhances initial fear-related freezing response in ro-




These data support the role of DR 5-HT projections to the BLA in the modulation 
of anxiety-like behavior and conditioned fear freezing response. Furthermore, our data us-
ing intersectional genetics approach and SERT-SAP are consistent with previous experi-
ments where increasing or depleting 5-HT levels in the BLA region respectively enhances 
or diminishes conditioned fear behavior and further support the hypothesis that increased 
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5-HT activity within the amygdala may be an important mechanism in the pathophysiology 
of severe anxiety disorders, as well as trauma-related disorders, such as PTSD (Wellman 
et al., 2007; Zanoveli et al., 2009). 
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4. Chapter IV: Identification of a Novel Perifornical Hypothalamic Projecting Sero-
tonergic System that Inhibits Innate Panic and Conditioned Fear Responses 
 
4.1. Introduction of Chapter IV 
Panic is an innate adaptive response to cope with an imminent threat with an inte-
grated pattern of behaviors (e.g., fighting or fleeing), and also include cardiovascular, res-
piratory, and endocrine changes. The seminal work of Hess and Brugger (Hess and 
Brugger, 1943), determined that the perifornical hypothalamic region (PeFR) was a puta-
tive panic generating site where electrical stimulation in cats produced panic associated 
defense reactions (e.g., piloerection, hissing, and arching of back). Subsequent work in 
rodents determined that pharmacological stimulation or disinhibition of the PeFR increases 
behavioral (running and escape) components of the “fight-or-flight” response that occur 
alongside increased physiological [blood pressure (BP), tachycardia, thermal changes, and 
hyperventilation) (Anderson and DiMicco, 1990; Di Scala et al., 1984; Duan et al., 1996; 
Markgraf et al., 1991; Olds and Olds, 1962; Shekhar et al., 1990; Shekhar and DiMicco, 
1987; Soltis and DiMicco, 1992). In human, stimulating the PeFR produces self-reports 
that they fear they are dying or having a panic attack (PA) as well as similar physiological 
responses (i.e., tachycardia, increased BP, thermal sensations, and hyperventilation) 
(Rasche et al., 2006; Schoenen et al., 2005). 
An interesting candidate underlying the panic responses within the PeFR is the 
orexin (OX) neuropeptide synthesizing neuronal population almost exclusive to this region 
(Peyron et al., 1998b; Thannickal et al., 2000). These OX producing neurons were found 
to be critical for the expression of anxiety- and panic-like responses in rats (Johnson et al., 
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2010) as panic-associated behaviors and cardiovascular responses elicited by 20% CO2 
inhalation (a suffocation inducing stimuli) were attenuated upon pharmacological inhibi-
tion of the OX1, but not OX2 receptors (Johnson et al., 2015a, 2012c). More importantly, 
OX was found to be elevated in the cerebrospinal fluid of human subjects with panic when 
compared to controls (Johnson et al., 2010), and in a recent clinical trial, the dual OX re-
ceptor antagonist suvorexant was found to improve anxiety symptoms in patients suffering 
from insomnia (Nakamura and Nagamine, 2017). 
Serotonin (5-HT) has long been shown to play a critical role in anxiety and psycho-
logical trauma related disorders, such as panic (PD) and post-traumatic stress disorders, 
respectively [(for review, see (Hale et al., 2012; Hood et al., 2016)]. Within the PeFR, 5-
HT appears to inhibit escape behaviors from local excitation or disinhibition and also stress 
induced endocrine responses via the 5-HT1A receptor. This is suggestive that 5-HT inhibits 
escape behaviors associated with panic but did not assess other aspects of an integrative 
panic response such as cardioexcitation, thermal changes and only assessed 5-HT’s role 
via the 5-HT1A and 5-HT2A receptors (da Silva et al., 2011; Nascimento et al., 2014). In 
support of a panicolytic role for the 5-HT1A receptor, OX neurons express 5-HT1A receptor 
(Collin et al., 2002; Muraki et al., 2004) and receive dense projections from the sero-
tonergic system (Ljubic-Thibal et al., 1999; Muzerelle et al., 2016). Additionally, electro-
physiological studies showed that 5-HT directly inhibits OX neurons, an effect that is 
blocked with a 5-HT1A receptor antagonist (Muraki et al., 2004). 
However, there is a gap in knowledge in serotonergic regulation of the PeFR in the 
context of panic-associated behaviors and physiological responses since site specific injec-
tions of drugs ignore circuit-specific neurotransmission and its physiological properties 
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that occur in vivo. Therefore, we hypothesize that optogenetic excitation of serotonergic 
fibers at the PeFR originating from the DR/MR will attenuate the physiological and behav-
ioral components of panic-like responses induced by a panicogenic/suffocation related 
stimuli (7.5% and 20% CO2 exposure). We also hypothesized that selective lesioning of 5-
HT fibers in the PeFR would lead to exacerbated physiological and behavioral components 
of panic-like responses induced by a panicogenic/suffocation related stimuli (7.5% and 
20% CO2 exposure). Finally, since the OX PeFR system projects to the amygdala (Peyron 
et al., 1998b) where it enhances fear conditioned behaviors (Dustrude et al., 2018; Flores 
et al., 2014), we also hypothesized that PeFR-projecting serotonergic system would play 
an inhibitory role on conditioned fear behaviors. 
In order to test these hypotheses, we used circuit-based loss- and gain-of-function 
studies to investigate the role of 5-HT originating from the DR/MR in the context of innate 
panic-associated behaviors and physiology and also in conditioned fear behaviors. To fur-
ther confirm that activating the PeFR not only induced panic-associated behaviors and 
physiology, but also conditioned avoidance, we utilized wireless optogenetics to excite 
glutamatergic neurons in the PeFR. We then utilized a gain-of-function approach with 
wireless optogenetic stimulation to selectively activate the PeFR-projecting serotonergic 
system while assessing innate anxiety- and panic-associated physiology and behaviors. Fi-
nally, in our loss-of-function study we first injected a selective anti-5-HT transporter-sap-
orin toxin (SERT-SAP) into the PeFR and assessed anxiety-like and conditioned fear re-
sponses, then injected a retrograde tracer into the same site to confirm lesioning of the 




4.2.1. Experiment 1: Effects of Optogenetic Stimulation of PeF Glutamatergic Neurons 
Our immunohistochemistry showed bright green fluorophore colocalized with OX+ 
neurons within the PeFR (Pearson correlation coefficient 0.63, Figure 13b). Optogenetic 
activation of glutamatergic cell bodies of ChR2-injected rats in the PeF led to robust in-
creases BP (virus x time interaction F(30,240)=14.26, p<0.0001), heart rate (HR, 
F(30,240)=6.47, p<0.0001, Figure 13c), and general motor activity (virus x time interaction 
F(30,240)=3.37, p<0.0001, Figure 13d) qualitatively analyzed as aversive behaviors [i.e. long 
periods of exophthalmos (p<0.0001) and immobility (p<0.0001) followed by running 
(p=0.007), Figure 13d, inset]. Optogenetic stimulation also virtually abolished SI time 
(two-tailed, unpaired Student’s t test, p<0.0001, Figure 13e) without promoting aggressive 
behavior. To further test whether ChR2 stimulation could induce conditioned aversive 
memory, we paired optical stimulation to one side of a two-chamber apparatus and ob-
served avoidance from the stimulation chamber (virus effect F(1,8)=22.91, p=0.001) during 
optical stimulation (p=0.001), short- (p=0.01), and long-term (p=0.01, n=5 each, Figure 
13f) sessions. Lastly, optical stimulation 90 min prior to euthanasia induced a marked in-
crease in cFos in OX+ neurons (Mann-Whitney test, p=0.007) (Figure 13g). 
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Figure 13 – Optogenetic stimulation of glutamatergic cell bodies in the perifornical hypo-
thalamus (PeF) elicits escape and cardiovascular excitation that resembles panic. (a) Sche-
matic illustration of rats bilaterally injected with AAV5-CaMKIIa-ChR2-eYFP or its con-
trol AAV-CaMKIIa-eYFP (not illustrated) into the PeF, and photostimulation with bilat-
eral wireless optical fiber implants over the PeF. (b) Representation of confocal images 
from rats expressing eYFP fibers (ChR2, green, left panel) and soma (control, green, right 
panel) and orexin A peptide (OXA)-expressing neurons (red, Alexa 640). Note co-locali-
zation between OXA+ and eYFP+ soma in control group (Pearson correlation coefficient 
0.63). (c) ChR2 rats had a significant increase in blood pressure (BP, circle signs, left y 
axis), heart rate (HR, square signs, right y axis), and (d) general motor activity (circle and 
square signs, *, p<0.01, between subjects differences using a Fisher’s LSD post hoc test) 
and its qualitative behavioral responses (inset two-tailed, unpaired Student’s t test, *, 
p<0.01), i.e. running (Run.), immobility (Immo.) and exophthalmos (Exoph.), during opto-
genetic stimulation (10 Hz, 10 ms, 1.5 mW, LED on-LED off, 5 min). Data obtained from 
freely moving rats surgically implanted with radiotelemetry probes. Note stable baselines 
for both BP, HR, and general motor activity (t-5 to t-1). (e) ChR2 rats had significant less 
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4.2.2. Experiment 2: Anatomical Confirmation of PeF-projecting Serotonergic Systems 
Utilizing CTB. 
Our experiment 2 showed that injections of the retrograde tracer CTB into the PeF 
(a) led to CTB expression in TPH+ neurons in the lwDR and MR (Figure 14e-f), but few 
in the DRD or DRV (Figure 14c-d, see topography of midbrain TPH+ neurons in Figure 
14b, n=4) with only 5-8% of CTB being expressed in TPH- neurons. This study revealed 
that 92-95% of PeF-projecting neurons within lwDR/MR express TPH, thus are sero-
tonergic. 
 
4.2.3. Experiment 3: Effects of Optogenetic Stimulation of PeF-Projecting lwDR/MR Fi-
bers on Physiology and Behaviors of Anxiety- and Panic-Associated Challenges 
Using the combination of a two-virus approach, we took advantage of the highly 
selective serotonergic projections from the lwDR/MR to the PeF (lwDR/MR→PeF) and 
injected the retrogradely trafficked CAV-CMV-Cre bilaterally into the PeF and either a 
Cre-dependent eYFP control (AAV-EF1a-DIO-eYFP) or active (Cre-dependent) ChR2 
(AAV-EF1a-DIO-ChR2-eYFP) into the lwDR/MR. We used this approach to activate the 
lwDR/MR→PeF ChR2-expressing fibers (lwDR/MR→PeF:ChR2 or its control :eYFP 
social interaction (SI) time test during photostimulation of the PeF in the SI test (two-tailed, 
unpaired Student’s t test, *, p<0.0001). (f) ChR2 rats had a significant lower difference 
score (percentage time spent in stimulation side minus percentage time spent in non-stim-
ulation side, *, p<0.05, between subjects differences using a Fisher’s LSD post hoc test) 
than the control group during optical stimulation (Stim.), short- (Short.), and long-term 
(Long.) sessions, but not during habituation (Hab.) in the real-time place preference/avoid-
ance (RTPP/A) test. (g) ChR2 rats (right panel) had significant more activation of the im-
mediate early gene cFos colocalized with OXA+ neurons (Mann-Whitney test, *, p=0.007) 
than control group (left panel). Abbreviations: 3V, third ventricle; f, fornix; 
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from this point forward, Figure 15a). In animals injected with active ChR2, we observed 
eYFP+ fibers in the PeF (Figure 15b, photo on the left) that co-localized with SERT signal 
(Figure 15b, photo in the middle). Expression of eYFP+ neurons were mostly localized in 
 
Figure 14 – Retrograde tracing from the perifornical hypothalamus (PeF) using Cholera 
toxin B subunit (CTB). (a) Injection site illustrating CTB injection (Alexa 567, red) injec-
tion into the PeF. (b) Topography of tryptophan hydroxylase (TPH, Alexa 488, green) im-
munoreactive serotonergic neurons in the midbrain Raphe nuclei [i.e., median Raphe (MR) 
nucleus and dorsal (DRD), ventral (DRV) and lateral wing (lwDR) divisions of the dorsal 
Raphe (DR) nucleus] In panels (c) through (e) are immunohistochemistry reactions against 
TPH and CTB highlighting mostly PeF-projecting serotonergic neurons originating from 
(e) lwDR and (f) MR, but only a few from (c) DRD and (d) DRV. Abbreviations: f, fornix; 
VMH, ventromedial hypothalamus. 
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the lwDR (Figure 15b, photo on the right) and MR (not shown), with almost none in 
DRD/DRV. Surprisingly, optogenetic stimulation of lwDR/MR→PeF:ChR2 animals led 
to a mild increase in BP (virus effect, F(1,17)=4.2, p=0.05), HR (F(1,17)=12.83, p=0.002, Fig-
ure 15c), and locomotion [i.e. general exploratory/self-directed behaviors: sniffing 
(p=0.008), rearing (p=0.02), and grooming (p=0.02), n=10 DIO-eYFP, 9 DIO-ChR2, Fig-
ure 15d]. Next, optical stimulation of lwDR/MR→PeF:ChR2 paired to open arm explora-
tion in the EPM greatly increased the total time spent in this region of the apparatus not 
only during, but also after paired optogenetic stimulation (virus effect F(1,14)=12.34, 
p=0.003, Figure 15e). The SI testing was carried out in four different sessions tested 
throughout four consecutive days: baseline (n=9 eYFP, 10 ChR2), optical stimulation (n=9 
each), bright light (n=9 each), and 20% CO2 (n=7 each) challenges (n’s differ between 
sessions due repeated disconnections of optogenetic stimulator during SI testing). This pro-
cedure resulted in a significant virus (F(1,61)=23.8, p<0.0001), session (F(3,61)=10.42, 
p<0.0001), and interaction (F(3,61)=4.08, p=0.01) effects, with optical stimulation of ChR2 
increasing SI time for all sessions except baseline (Figure 15f). Exposure to RTPP/A led 
to a strong place preference behavior of ChR2 group [virus x session (F(3,39)=3.75, p=0.01)] 
during optical stimulation (p=0.001), 45 min (p=0.01), and 24 hour (p=0.03) sessions (n=7 
DIO-eYFP, 8 DIO-ChR2; Figure 15g). Lastly, optical stimulation of 
lwDR/MR→PeF:ChR2 attenuated CO2-induced (7.5 and 20%) increases in BP compared 
to eYFP (virus x time interaction F(19,285)=2.61, p=0.0003 and F(19,304)=2.61, p=0.0003, re-
spectively, Figure 15h). After activation of lwDR/MR→PeF fibers, there was decreased 










4.2.4. Experiment 4: SERT-SAP Injection into the PeF Selectively Lesions Local SERT 
Fibers and Their Associated Cell Bodies in the lwDR and MR. 
SERT-SAP injection in the PeF significantly reduced the density of local SERT-
positive fibers in the PeF by approximately 42% (two-tailed, unpaired Student’s t test, 
p=0.001), but did not change the density of local amygdala fibers (control site, n=7 each, 
Figure 16b), which receives sparse fibers from PeF-projecting 5-HT neurons (Muzerelle 
et al., 2016), if any. In control IgG-SAP rats, bilateral injections of CTB into the PeF led  
Figure 15 – In the gain-of-function study, optogenetic stimulation of perifornical hypo-
thalamus (PeF)-projecting serotonergic terminals reduced anxiety- and panic-associated 
responses and promoted increased exploration. (a) Schematic illustration of rats bilaterally 
injected with AAV5-DIO-ChR2-eYFP or AAV5-DIO-eYFP (not illustrated) into the dor-
sal Raphe nucleus (DR) and CAV-CMV-Cre into the PeF, and photostimulation with bi-
lateral wireless optical fiber implants over the PeF. (b) Representation of confocal images 
from rats expressing ChR2-eYFP fibers (green, photo on the left) that colocalized with 
serotonin transporter (SERT, red, Alexa 640, photo in the middle) in the PeF and ChR2-
eYFP fibers (green, photo on the right) in the lateral wings (lwDR), and less fibers in the 
dorsal (DRD) and ventral (DRV) DR with tryptophan hydroxylase (TPH)+ neurons (red, 
Alexa 640). Median Raphe nucleus (MR) is not shown. Numbers indicate distance, in mm, 
from bregma according to (Paxinos and Watson, 1998). Optogenetic stimulation (20 Hz, 5 
ms, 10 mW, LED on-LED off, 5 min) of lwDR/MR→PeF:ChR2 rats induced a significant 
(c) increase in blood pressure (BP, circle signs, left y axis), heart rate (HR, square signs, 
right y axis) and (d) general motor activity (circle and square signs). (e) 
lwDR/MR→PeF:ChR2 rats had increased open arm exploration during (1-5 min) and post 
(6-10 min, line graphs, left y axis) optogenetic stimulation in the elevate plus-maze (EPM) 
test (see total time, in s, of open arm exploration in bar graphs and right y axis). Compared 
to controls, photostimulation of lwDR/MR→PeF:ChR2 rats (f) increased social interaction 
(SI) time during stimulation (Stim.), bright-light (B.L.), and CO2 sessions [symbols are: 
*comparison between groups; #within groups compared to baseline (Basel.)]; (g) increased 
the difference score (percentage time spent in stimulation side minus percentage time spent 
in non-stimulation side) real-time place preference/avoidance (RTPP/A) test; (h) attenu-
ated CO2-induced increases in BP in the CO2 challenge + photostimulation (photostim.) 
test; and (i) attenuated cFos responses in in orexin (OX)+ neurons in the PeF. Graphs in (c-
h) are two-way ANOVA followed by Fisher’s LSD post hoc test, whereas bar graphs in 
(c, e, and i) are unpaired Student’s t test. * and # are p<0.05. Abbreviations: 3V, third 





Figure 16 – Injection of saporin (SAP) toxin conjugated to the serotonin transporter anti-
body (SERT-SAP) lesions local perifornical hypothalamus (PeF) SERT+ fibers and their 
associated tryptophan hydroxylase (TPH)+ cell bodies the median (MR) and lateral wings 
(lwDR) division of the dorsal Raphe (DR). (a) Schematic illustration of rats bilaterally 
injected with SERT-SAP or its control IgG-SAP (not illustrated) and the retrograde tracer 
Cholera toxin b subunit (CTB) into the PeF. (b) SERT-SAP injected rats had significant 
reduced (two-tailed, unpaired Student’s t test, *, p=0.001) expression of SERT+ fibers in 
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to CTB expression in many TPH+ neurons in the MR and lwDR, but few in DRD and DRV 
(see topography of midbrain TPH+ neurons in Figure 16c and co-localizations in Figure 
16d). SERT-SAP injections into the PeF also respectively reduced the total number of sin-
gle-TPH+ (Figure 16e) and double-CTB+/TPH+ (Figure 16f) neurons in the MR (p=0.03; 
p=0.02) and lwDR (p=0.0004; p=0.01), but not in the DRD or DRV (n=7 IgG-SAP, 6 
SERT-SAP; one animal excluded due poor TPH staining). No SERT-SAP lesioning effects 
were observed in non-TPH neurons (neutral red+ cells, Figure 16g). 
 
4.2.5. Experiment 5: Effects of SERT-SAP Injections into the PeF on Physiology and Be-
haviors 
In SERT-SAP lesioned rats, while low CO2 exposure elicited moderate increases 
only in BP (treatment effect F(1,12)=11.01, p=0.006), higher CO2 concentration induced ro-
bust elevation in both BP (treatment effect F(1,12)=7.62, p=0.017 and treatment x time in-
teraction F(19,228)=3.65, p<0.0001, Figure 17a) and locomotor activity (treatment effect 
F(1,12)=8.54, p=0.01, Figure 17b). Lesioned rats displayed reduced total SI time (p=0.02, 
n=7 each, Figure 17c), decreased the latency to escape the open arm [i.e. treatment effect 
(F(1.11)=7.16, p=0.021, n=7 IgG-SAP, 6 SERT-SAP; one animal excluded due repeated falls 
from ETM; Figure 17d)], but did not have differences on avoidance in the ETM and OF 
the PeF (left lower panel photograph) than IgG-SAP rats (left upper panel photograph), but 
not in the basolateral amygdala (BLA, right panel photographs). (c) SERT-SAP injected 
rats (bottom row) had decreased total number of TPH+ [red, Alexa 640, bar graphs in (d)] 
and CTB+/TPH+ [CTB green, Alexa 488, bar graphs in (e)] neurons in the lateral wings 
(lwDR) DR and MR, but not in the dorsal (DRD)/ventral (DRV) DR when compared to 
IgG-SAP group (top row). See topography of MR and divisions of DR in Figure 14b. (f) 
SERT-SAP injections did not reduce total number of non-TPH neurons in none of the DR 
and MR regions with neutral red counter staining [two-tailed, unpaired Student’s t test, *, 




behaviors (not shown). Lastly, intra-PeF injections of SERT-SAP did not affect fear acqui-
sition (Figure 17e), but did enhance overall freezing responses during fear extinction [i.e., 
main effect of treatment (F(1,12)=23.72, p=0.0004) and treatment x time interaction 
(F(19,228)=2.69, p=0.0003, Figure 17f)]. 
 
Figure 17 – In the loss-of-function study, injection of saporin (SAP) toxin conjugated to 
the serotonin transporter antibody (SERT-SAP) into the perifornical hypothalamus (PeF) 
promotes anxiety-, fear-, and panic-associated responses. SERT-SAP injected rats had: (a) 
increase in blood pressure and (b) general motor activity in the CO2 challenge; (c) decrease 
in social interaction (SI) time in the SI test; (d) decrease latency to escape the open arm in 
the elevated T-maze (ETM); (e) normal acquisition of freezing response to tone (T) + shock 
(S) pairings; and (f) increase freezing response to cue-induced conditioned fear and also 
delayed extinction (*, between groups; #, compared to T1 within groups). Part (c) and bar 
graphs in (e) and (f) are two-tailed, unpaired Student’s t test; bar graph in (d) and line 
graphs (a-b) and (e-f) are two-way ANOVA followed by Fisher’s LSD post hoc test. *, 
p<0.05; ***, p<0.0005; #, p<0.05. Abbreviations: Atm, atmospheric; Esc., escape re-




In our first experiment we confirmed that injections of CaMKIIa ChR2 virus into 
the PeFR led to many eYFP+ fibers in the PeFR region, and high co-localization between 
OXA and eYFP+ soma with CaMKIIa control virus. Optogenetic stimulation of ChR2 
group, but not control, led to robust increases in exophthalmos; escape associated running; 
decreased social interaction times; as well as cardioexcitation; and increases in core body 
temperature (data not shown); and in cellular cFos responses in OXA+ neurons. These re-
sponses are similar to those described in the literature utilizing both pharmacological 
(Freitas et al., 2009; Shekhar and DiMicco, 1987; Ullah et al., 2017, 2015) and electrical 
stimulation (de Bortoli et al., 2013; Lammers et al., 1988) of the PeFR of rats. The optoge-
netic excitation of glutamatergic neurons in PeFR also induced an unconditioned and con-
ditioned place aversion, which is consistent with the OX/glutamate PeFR system projecting 
to the amygdala (Dustrude et al., 2018; Peyron et al., 1998b) where it enhances conditioned 
fear behaviors (Dustrude et al., 2018; Flores et al., 2014). These effects are not only a direct 
indication of the averseness of glutamatergic stimulation in the PeF, but also indicate the 
capacity of this region to organize some forms of emotional learning canonically seen in 
fear conditioning experiments (LeDoux, 2000; Phelps and LeDoux, 2005). Collectively, 
optogenetic stimulation of the PeF promotes various orchestrated behavioral and physio-
logical responses that are components of the “fight-or-flight” repertoire, thus reinforcing 
its role as one of the putative brain regions underlying panic behavior. 
As stated in the introduction, there is evidence that the 5-HT1A receptor in the PeFR 
inhibits escape behaviors from local excitation or disinhibition, but little is known about 
the role of serotonergic neurotransmission in physiological and behavioral panic responses 
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or conditioned fear responses in this region. In order to assess the role of serotonergic neu-
rotransmission in these responses in the PeFR we first injected a retrograde tracer CTB into 
the PeFR and determined that the majority of PeFR-projecting serotonergic neurons origi-
nated in the lwDR and MR, with the majority of CTB+ neurons being serotonergic (92-
95%). This is consistent with previous tracing studies revealing that most of the sero-
tonergic neurons innervating the PeFR originate from the lwDR and MR (Ljubic-Thibal et 
al., 1999; Muzerelle et al., 2016). We then used an intersectional genetics approach where 
we injected a CAV-CMV-Cre virus into the PeFR and a Cre-dependent AAV-EF1a-DIO-
Chr2-eYFP into the lwDR MR. The combination of these two viruses induced expression 
of ChR2 selectively onto lwDR and MR neurons projecting to PeFR, which colocalized 
with local serotonergic terminals (i.e., SERT expression). Here, wireless optogenetic exci-
tation of ChR2 fibers in the PeFR that originated from the lwDR and MR resulted in a mild 
increase in the cardiovascular parameters during optogenetic stimulation. It is noteworthy 
that the behavior repertoire was qualitatively different from those observed in our first ex-
periment with optogenetic excitation of glutamatergic cell bodies in the PeF. Here, rats 
displayed investigation-driven behaviors, such as increased exploration, accompanied by 
sniffing and occasional rearing, and we cannot discard the possibility that these factors may 
have contributed to the cardioexcitation. In agreement with these results, 5-HT release in 
the hypothalamus has been linked to the control of wakefulness responses in different 
stances (Houdouin et al., 1991; Imeri et al., 1994; Yuki C. Saito et al., 2018). Moreover, 
wireless optogenetic excitation of ChR2 fibers in the PeFR that originated from the lwDR 
and MR also increased time spent on the open arm; increased social interaction time; and 
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induced conditioned place preference paired with photostimulation, effect observed 24 
hours post-conditioning. These are all consistent with an anxiolytic effect. 
We then exposed rats to a suffocation-associated stressor (i.e., 5 min infusion of 
normoxic 20% CO2) that elicits core symptoms of a panic attack in humans (e.g., cata-
strophic fear accompanied by cardiovascular and thermoregulatory responses) (Forsyth et 
al., 2000). This CO2 challenge also has predictive validity since fluoxetine and alprazolam, 
two clinically relevant panicolytic drugs utilized to treat patients with recurrent panic at-
tacks, attenuate escape responses (Spiacci et al., 2018) and panic-associated behaviors and 
physiological responses (Johnson et al., 2015a, 2012b) elicited by 20% CO2 inhalation in 
rodents. Optogenetic excitation of the lwDR/MR fibers that project to the PeFR attenuated 
CO2-induced increases in pressor responses and reductions in social interaction time, as 
well as decreased the number of cFos responses in OXA-producing neurons within the 
PeFR. Collectively these data support the hypothesis that serotonergic neurotransmission 
in the PeFR inhibits anxiety avoidance and innate panic behaviors. This hypothesis is fur-
ther supported in that OX/glutamatergic neurons express the 5-HT1A receptor (Collin et al., 
2002; Muraki et al., 2004) and electrophysiological studies show that a 5-HT1A receptor 
antagonist blocks 5-HT direct inhibition of OX neurons (Muraki et al., 2004) and selective 
OX1 receptor antagonists attenuate panic associated behavioral, cardiovascular, and ther-
mal responses to 20% CO2 challenges (Johnson et al., 2015a, 2012b). 
In our final experiment we tested the hypothesis that selective lesioning of 5-HT 
projections to the PeFR would induce a panic and phobia vulnerable state. This hypothesis 
is based on results from previous experiments, but also that finding that OX neurons send 
selective projections to the lwDR and MR (Peyron et al., 1998b) where they excite local 5-
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HT neurons via the OX1 receptor (Brown et al., 2002). In order to do this we injected 
SERT-SAP into the PeFR where we observed a 42% reduction in the density of local 
SERT+ fibers that coincided with selective decrease of the total number of TPH+ neurons 
in the lwDR and MR, but not in the DRD/DRV (no off-target effects on local non-TPH 
neutral red cells were observed). This same pattern was confirmed by the highly co-local-
ized CTB+/TPH+ neurons (92-95%), which showed similar amount of reduction in the same 
Raphe regions. It is noteworthy that no alterations were observed in the SERT+ fibers in 
the BLA, a structure that receives less innervation arising from lwDR/MR (Muzerelle et 
al., 2016), hence a control site. Using the same lesioning approach in a different circuit, we 
were able to induce less extensive reductions of local PeFR 5-HT fibers here when com-
pared to our previous study in the BLA injections of SERT-SAP (~85%) (Johnson et al., 
2019), but higher than those reductions in the medulla observed in a previous study (28%) 
(Nattie et al., 2004). Lesioning of the lwDR/MR→PeFR serotonergic circuit increased in-
nate anxiety- and panic-associated responses measured by reduced SI time, decreased es-
cape latency in the ETM and enhanced general locomotor activity and increased pressor 
response to CO2 challenges. 
Similar to lesioning 5-HT terminals in the PeFR, chronic disinhibition of GABA 
synthesis in the PeFR also induces a panic vulnerable state (Johnson et al., 2008; Johnson 
and Shekhar, 2006; Molosh et al., 2010). OX neurons also express GABAA receptor subu-
nits and are disinhibited by bicuculline methiodide or inhibited by muscimol, antagonist 
and agonist of GABAA receptor, respectively (Eggermann et al., 2003). Along those lines, 
in vitro bath application of 5-HT or optogenetic stimulation of local 5-HT terminals in 
brain slices produce GABAA-mediated inhibitory post-synaptic currents in OX neurons 
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(Chowdhury and Yamanaka, 2016). One explanation could be the co-release of GABA and 
5-HT by serotonergic terminals since TPH-producing neurons in the Raphe nuclei have 
been shown to co-express the GABA rate-limiting enzyme glutamic acid decarboxylase 
(GAD) (Belin et al., 1983; Day et al., 2004; Fu et al., 2010; Millhorn et al., 1988, 1987; 
Prouty et al., 2017). However, very few (0.1-0.7%) of serotonergic DR and MR neurons 
co-express GAD (Fu et al., 2010; Prouty et al., 2017; Stamp and Semba, 1995). This makes 
less likely that the GABAA-mediated inhibition of OX neurons is due co-release of GABA 
from PeFR-projecting lwDR/MR serotonergic fibers. A more plausible explanation seems 
to be the direct activation of local GABAergic interneurons in the PeFR via 5-HT2A recep-
tors, but this remains to be tested. Whatever the explanation may be, the inhibitory effects 
mediated by the serotonergic neurotransmission onto OX neurons in the PeFR seems to be 
mediated by 5-HT and GABA. 
Even though lesioning of the PeFR-projecting serotonergic neurons did not alter 
fear acquisition, it did lead to reduced fear extinction when presented with tone only. Alt-
hough we did not see any significant reduction of 5-HT fibers in the amygdala, we cannot 
exclude this region from being involved in the alterations of freezing behavior observed in 
our experiments. This is due the fact that OX neurons project heavily to the amygdala 
(Peyron et al., 1998a) and play a critical role in the consolidation and extinction of aversive 
memories, with OX1 antagonist enhancing and OX1 peptide impairing amygdala-based 
fear extinction in cued fear conditioning (Flores et al., 2014). This role of OX in the context 
of the mechanisms of persistent fear was further explored by Molosh and colleagues. These 
authors showed that panic-prone rats submitted to chronic reduction of GABA synthesis in 
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the PeF had sustained activation of amygdala-projecting PeF pathway and displayed en-
hanced excitatory synaptic transmission and impaired mGluR2 signaling of principal neu-
rons in the basolateral amygdala (Molosh et al., 2018). Therefore, additional experiments 
manipulating the orexinergic neurotransmission in the amygdala are needed to confirm its 
involvement mediating conditioned fear responses in the context of reduced serotonergic 
neurotransmission in the PeF. 
Our data presented here contrast with the view that 5-HT may have only a phasic 
role in the hypothalamus in the context of innate panic-like behavior as suggested by others 
(de Bortoli et al., 2013; Nascimento et al., 2014). Our loss-of-function experiments may 
reflect the fact that ablation of lwDR/MR→PeF serotonergic pathway causes a more pro-
found elimination of 5-HT modulatory effects in the PeFR than does pharmacological in-
hibition, since this would also alter colocalized neurochemicals. One could raise the possi-
bility that our circuit-targeted ablation may have lesioned other non-serotonergic popula-
tions at the Raphe projecting sites. However, the fact that neutral red-positive neurons in 




The past belief that central serotonergic systems are functionally homogeneous in 
regulating innate panic and conditioned fear was one key barrier. The idea that there are 
topographically organized subsets of 5-HT neurons, with unique afferents, efferents and 
functional properties has since become well accepted (Hale et al., 2012). Based on the data 
presented here and in a series of previous publications, we have identified a novel 5-HT 
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sub-system that projects to and inhibits a panic generating brain region that also influences 
conditioned fear responses. These data provide new insights into adaptive panic and fear 
but also how disruption of this 5-HT system can lead to a vulnerability to panic and condi-
tioned fear responses that are associated with panic attacks, panic disorder (de Beurs et al., 
1994; Margraf et al., 1987; Taylor et al., 1986), and highly comorbid phobias (Kessler et 
al., 2006).  
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5. Chapter V: Discussion 
5.1. Overall Considerations 
Serotonin is heavily implicated in anxiety, fear, and panic, but it seems to have a 
heterogeneous response depending on the brain region where it is exerting its role. In the 
amygdala, 5-HT has been largely implicated in promoting anxiety and fear [for review, see 
(Bauer, 2015; Bocchio et al., 2016; Hindi Attar et al., 2012)] whereas in the PeF only a 
limited amount of site-specific pharmacological studies support 5-HT’s anti-escape role in 
the context of aversive-promoting environments (Biagioni et al., 2016, 2013; de Bortoli et 
al., 2013; Nascimento et al., 2014). However, it is hard to determine diffusion rates of site-
specific administration of agonists/antagonists, and they most likely fail to recapitulate how 
physiological DR/MR networks modulate/organize behaviors throughout their down-
stream brain targets [for review, see (Hayes and Greenshaw, 2011). A circuit-based ap-
proach associated with physiological stimulation parameters is a promising tool to start 
addressing such questions. Surprisingly, only a few studies investigated the role of specific 
manipulation of serotonergic network in the amygdala (Ren et al., 2018) and extended 
amygdala (Marcinkiewcz et al., 2016), and none to our knowledge investigated in the con-
text clinically relevant panicogenic stimuli such as CO2 challenge. 
Our major findings support the hypothesis that serotonergic neurons innervating 
the BLA and PeF constitute distinct networks concentrated within DRD/DRV and 
lwDR/MR, respectively. More importantly, selective manipulation of these networks with 
gain- and loss-of-functions approaches in association with behavioral paradigms assessing 
anxiety/fear responses and clinically relevant panic provocation induced by CO2 inhalation 
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revealed that while DRD/DRV→BLA enhances anxiety- and fear-associated responses, 
lwDR/MR→PeF dampens panic- and fear-associated responses. 
The notion that the amygdala underlies fear emotional states is widely accepted in 
the neuroscience field and has been extensively studied under conditioned fear paradigms 
[for review, see (Campese et al., 2016; Izquierdo et al., 2016; Johansen et al., 2011; 
LeDoux, 2007)]. On the other hand, the involvement of the PeFR on panic-related re-
sponses, more specifically the OX-producing neurons, has been proposed by our lab 
(Johnson et al., 2010) and gained strength over time utilizing mainly pharmacological ma-
nipulations [for review, see (Johnson et al., 2014, 2012a). Therefore, before applying our 
gain- and loss-of-function approaches to question 5-HT’s modulation in the PeF, we de-
cided to better characterize the role of PeFR in panic. In order to do that, we used wireless 
optogenetic approach to selectively stimulate glutamatergic neurons within the PeF. 
 
5.2. Wireless Photostimulation of Glutamatergic and Orexin-Producing Neurons in the 
Perifornical Hypothalamic Region Elicits Escape Behavior and Intense Cardioexcitation  
In our first experiment of Chapter IV, we confirmed that injections of CaMKIIa 
ChR2 virus led to many eYFP+ fibers in the PeFR, and after immunostaining for OXA in 
control rats, we observed high co-localization between this neuropeptide and eYFP+ soma. 
Optogenetic stimulation of ChR2 group, but not control, led to robust increases in BP and 
HR that were accompanied by a constant exophthalmos and long periods of freezing inter-
spaced by short vigorous locomotor episodes of escape (running), behaviors typically aver-
sive. These behavioral and physiological responses observed here are similar to those using 
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chemical (Freitas et al., 2009; Shekhar and DiMicco, 1987; Ullah et al., 2017, 2015), elec-
trical (de Bortoli et al., 2013; Lammers et al., 1988), and optogenetic stimulation (Li et al., 
2018) of the PeFR of rats. Particularly in the latter case, selective optogenetic activation of 
glutamatergic neurons in the PeF/LH that project to the dPAG induced escape from an 
artificial predator, suggesting the involvement of the PeF in aversive behaviors (Li et al., 
2018). 
The PeFR was first implicated in the classic “fight-or-flight” behavior almost a 
century ago by Bard (Bard, 1928) and later by the seminal work of Hess and Brugger 
(1943). However, classic experiments involving local lesions and non-selective electrical 
stimulation have also implicated the PeFR as a crucial node responsible for aggressive 
behavior (Egger and Flynn, 1963; Hutchinson and Renfrew, 1966; Siegel et al., 1999) that 
induced attack in various species including rat, cat, and monkey (Lammers et al., 1988; 
Lipp, 1978; Siegel and Pott, 1988). This is likely due the fact that the hypothalamus is a 
highly complex structure with various anatomical and cellular configurations (Puelles and 
Rubenstein, 2015; Shimogori et al., 2010), and that the electric current utilized in those 
studies is a non-selective stimulus that activates not only cell bodies but also fibers of pas-
sage. This inevitably limits the conclusions regarding the neuronal groups underlying sev-
eral behavioral changes observed in those studies. 
Contradicting the aggressive behavior reported above, it is noteworthy that optoge-
netic stimulation of ChR2 group virtually abolished SI time without inducing aggression. 
This surprisingly selective increase in social anxiety avoidance behavior was accompanied 
by cFos activation within the PeFR that co-localized with the panic implicated OXA-pro-
ducing neurons (Johnson et al., 2010). Indeed, recent studies utilizing selective optogenetic 
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stimulation have shown that the aggressive behavior is particularly associated with the ven-
tromedial hypothalamus (VMH), ventrolateral part (VMHvl) (Lin et al., 2011), more spe-
cifically the population expressing the Estrogen receptor 1 (Lee et al., 2014), although other 
neuronal populations are yet to be tested. 
Perhaps the most striking results were not the dramatic place avoidance from the 
stimulation chamber observed during the training session in the RTPP/A test per se, but 
the avoidance behavior in the short- and long-term memory sessions. Even though the 
short-term memory (45 min) avoidance behavior observed here is similar to that described 
after stimulation of a specific population of SF1+ neurons in the VMH (Kunwar et al., 
2015), this is the first time to our knowledge that such long-lasting (24 hours) avoidance 
behavior is reported post-stimulation of the PeF and adjacent regions. These effects are not 
only a direct indication of the averseness of glutamatergic stimulation in the PeF, but also 
indicate the capacity of this region to organize some forms of emotional learning canoni-
cally seen in fear conditioning experiments and attributed to the amygdala (LeDoux, 2000; 
Phelps and LeDoux, 2005). Collectively, optogenetic stimulation of the PeF promotes var-
ious orchestrated behavioral and physiological responses that are components of the “fight-





5.3. The Amygdala- and Perifornical Hypothalamus-Projecting Serotonergic Systems 
Originate from Distinct Neuronal Populations in the Dorsal and Median Raphe Nuclei 
The following experiments of Chapters III and IV focused on determining which 
5-HT systems projected to the BLA and PeF, respectively. Here, we confirmed that injec-
tions of a retrograde tracer into the BLA or PeF resulted in many CTB+/TPH+ neurons 
concentrated in the DRD/DRV or lwDR/MR, respectively, with approximately 92-95% of 
co-localization between CTB+ and TPH+, and very few CTB+ that were non-TPH cells. It 
is important to emphasize that the retrograde labelled neurons were restricted to the 
DR/MR, sparing the surrounding brain regions on the same coronal section. Our antero-
grade tracers Phal-l into the midline DRD/DRV revealed a high density of fibers in the 
BLA and a moderate density of fibers within the bed nucleus of the stria terminalis (BNST, 
Figure 18a). These results are consistent with the non-specific retrograde tracer CTB (Hale 
et al., 2008; Ljubic-Thibal et al., 1999) and with conditional anterograde tracer (Cre-de-
pendent AAV with a fluorescent reporter) that was restricted to serotonergic neurons 
[SERT-Cre mouse (Gong et al., 2007)] observed in the connectome of the mouse brain in 
the Allen Brain Atlas (Oh et al., 2014; Figure 18b) and by others (Muzerelle et al., 2016). 
Even though it was already expected, the similar pattern of anterograde tracing confirmed 
how conserved are the DRD/DRV→BLA and lwDR/MR→PeF projections between these 
two species, an important issue that should be considered when doing pre-clinical research 
aiming for translational implications. Collectively, the combination of our anterograde and 
retrograde tracing studies allowed us to determine not only which site within the BLA and 
PeF to pursue for our following gain- and loss-of-function experiments, but more im-
portantly it showed how selective were the projections from the serotonergic system to 
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those sites. We consider this to be of utmost importance since it allowed us to implement 
the intersectional genetics approach not only to selectively manipulate the serotonergic 
systems, a matter discussed later, but also to use this same approach as a conditional ante-
rograde tracing to further confirm our neuroanatomical findings with CTB (Chapters III 
and IV), and Phal-l (Chapter III). 
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The anatomical findings taken from the intersectional genetic approach were ex-
tremely valuable, especially for the PeF-projecting serotonergic system. 
 
Figure 18 – Basolateral amygdala (BLA)-projecting dorsal (DRD) and ventral (DRV) di-
visions of the dorsal Raphe nucleus (DR) also send collaterals to the bed nucleus of stria 
terminalis (BNST). (a) Photos are coronal sections of the BNST [orange/brown DAB are 
Phaseolus vulgaris leucoagglutinin (Phal)-immunoreactive fibers with purple cresyl violet-
stained cells of low (left) and high (right) magnification photos from Phal-injected rats 
from Figure 10a-c. (b) Photos represent low (left) and high (right) magnification coronal 
sections of the BNST from a serotonin transporter (SERT)-Cre mouse where a Cre-de-
pendent AAV with a fluorescent reporter was injected into the DR (see Figure 10d) and 
provided by the connectome of the Brain in the Allen Brain Atlas (Oh et al., 2014). (c) 
Photos represent low (left) and high (right) magnification coronal sections of the BNST 
from a rat with CAV-CMV-Cre injected bilaterally into the BLA and AAV-DIO-EF1a-
ChR2-eYFP injected into the midline DR (see Figure 12). Image credit for part (b): Allen 
Institute for Brain Science. 
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DRD/DRV→BLA:ChR2 rats showed highly co-localized SERT+/eYFP+ fibers in the BLA 
(Chapter III) that sent collateral inputs to the BNST (Figure 18 and Figure 19c), but not 
to the PeF (Figure 19e). In Chapter IV, lwDR/MR→PeF:ChR2 rats displayed equally co-
localized fibers in the PeF and, to our surprise, collaterals in the PAG (Figure 19d), but 
not in the BLA (Figure 19f). Therefore, both the BLA and the PeF serve as control sites 
for each other, as suggested in the findings of previous work (Muzerelle et al., 2016). This 
has important anatomical implications for the Deakin/Graeff hypothesis elaborated almost 
30 year ago (Deakin and Graeff, 1991). At that time, these authors considered the DR as a 
homogeneous structure, and proposed that serotonergic projections to the amygdala and 
PAG would respectively facilitate anxiety/fear when processing potential/distal threats, but 
would restrain unconditioned “fight-or-flight” panic responses to proximal/imminent dan-
gers (Deakin and Graeff, 1991). Therefore, we showed anatomical evidence of two distinct 
networks projecting to the BLA and, most importantly, our tracing data also suggest that 
the PeF shares collaterals with the originally proposed panic-restraining circuit projecting 
to the PAG. 
 
5.4. Loss-of-Function Studies: Lesioning of the Serotonergic Network with Saporin Toxin 
Dampens Conditioned Fear in the Amygdala and Enhances Conditioned Fear and Innate 
Panic in the Perifornical Hypothalamic Region 
Because 5-HT is heavily implicated in anxiety, fear, and panic, but its role under 




Figure 19 – Different targets of the Basolateral amygdala (BLA)- and perifornical hypo-
thalamus (PeF)-projecting serotonergic networks. (a) Amygdala-projecting eYFP+ fibers 
in the BLA, (c) their collaterals in the bed nucleus of stria terminalis (BNST), and (e) ab-
sence of fibers in the PeF. (b) PeF-projecting eYFP+ fibers in the PeF, (d) their collaterals 
in the periaqueductal gray (PAG), and (f) absence of fibers in the BLA Abbreviations: 3V 
third ventricle, a.c. anterior commissure, Aq. cerebral aqueduct, dPAG, dlPAG, lPAG, and 
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networks in the modulation of anxiety-, fear-, and panic-like behaviors and cardiovascular 
responses using manipulations of the BLA- and PeF-innervating serotonergic systems. 
This was first assessed in the loss-of-function studies, in which SERT-SAP was injected 
into the BLA or PeF. Specific lesions of the serotonergic systems resulted in decreased 
conditioned fear behavior in the BLA, but increased conditioned fear and innate panic re-
sponses in the PeF. 
Before discussing the effects on anxiety, fear, and panic, it is important to mention 
that SERT-SAP-induced lesions produced ~90% and 42% reductions in the density of 
SERT+ fibers in the BLA and PeF, respectively. These lesions are higher than those reduc-
tions in the medulla observed by Nattie et al. (28%) (Nattie et al., 2004). Moreover, injec-
tions of SERT-SAP into the BLA and PeF also reduced the total number of TPH+ neurons 
almost exclusively in their respective Raphe sources, i.e. DRD/DRV and lwDR/MR, re-
spectively. The only exception was the reduction of a few neurons, yet significant, in the 
lwDR of the BLA injected SERT-SAP group. Because we injected CTB after SERT-SAP 
lesioning had already occurred (for experimental timeline, see Figure 5), double labelled 
CTB+/TPH+ neuronal counts reflected the previous reductions of single TPH+ counts ob-
served in the DRV/DRD and lwDR/MR. Accordingly, we also noted that only 5-8% of 
CTB-expressing cells in the DRD/DRV and lwDR/MR were non-serotonergic. Equally 
important, animals injected with SERT-SAP in the BLA or PeF did not show alterations in 
the SERT fiber density of their respective control sites, i.e. PeF and BLA (Figure 19e and 
f). 




SERT-SAP injection into the BLA did not alter SI behavior but did attenuate con-
ditioned fear response during extinction compared to control group injected with IgG-SAP. 
Overall, this loss-of-function approach is consistent with our previous work (Johnson et 
al., 2015b) and previous 5,7-DHT study in which reductions of 5-HT signaling in the amyg-
dala following contextual fear conditioning reduced recall of fear-associated freezing 
(Izumi et al., 2012). Although we did not see a significant reduction in SI here, we (Johnson 
et al., 2015b) and others (File et al., 1981) did see significant reductions in SI following 
5,7-DHT injections into the amygdala. An explanation to this would be that while we ob-
served lesioning of SERT fibers and their associated cell bodies in the DR/MR here with 
SERT-SAP treatment, other authors (File et al., 1981; Johnson et al., 2015b) reported only 
depletion of 5-HT after 5,7-DHT injections (no signs of physical lesioning of SERT fibers 
nor serotonergic cell bodies). 
Partially agreeing with our findings, Baratta and colleagues injected a Cre-depend-
ent Arch-GFP AAV into the midline DR of SERT-Cre mice and observed that optogenetic 
inhibition of the DR attenuated only stress-enhanced fear (Baratta et al., 2016). The lack 
of effect on normal cue-induced fear may have been due to use of a reduced shock intensity 
or species differences. Future studies are needed to understand how exactly lesioning or 
exciting DRD/DRV 5-HT projections to the BLA is altering electrophysiological activity 
of BLA projection neurons that control anxiety- and fear-related behavioral responses. 
Conversely, selective lesion of the lwDR/MR→PeF serotonergic pathway in Chap-
ter IV increased overall freezing response and delayed extinction during the extinction pro-
tocol without altering acquisition of conditioned fear. Although we did not see any signif-
icant reduction of SERT+ fibers in the amygdala in Chapter IV, we cannot exclude this 
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region from being involved in the alterations of freezing behavior observed in our experi-
ments. This is due the fact that OX neurons project heavily to the amygdala (Peyron et al., 
1998a) and play a critical role in the consolidation and extinction of aversive memories, 
with OX1 antagonist enhancing and OX1 peptide impairing amygdala-based fear extinc-
tion in cued fear conditioning (Dustrude et al., 2018; Flores et al., 2014). 
This role of OX in the context of the mechanisms of persistent fear was further 
explored elsewhere. Molosh and colleagues showed that panic-prone rats submitted to 
chronic reduction of GABA synthesis in the PeF have sustained activation of amygdala-
projecting PeF pathway and display enhanced excitatory synaptic transmission and im-
paired mGluR2 signaling of principal neurons in the BLA (Molosh et al., 2018). Therefore, 
additional experiments manipulating the orexinergic neurotransmission in the amygdala 
are needed to confirm its involvement mediating increased freezing responses and impaired 
extinction in the context of deficient serotonergic neurotransmission in the PeF. 
Interestingly, injection of SERT-SAP into the PeF increased innate anxiety- and 
panic-associated responses measured by reduced SI time and decreased escape latency in 
the ETM, respectively, when compared to control IgG-SAP rats. More importantly, our 
results from the PeF lesioning with SERT-SAP are particularly relevant when compared to 
rats submitted to the panic-prone model with l-allylglycine leading to chronic GABA dis-
inhibition in the PeF. These rats display similar cardioexcitation and marked increase in 
innate-anxiety following 7.5% CO2 inhalation (Fitz et al., 2003) or i.v. infusions of 0.5 M 




Aside from this panic-prone model, naïve rats exposed to low CO2 concentrations 
(7%) display increases only in respiratory activity without mobilizing other components of 
panic-associated responses (Akilesh et al., 1997). Conversely, higher concentration of CO2 
(20%) elicits not only anxiety- and fear-associated behaviors, but also marked cardiovas-
cular and thermoregulatory responses associated with panic states (Federici et al., 2019; 
Johnson et al., 2012c, 2011; Spiacci et al., 2018; Ziemann et al., 2009). This latter condition 
seems to recapitulate the 20% CO2 panic provocation model used in the clinic to evoke 
symptoms that match the criteria for PAs in healthy subjects (Forsyth et al., 2000). 
Further confirmations of the CO2 challenge being a suitable option to model PAs 
in laboratory animals can be observed elsewhere. Spiacci and colleagues showed that treat-
ments with Fluoxetine and Alprazolam, two clinically relevant panicolytic drugs utilized 
to treat patients with PD, are able to attenuate escape responses elicited by 20% CO2 inha-
lation (Spiacci et al., 2018). 
Even though these studies collectively show that the CO2 challenge can be used to 
model PAs in animals, none of them manipulated the serotonergic network innervating the 
PeF in the context of CO2-induced panic provocation. We utilized the same CO2 challenge 
paradigms (7 and 20%) in order to address this issue. Interestingly, lesioning of the 
lwDR/MR→PeF serotonergic network enhanced general motor activity and increased BP 
in the CO2 challenge, facilitating panic-like responses. 
These effects are in agreement with the potentiation of the defensive responses elic-
ited by chemical stimulation of the PeF post local lesioning of 5-HT fibers with local in-
jections of 5,7- DHT (Gołebiewski and Romaniuk, 1985). Because it has been previously 
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shown that OX-expressing neurons in the PeF are directly inhibited by 5-HT via post-syn-
aptic 5-HT1A receptors (Chowdhury and Yamanaka, 2016; Muraki et al., 2004; Saito et al., 
2018), our results from SERT-SAP injections can be explained by direct effects of reduced 
inhibitory tone due loss of serotonergic innervation onto OX neurons in the PeF. Alterna-
tively, OX neurons also express GABAA receptor subunits and are excited by bicuculline 
methiodide and inhibited by muscimol, antagonist and agonist of GABAA receptor, respec-
tively (Eggermann et al., 2003). One explanation could be the co-release of GABA and 5-
HT by serotonergic terminals since TPH-producing neurons in the Raphe nuclei have been 
shown to co-express GAD (Belin et al., 1983; Day et al., 2004; Fu et al., 2010; Millhorn et 
al., 1988, 1987; Prouty et al., 2017). However, very few (0.1-0.7%) of serotonergic DR and 
MR neurons co-express this enzyme required for GABA synthesis (Fu et al., 2010; Prouty 
et al., 2017; Stamp and Semba, 1995), which weakens the assumption that GABAA-medi-
ated inhibition of OX neurons are due co-release of GABA from PeFR-projecting 
lwDR/MR serotonergic fibers. A more plausible explanation seems to be the direct activa-
tion of local GABAergic interneurons in the PeFR via 5-HT2A receptors, a matter yet to be 
investigate. 
Another alternative one could consider is the participation of glutamate signaling. 
Even though the co-release of 5-HT and glutamate has been reported for various Raphe 
nuclei (Amilhon et al., 2010; Hioki et al., 2010), only 5% of the TPH2‐producing neurons 
in the lwDR co-localize with vesicular glutamate transporter 3 (Hioki et al., 2010). This 
helps explain the lack of direct effects of glutamate neurotransmission in OR neurons after 
optogenetic stimulation of serotonergic terminals in PeF slices (Chowdhury and 
Yamanaka, 2016), making this a less likely option in this region. 
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Our data presented here contrast with the view that 5-HT may have only a phasic 
role in the hypothalamus in the context of innate panic-like behavior as suggested by others 
(de Bortoli et al., 2013; Nascimento et al., 2014). Our loss-of-function experiments may 
reflect the fact that ablation of lwDR/MR→PeF serotonergic pathway causes sustained de-
creases of 5-HT in the PeF when compared with the transient inhibition obtained with 
pharmacological approach. Therefore, our loss-of-function approach reflects more closely 
pathological states in which patients diagnosed with PD were suggested to have reduced 
serotonergic neurotransmission [for review, see (Graeff, 2017)]. One could raise the pos-
sibility that our circuit-targeted ablation may have unspecific effects at non-serotonergic 
neurons in the Raphe projecting sites. However, the fact that SERT-SAP did not change 
total number or neurons assessed by neutral red staining in the various Raphe nuclei weak-
ens this possibility. 
 
5.5. Gain-of-Function Studies: Photostimulation of Serotonergic Network Enhances Anxi-
ety and Conditioned Fear in the Amygdala and Dampens Conditioned Fear and Panic in 
the Perifornical Hypothalamic Region 
The foregoing loss-of-function experiments raised the question whether the de-
creased conditioned fear and facilitation of innate anxiety- and panic-like responses could 
be reverted if we used a circuit-based approach that enhanced 5-HT release in the BLA or 
PeF, respectively. To address this matter, we took advantage of the highly selective sero-
tonergic projections (92-95%) from the DRD/DRV to the BLA or lwDR/MR to the PeF 
observed in our previous anatomical experiments and utilized a combination of the retro-
gradely trafficked Cre-expressing CAV (Soudais et al., 2001) injected either in the BLA or 
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in the PeF and a Cre-dependent ChR2 in the DR/MR. As discussed above, the eYFP ex-
pression in the Raphe nuclei confirmed the anatomy of our retrograde tracing results and 
data in the literature (Ljubic-Thibal et al., 1999; Muzerelle et al., 2016), with the BLA and 
PeF injected animals co-expressing TPH and eYFP in DRD/DRV and lwDR/MR, respec-
tively. 
Surprisingly, photostimulation of BLA-projecting DRD/DRV serotonergic cell 
bodies per se did not produce any behavioral nor cardiovascular responses in resting rats 
(no aversive stimuli were given) habituated to the stimulation box (Figure 20). It has been 
shown that electrical or chemical stimulation of the basolateral or central amygdala of cats, 
rabbits, or rats can produce behavioral and physiological changes that resembles a state of 
fear, such as cessation of ongoing behavior, increase in BP, HR, and plasma levels of cor-
ticosterone (Applegate et al., 1983; Dunn and Whitener, 1986; Feldman et al., 1982; Harper 
et al., 1984; Iwata et al., 1987). Accordingly, in humans, even though not all subjects re-
ported subjective emotional responses during amygdala stimulation trials (Meletti et al., 
2006), stimulation to the amygdala can induce an array of emotional experiences ranging 
from positive (e.g. elation) to negative emotional (e.g., fear) (Bijanki et al., 2014; Inman et 
al., 2018; Lanteaume et al., 2007; Meletti et al., 2006; Smith et al., 2006). The negative 
emotional responses are more frequently observed at higher amplitudes of stimulation, and 
are commonly followed by increased skin conductance and increase in HR (Inman et al., 
2018), responses typically observed in fear-promoting situations. 
However, we have to take in consideration that while electrical stimulation directly 
activates neurons and fibers of passage, chemical stimulation is mediated by glutamate 
neurotransmission, the main excitatory neurotransmitter in the brain. Serotonin, on the 
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other hand, serves as a neuromodulator and particularly in the amygdala it is suggested to 
regulate the excitability of BLA principal neurons directly via 5-HT2C receptors 
(Greenwood et al., 2012; Li et al., 2003) and indirectly via local GABAergic interneurons 
expressing 5-HT2A receptors (Jiang et al., 2009; McDonald and Mascagni, 2007; Rainnie, 
1999; Yamamoto et al., 2012). Therefore, in the absence of aversive stimuli that normally 
trigger amygdala activity, serotonergic neurotransmission per se may very well have little, 
if any, effects on BLA firing rate. The lack of behavioral and cardiovascular responses 
observed here are an indication of this. 
Serotonin had a different effect in the presence of an aversive stimulus. Even 
though photostimulation of DRD/DRV→BLA:ChR2, but not eYFP control, did not alter 
fear acquisition nor consolidation, it did increase freezing in the initial tone presentation 
during recall/extinction session. The stimulation also led to anxiety-associated reduction in 
SI time in the open field. Accordingly, we then verified that optogenetic stimulation also 
increased cellular cFos response within serotonergic neurons in the DRV and DRD and 
within the cells in the BLA. In agreement with our results, Baratta and colleagues injected 
 
Figure 20 – Optogenetic stimulation of basolateral amygdala (BLA)-projecting 
DRD/DRV serotonergic cell bodies. Photostimulation (20 Hz, 5 ms, 1.5 mW, LED on-
LED off, 5 min) of DRD/DRV cell bodies did not produce (a) general motor activity (circle 
and square signs), (b) blood pressure (BP, circle signs, left y axis), nor heart rate (HR, 
square signs, right y axis) in freely moving rats. 
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a Cre-dependent Arch-GFP AAV into the midline DR of SERT-Cre mice and observed 
that optogenetic inhibition of the DR attenuated conditioned fear responses only in stressed 
animals (Baratta et al., 2016). The lack of effect on normal cue-induced fear may have been 
due to use of a reduced shock intensity or species differences. 
Although we observed significant collaterals in the BNST, we did not see a signif-
icant increase in cFos in this region. Even though this a negative finding, it is noteworthy 
that optogenetic excitation of ChR2 expressing 5-HT terminals in the BNST of SERT-Cre 
mice enhanced anxiety-related behaviors and conditioned fear behaviors (Marcinkiewcz et 
al., 2016). Based on our anatomical experiments, the source of some of the serotonergic 
inputs to the BNST are shared collaterals of BLA-projecting neurons within the midline 
DR. 
In regards to what is known about 5-HT effects in the BLA there are two factors to 
consider: 5-HT induces both excitatory and inhibitory actions depending on the receptor 
subtype and 5-HT receptor subtypes are expressed on both GABAergic interneurons and 
glutamatergic projection neurons (McDonald and Mascagni, 2007). Glutamatergic princi-
pal neurons that enhance anxiety and conditioned fear responses have high expression of 
excitatory 5-HT2C receptors in the dorsal part of the BLA [i.e., LA; (Greenwood et al., 
2012; Li et al., 2003)] and 5-HT excites these neurons via the 5-HT2C receptor (Yamamoto 
et al., 2014). Additionally, acute injections of 5-HT, an SSRI, or a 5-HT2C receptor agonist 
into the BLA induce anxiogenic responses (Vicente and Zangrossi, 2012). Yet, application 
of 5-HT in the BLA region initially produces inhibitory responses by depolarizing GA-
BAergic interneurons (Bocchio et al., 2015; Rainnie, 1999) which have high expression of 
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excitatory 5-HT2A receptors (McDonald and Mascagni, 2007) and play a role in the depo-
larization (Bocchio et al., 2015). However, previous studies show that stress- and fear-
related conditions can produce prolonged release of 5-HT that may lead to loss of local 
inhibition (Amat et al., 1998; Zanoveli et al., 2009), and there is evidence that this can 
potentially reduce local GABA inhibition and produce excitation of glutamatergic neurons. 
For instance, stress exposure can induce downregulation of 5-HT2A receptor expression in 
the BLA and reduce 5-HT’s effects on local GABAergic tone (Jiang et al., 2009). This 
could lead to excitation of glutamatergic neurons, which play a critical role in enhancing 
fear conditioning. This hypothesis is supported by previously mentioned studies where in-
itial treatment of rats with SSRIs increases extracellular 5-HT in the amygdala by ~150% 
(Bosker et al., 2001), enhances initial fear-related freezing response in rodents (Ravinder 
et al., 2013), and enhances conditioned fear in humans (Grillon et al., 2007).  
Overall, the aforementioned data support the hypothesis that serotonergic neurons 
in the DRD/DRV that project to the BLA enhance anxiety-like behavioral and conditioned 
fear response. 
In Chapter IV, photostimulation of lwDR/MR→PeF fibers induced arousal in rest-
ing rats habituated to the stimulation box. Even though there was a mild, yet significant, 
increase in the cardiovascular parameters during optogenetic stimulation, it is noteworthy 
that the behavior repertoire was qualitatively different from those observed in our first ex-
periment with optogenetic excitation of glutamatergic cell bodies in the PeF (see section 
5.2). Here, rats displayed investigation-driven behaviors, such as increased exploration, 
accompanied by sniffing and occasional rearing, and we cannot discard the possibility that 
these factors may have contributed to the cardioexcitation. In agreement with these results, 
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5-HT release in the hypothalamus has been linked to the control of wakefulness responses 
in different stances (Houdouin et al., 1991; Imeri et al., 1994; Yuki C. Saito et al., 2018). 
Interestingly, we observed that photostimulation conditions that initially evoked 
arousal/increased exploration at neutral environments were also associated with 1) in-
creased spatial exploration of the inherently aversive open arm in the EPM, and 2) aug-
mented social exploration/interaction with or without anxiogenic/panicogenic stimuli in 
the SI test. Regarding the EPM, ChR2 excitation increased open arm exploration even after 
the light stimulation ceased, suggesting a sustained anti-aversive effect of 5-HT in the PeF. 
This can be explained when we take into account that 5-HT neurotransmission has been 
reported to be predominantly non-junctional, i.e. when the localization of the ligand’s re-
ceptors lack direct synaptic contact as observed for several brain regions (Descarries et al., 
1990; Umbriaco et al., 1995). Even though anatomical confirmations have not been yet 
established for the PeF, electrophysiological data suggest that 5-HT can use volume trans-
mission as a mode of communication in the PeF as there was a significant delay (approxi-
mately 7 seconds) from the time between 5-HT terminals activation and recorded inhibitory 
post-synaptic currents in OX neurons (Chowdhury and Yamanaka, 2016). 
With respect to SI, activation of ChR2 fibers in the PeF increased SI time during 
stimulation session and blunted the anxiogenic effects of bright light challenge. Although 
photostimulation of lwDR/MR→PeF fibers post-CO2 challenge did not prevent a signifi-
cant reduction in SI time when compared to the same group during the stimulation session, 
serotonergic network activation still countered the aversive effects of CO2 inhalation since 
SI time of ChR2 animals was higher than control group within the same session. Collec-
tively, these tests are strong evidences of anxiolytic properties mediated by 
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lwDR/MR→PeF optogenetic stimulation as these paradigms are validated models for test-
ing anxiety-like behavior in rodents (File, 1980; Pellow et al., 1985; Pellow and File, 1986). 
As mentioned in the section 5.4, panic prone and naïve rats and PD and healthy 
subjects seem to have similar responses to mild (7%) and high (20%) CO2 inhalations. 
Despite this particularly relevant similarity, none of the previous studies focused on inves-
tigating the specific effects of 5-HT neurotransmission in the PeF in the context of CO2-
induced panic provocation. In order to address this issue, we utilized the same CO2 chal-
lenge paradigms (7 and 20%) coupled to photostimulation of 5-HT fibers of the 
lwDR/MR→PeF circuit. Remarkably, excitation of 5-HT fibers was able to attenuate the 
BP increase induced by both CO2 challenges used here. More importantly, the BP response 
from ChR2 group submitted to 20% CO2 was similar to the BP levels of rats from control 
group exposed to 7% CO2. Additionally, our post-mortem analysis showed that photostim-
ulation of the PeF-projecting lwDR/MR fibers prior to euthanasia was able to decrease cell 
activity of OX A-expressing neurons assessed by cFos activation. This is particularly in-
teresting when taking into consideration previous studies from our lab showing the im-
portance of the orexinergic neurotransmission and OX1 receptor underlying panic-like re-
sponses evoked by CO2 challenges (Bonaventure et al., 2017; Johnson et al., 2015a, 2012c). 
As explored previously, 5-HT has inhibitory effects onto OX-producing neurons in 
the PeF (Chowdhury and Yamanaka, 2016; Muraki et al., 2004), but to our knowledge, this 
study is the first to unveil causal relationship regarding which neuronal populations in the 
Raphe nuclei are implicated in the attenuation of panic-associated responses utilizing a 
circuit-based approach. Equally important, these findings are also extremely relevant to 
update the influential Deakin/Graeff hypothesis. Initially overlooked by these authors, here 
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we identify specific serotonergic projections from lwDR/MR to the PeF and provide evi-
dence that direct activation of such circuit confers anti-panic properties in both ethologi-
cally and clinically relevant models of panic. Along those lines, the identification of spe-
cific circuits controlling anxiety, fear, and panic responses is a fundamental step towards 
the development of more effective therapies for psychiatric conditions such as anxiety and 
trauma-based disorders (e.g. PD and PTSD, respectively). 
Lastly, because previous photostimulation of glutamatergic cell body in the PeF 
produced a remarkable avoidance behavior in RTPP/A test that extended up to 24 hours 
post-stimulation, we questioned what would be the behavioral effects of optogenetic stim-
ulation of lwDR/MR→PeF pathway using the same model. To our surprise, photostimula-
tion of this pathway led to a marked place preference behavior during training session that 
persisted not only for 45 min (short-term), but also lasted 24 hours thereafter (long-term 
memory session). Since our optical fibers were indisputably located above the PeF, the 
most parsimonious explanation would be that these reward-like behaviors were due acti-
vation of PeF-projecting lwDR/MR neurotransmission. 
However, because there were additional fibers in the LH, we cannot exclude the 
possibility that our lwDR/MR→PeF terminal activation was 1) stimulating fibers of pas-
sage that innervated the LH and also expressed ChR2; and/or 2) stimulating local PeF fibers 
that collateralized to the LH. Indeed, the LH has long been proposed as a brain area that 
produces self-stimulation and reward-like behaviors with electrical stimulation (Olds, 
1958, 1956; Olds and Milner, 1954). Moreover, recent optogenetic studies demonstrated 
that activation of DR 5-HT neurons promotes reward (Fonseca et al., 2015; Miyazaki et 
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al., 2014), and these effects were suggested to be mediated by projections to ventral teg-
mental area (Liu et al., 2014; Wang et al., 2019) and nucleus accumbens (Liu et al., 2014). 
In the LH, pharmacological studies often provided conflicting results regarding the role of 
5-HT either promoting or suppressing reward-related behaviors [for review, see (Luo et al., 
2015)]. Such contradiction can be explained by the fact that it is hard to determine diffusion 
rates of intracranial administration of specific receptor agonist or antagonist. Moreover, 
such drug deliveries inevitably miss the global mechanism of how physiological DR neu-
rotransmission modulates/organizes behaviors throughout their downstream brain targets 
[for review, see (Hayes and Greenshaw, 2011). A circuit-based approach associated with 
physiological stimulation parameters seems to be the neuroscientist’s latest and best tool 
to start tackling such questions. Even though we cannot answer whether the place prefer-
ence observed here was mediated by lwDR/MR neurotransmission in the PeF or LH, or the 
combination of both, this certainly poses an interesting venue that deserves to be addressed 




6. Chapter VI: Concluding Remarks and Future Directions 
In this dissertation, our retrograde tracing results demonstrated that anatomically 
different DR sub-systems and MR innervate the BLA and PeFR in a distinct manner. While 
the BLA-projecting neurons were localized in the DRD/DRV, the PeFR-projecting sero-
tonergic neurons were concentrated in the lwDR and MR. In both cases, the projections 
were almost exclusively serotonergic. 
Our behavioral and physiological analyses in the gain- and loss-of-function studies 
reflected the aforementioned anatomical pattern, and in most cases manipulation of these 
BLA- and PeFR-projecting serotonergic sub-systems resulted in distinct, even opposing, 
functions. While lesioning of the BLA-innervating 5-HT network facilitated the extinction 
of conditioned fear behavior, the PeFR counterpart not only did the opposite to conditioned 
fear responses, but also increased social anxiety avoidance, panic-associated escape, and 
enhanced cardioexcitation during suffocation-related CO2 challenges. In the gain-of-func-
tion studies, selective activation of BLA-projecting 5-HT networks with wireless LED im-
paired the extinction of conditioned fear behavior and enhanced social anxiety avoidance. 
Conversely, excitation of lwDR/MR ChR2+ terminals in the PeFR decreased anxiety asso-
ciated behaviors, induced conditioned place preference, and attenuated CO2-induced panic 
(e.g., flight/escape behaviors and cardioexcitation). 
Collectively, the results provided here support previous findings that the DR should 
no longer be viewed as a homogeneous cluster of cells (Commons, 2016, 2015; Hale and 
Lowry, 2011; Ren et al., 2018), but rather as sub-systems with unique projection patterns 
that are capable of controlling distinct, and even opposing, functions, such as conditioned 
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fear responses. While the results presented in this dissertation provide new insights regard-
ing the neural circuits within the DR and MR underlying the modulation of anxiety, fear, 
and panic, they also raise important questions about more selective pharmacological alter-
natives for treating the different anxiety and trauma-based disorders. 
Currently, SSRIs are the first line of pharmacological treatment for anxiety and 
trauma-based disorders, such as PD and PTSD, respectively [for review, see (Koen and 
Stein, 2011)]. The anxiolytic effects of SSRI therapy occur 2-3 weeks following daily treat-
ments and there is evidence that they actually increase anxiety initially (Masand and Gupta, 
1999; Spigset, 1999; Teicher et al., 1990). Based on our results, this initial increase in 
anxiety could be explained by the fact that SSRIs do not distinguish between the different 
serotonergic sub-systems in the Raphe nuclei, ultimately increasing 5-HT release in various 
regions, including the BLA. A way to circumvent these unwanted side effects would be the 
development of new, more selective, drugs capable of targeting specific 5-HT sub-systems 
while sparing others.  
We have provided evidence that help understand the complexity of the DR and MR 
serotonin system. Although challenging, such effort can aid the development of more ef-
fective pharmacotherapies for brain disorders involving anxiety, fear, and panic. However, 
follow up experiments are still needed to meet this challenging task. For instance, even 
though the DR and MR networks manipulated here were highly selective for 5-HT (92-
95%), one could argue what effects did these remnant fibers have on the behavioral and 
physiological parameters we tested. This question can be addressed with the aid of Cre-
expressing lines restricted to TPH and SERT neuronal populations in association with the 
intersectional genetics approach to virtually exclude off-target expression of ChR2. In vitro 
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experiments involving selective manipulation of the BLA and PeF 5-HT networks and 
electrophysiology dissecting the contribution of specific 5-HT receptors and possible co-
released neurotransmitters would also help advance the knowledge about the mechanisms 
underlying local cell activation/inhibition. Lastly, because the Raphe system has distinct 
molecular signatures (Calizo et al., 2011; Fernandez et al., 2015; Gaspar and Lillesaar, 
2012; Kiyasova et al., 2011), it would be of utmost importance to determine eventual idi-
osyncrasies of the BLA- and PeF-projecting serotonergic neurons. One way to achieve this 
is through specialized flow cytometry (fluorescence-activated cell sorting, or FACS), 
which provides a method for sorting a heterogeneous mixture of cells, one at a time, based 
upon the specific light scattering and fluorescent characteristics of each cell. As the field 
of individualized pharmacotherapy based on molecular profiling advances, identifying mo-
lecular signatures of the aforementioned 5-HT systems through FACS seems a viable op-
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